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Abstract
This thesis consists of three essays on information, decision-making and health. All three
concern the relationship between the choices consumers would make if they were "fully
informed" in an appropriate sense and the choices we actually observe.
Chapter 1 considers how we can determine whether consumers are appropriately taking
into account health information when they make their food consumption decisions. The
fundamental idea is to determine the value of a statistical life (VSL) implicit in food con-
sumption decisions and to compare this value with previous estimates of the VSL. The main
positive result is that the VSL estimated from food consumption is about 1/10th as large
as estimates from other contexts. I also consider the normative implications under the as-
sumption that VSL estimates from other contexts indicate how individuals would behave
if they were "fully informed" and discuss what additional evidence might support such an
assumption.
Chapter 2, co-authored with Jonathan Gruber, performs an analogous exercise in the
case of health care plans. Where Chapter 1 makes the normative assumption that consumers
should value years of life equally regardless of where they come from (e.g. eating healthier
foods or reducing risk of on-the-job death), Chapter 2 makes the normative assumption
that consumers should value a dollar of cost savings equivalently whether it comes through
premiums or out of pocket costs. This restriction can then be used to evaluate whether
consumers are choosing appropriately. The chapter studies this question in the context of
Medicare Part D Prescription Drug Plan, the most significant privatization of the delivery
of a public insurance benefit in recent history.
Chapter 3 attempts to consider the circumstances in which the partial equilibrium welfare
analyses performed in parts 1 and 2 extend to a general equilibrium setting in which prices
and product characteristics respond endogenously to changes in demand. In particular,
Chapter 3 derives conditions under which more information leads to welfare gains in general
equilibrium taking into account the endogenous response of firms' pricing and product quality
decisions.
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Title: Professor of Economics
Thesis Supervisor: Michael Greenstone
Title: 3M Professor of Environmental Economics
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Chapter 1
What Would We Eat if We Knew
More: The Implications of a
Large-Scale Change in Nutrition
Labeling
1.1 Introduction
The World Health Organization estimates that individuals in the developed world could
extend their life-span by a mean of 1.9-3.4 years through healthier dietary habits (World
Health Organization 2002). Valuing these life-years at $100, 000 (Gruber and Koszegi 2001),
this implies about a trillion dollars in life-years lost every year in the US alone by not
eating the healthiest possible diet.1 The aim of the paper is to determine the extent to
which providing more information about nutrition shifts individuals towards healthier diets
- and whether the response to this information, relative to the response to price changes,
0Thanks especially to my advisors Jon Gruber, Michael Greenstone, and Glenn Ellison, and to Karen Li
for outstanding research assistance. Thanks also to Hunt Alcott, David Autor, Peter Diamond, Tatyanan
Deryugina. Esther Duflo, Amy Finkelstein, Elena Harmon, Jerry Hausman, Panle Jia, Whitney Newey,
Amanda Pallais, Michael Powell, luliana Pascu, Mar Reguant, Steven Ryan, Ashley Swanson and Joseph
Shapiro for helpful comments and suggestions. Thanks also to lary Brandt and Tomoko Shimikawa for
assistance in obtaining data. Funding for this work was provided by NIA grant T32 AG000186-21.
iDetails of these calculations are described in the online appendices.
suggests that individuals are appropriately incorporating nutritional information into their
food consumption decisions. Does one trillion dollars a year represent the willingness to
pay for the taste and convenience of unhealthy foods, or does it represent gains that can be
realized through policies which lead to healthier eating?
I investigate these questions by studying perhaps the largest case of mandated information
provision in US history: the Nutrition Labeling and Education Act. This act mandated
nutrition labeling of all prepackaged foods in the US beginning in 1994. I present evidence
indicating that this law did impact consumption and develop a model of food demand as a
function of nutrient characteristics which allows me to generate revealed preference estimates
of its benefits. The model also allows me to evaluate the potential benefits from additional
information about nutrient content such as the recent law mandating calorie labeling in all
chain restaurants (Rosenbloom 2010). Finally, I compare the observed response to nutrient
information to a benchmark response computed from medical evidence and the value of a
statistical life (VSL).
The intuition is as follows: suppose we observe that consumers receive new information
about nutrient content and negatively update their beliefs about the health consequences of
cheeseburgers, but their consumption remains unchanged. If this occurs because they really
love cheeseburgers, they should also be unresponsive to prices. If we observe that consumers
readily substitute away from cheeseburgers when the price increases but not when they get
bad news about health consequences, then they must place a low value on health. We can
compare the implicit value of health to the VSL estimated from other choices and ask whether
consumer behavior appears consistent across settings. One can equivalently think of this
exercise as starting with the value of the health benefits of eating different foods and asking
what fraction of these benefits can be realized given the degree to which consumers already
incorporate health information into their consumption decisions and given the willingness
to substitute to foods which may be less desirable along other dimensions such as taste and
price.
An important motivation for this project is to bridge the gap between two competing
methodologies for analyzing policies which impact health. Many health policy analysts and
some economists compute the benefits of such policies in terms of life-years saved, but do
not consider whether consumers are made worse-off along other dimensions through substi-
tution to otherwise less desirable alternatives (see e.g. World Health Organization 2002 and
Variyam and Cawley 2006). Alternatively, many economists assume that individuals appre-
ciate the full cost of their food consumption decisions and focus only on the benefits of health
arising from externalities generated by the health insurance system (Bhattacharya and Sood
2006). My analysis follows O'Donoghue and Rabin (2006) and Gruber and Koszegi (2001)
in accounting for revealed preference data, but also attempting to account for "internalities"
from sub-optimal choices. While those analyses take a bottom-up approach to identifying
internalities via a particular mechanism, my approach provides a top-down picture which
connects directly with the health benefits of a particular policy by measuring the degree to
which consumers incorporate those health benefits into their consumption decisions. To the
extent that the VSL measured in other contexts reflects fully-informed and time-consistent
decisions, one can think of my analysis as a kind of omnibus test which detects internali-
ties generated by time inconsistent behavior as well as internalities generated by imperfect
information about the relationship between diet and health.2
The main results are as follows: the structural model I estimate implies that the NLEA
led to a reduction in calorie intake of 50-90 calories among label users. The model is identified
based on the fact that consumption of calorie-intense foods fell within product groups and
that calorie consumption fell most in those product groups which experienced the largest
increase in labeling. This result is consistent with (the lower end) of several reduced form
estimates identified by comparing calorie consumption among label users and non-label users,
and with earlier studies of the impact of labeling on consumption. When I examine the
response to particular nutrients, I find that the reduction in calories appears mainly to be
due to a reduction in fat intake. The welfare benefits estimated via revealed preference
imply that labeling led to a $25-40 annual gain, and that an additional gain of $40480
annually is possible with additional labeling. Reconsidering these benefits using benchmark
preferences computed from the VSL gives answers four times as large. Taking into account
2 O:Donoghue and Rabin (2006) note that the parameter # in their theoretical model could be interpreted
to incorporate other sources of consumer error besides hyperbolic discounting and they simulate the implica-
tions of the model for different values of ,. One can then think of this project as an attempt to operationalize
their framework by calibrating a model allowing for multiple 3*s to reflect multiple dimensions of nutrient
information.
the willingness to substitute to different foods and estimates of consumers current beliefs
about health information, I find that the potential annual welfare gain from fully informed
choices remains as high as 30-40% of the monetary value of the potential life-year gains from
the healthiest possible diet.
Section 1.2 describes a simple example to explain how the structural model identifies
the willingness to pay for each nutrient. Section 3.2 briefly reviews some related literature.
Section 1.4 describes the available data on labeling, food consumption and prices. Section
1.5 reports reduced form estimates documenting that the NLEA appears to have led to a
decrease in the consumption of high calorie foods relative to low calorie foods in product
groups where labeling increased. Section 1.6 introduces the model of labeling and food
demand, and reports estimates of the willingness to pay for nutrient content for several
nutrients. In Section 1.7, I perform several welfare exercises evaluating the impact of the
NLEA taking preferences as given, and in Section 1.8 I re-evaluate these gains given a
normative benchmark derived from expert medical knowledge and assumptions about the
value of additional life-years. Section 3.6 concludes.
1.2 A Simple Example
The main goal of this paper is to understand whether food consumption decisions adequately
incorporate health information. My focus will be on the consumer response to nutrient
information. I attempt to understand both how consumers respond to additional information
about nutrient content and how they would respond if they were fully aware of how experts
understand the relationship between nutrient content and health and behaved in a time-
consistent way. There are two reasons I focus on nutrient information: first, because this
explains a large amount of the variation in experts' assessment of the health consequences of
different foods (Martin, Beshears, Milkman, Bazerman, and Sutherland 2009) and second,
because I am able to use the nutrition labeling law as a source of variation to analyze the
impact of nutrient information on consumption.
I define the willingness to pay for nutrient content as the marginal rate of substitution
between nutrient content and prices. In this section, I present a. simple example to make
more transparent how I estimate the willingness to pay for nutrient content for a given
nutrient. When nested in a broader system of food demand equations, these willingness
to pay parameters allow me to compute the welfare gain from additional information about
nutrient content and can be compared to benchmark normative values to determine if welfare
gains exist from further informing consumers.
To identify the willingness to pay parameters, I ask the following question: what is the
change in consumption induced by a change in information about nutrient content, and what
is the magnitude of the change in price necessary to induce the same change in consumption?
Table 1.1 presents a fictional product group consisting of 4 salad dressings. Of these four,
three experience a change in labeling. Assume for now that consumer beliefs in all periods
are directly observable and that calories are the only nutrient. The variation necessary to
identify the parameters of interest is the ex post calorie content: after labeling, consumers
learn that Dressing 2 is healthier than they thought (fewer calories / gram), Dressing 3
is as healthy as they thought, and Dressing 4 is less healthy than they thought. Further,
there is a relative decline in the consumption of dressings for which individuals received
bad news (despite the overall increase in dressing consumption): when the relative change
in consumption of Dressings 2-4 is attributed entirely to the change in information, this
implies that an increase of 1 calorie / gram in caloric intensity leads to a 1 gram reduction
in consumption.
To move from this observation to an estimate of the willingness to pay for a reduction in
calorie content, the magnitude of this decline must be compared to the marginal impact of
price on consumption. Suppose that for each of the labeled products, O = -1 (where price
is measured in cents). That is, a $.01 increase in price/gram leads to a 1 gram reduction in
demand. Then a $.01 increase in price/gram has the same impact on consumption as a 1
calorie/gram increase in nutrient content. This implies a willingness to pay for a reduction
in calorie content of $.01 per calorie. Note that this identification method does not assume
unhealthy foods are less desirable in cross-section, or even that individuals are equally as
willing to substitute away from unhealthy foods as healthy foods. It may well be the case
that individuals prefer the taste of foods with undesirable nutrient profiles and that they are
less willing to give up these foods. To the extent that this is the case, the price elasticity for
such foods will be smaller, so for a given change in information, the same observed change
in consumption would translate into a larger willingness to pay for nutrient-content.
I assume in Table 1.1 that consumers' beliefs about calorie content are observable in all
periods. Throughout, I maintain the assumption that label users know exactly the content
of labeled foods. Below, I calibrate a model of beliefs about nutrient content for unlabeled
foods using data from other studies which directly elicited beliefs about the nutrient content
of unlabeled foods.
1.3 Literature Review
The theoretical literature examining the impact of information on health-related choices
stretches back many years (e.g. Grossman 1972); the empirical literature is newer but
growing. Alan Mathios and Pauline Ippolito conducted a series of studies in the early 1990s
investigating the impact of nutritional information on dietary behavior after the removal
of federal restrictions on health advertising. Ippolito and Mathios (1990) found that when
the government lifted a regulation prohibiting the advertising of health claims in the mid-
80s, consumption of high fiber cereals increase, and new cereal products higher in fiber were
introduced. Ippolito and Mathios (1995) examine time series data on fat consumption during
the same period and conclude that the removal of barriers to advertising on saturated fats
led to a reduction in saturated fat consumption. A few recent studies have investigated the
impact of calorie-labeling in restaurants: Elbel, Kersh, Brescoll, and Dixon (2009) collects
consumer receipts from low-income fast food restaurants in New York and find that while
consumers claim to use calorie information, there is no discernable impact of labeling on
consumption. Bollinger, Leslie, and Sorensen (2010) finds a modest 6% reduction in calorie
consumption at Starbucks after menus begin listing calorie information; calories consumed
of food products fell by 14% per serving, while there was no change in the consumption of
beverage products.
There is also a substantial literature outside of economics studying the impact of the
NLEA. Moorman (1996) conducted detailed surveys of shoppers in supermarkets just before
and just after the NLEA took effect to determine its impact on consumer information pro-
cessing. She found that after the passage of the NLEA, consumers were more informed about
the fat content of recently purchased products and spent more time comparing alternative
products within food groups, especially for unhealthy products. She did not directly ex-
amine how this knowledge impacted food consumption. Balasubramanian and Cole (2002)
also conduct in-store surveys, and they also find that post-NLEA consumers spend more
time shopping, but attribute this to the increased presence of nutrition claims other than
those appearing on the nutrition facts label. They find that after the passage of the NLEA,
consumption of foods labeled "low fat" or "low sodium" increased.
None of the existing studies of label use attempt to evaluate the normative benefits of
nutrition labeling via revealed preference. The three labeling studies most closely related
to the analysis in this paper are Mathios (2000), Variyam and Cawley (2006) and Variyam
(2008). Mathios (2000) studies the impact of the NLEA on the demand for salad dressings;
he finds that prior to the NLEA only the lowest-fat salad dressings voluntarily labeled,
and after the NLEA there was a significant decline in sales for the highest fat dressings.
Variyam and Cawley (2006) and Variyam (2008) compare label users and non-label users
using difference-in-difference methods to investigate the impact of the NLEA and label use on
nutrient consumption and obesity (measured using body-mass index). They find decreases
in obesity rates among non-hispanic white-women which they estimate leads to a $63 to $166
billion dollar reduction in life-years lost over a 10 year period.
The existing literature on nutrition labeling convincingly identifies the impact of labeling
on consumption in specific settings or for a limited range of products (Bollinger et al. 2010,
Mathios 2000, and Kiesel and Villas-Boas 2009). I extend this literature in three ways. First,
using food diary data, I evaluate how labeling of particular products impacts overall food
consumption given a model of satiation in which a reduction in the consumption of some
foods leads to an increase in the consumption of other foods; this addresses the concern in
earlier studies that a reduction in the consumption of labeled products may be offset by an
increase in the consumption of other products. Second, the NLEA provided disaggregated
information about the components of calorie-content from fats, proteins and carbohydrates,
and so can be used to analyze whether individuals responded differently to calories of different
sorts; e.g. whether consumers are more sensitive to calories from fats than to calories from
proteins. Such analysis is especially urgent in light of the fact that the recently passed
Patient Protection and Affordable Health Care Act includes provisions mandating that all
large chain-restaurants post total calorie information. Third, the existing literature focuses
on the positive impact of labeling on nutrient consumption and its potential impact on
obesity: none of the existing studies evaluate its normative impact via revealed preference.
The structural model I estimate allows me to consider the offsetting cost of being more
nutritious: individuals are consuming potentially less desirable foods all else equal, so the
potential health gains overstate the welfare increase from dietary changes.
The methodology in this paper relates to a broader literature in behavioral welfare eco-
nomics. The analysis here can be thought of as an attempt to operationalize the theoretical
framework developed in O'Donoghue and Rabin (2006) to analyze internalities in food con-
sumption decisions in the context of a richer model of nutrient information and food demand.
The method of determining a benchmark weight to attach to product characteristics based
on values derived from decisions in other contexts has previously been applied in Abaluck and
Gruber (2009) and Allcott and Wozny (2010). More generally, the analysis here is consistent
with the choice-theoretic framework developed by Bernheim and Rangel (2008) given a set
of assumptions about the welfare-relevant choice domain, 3 and directly follows the agenda
for behavioral welfare economics laid out by Beshears et al. (2008). I use a structural model
to infer how estimated preferences would vary with more contextual information; ultimately,
this model should be tested using data on how such contextual information impacts choices.
1.4 Data and Institutional Background
The Nutrition Labeling and Education Act was passed in 1991 and mandated the presence
of nutrition labeling on all prepackaged foods beginning in 1994. I analyze the impact of this
law on food consumption by combining labeling data from the FDA at the product group
3The relationship between the exact normative assumption I make above - that the VSL from other
contexts should be used to specify the normative-utility function - and the framework in Bernheim and
Rangel (2008) depends on the positive explanation for why VSLs differ across settings. If the VSL from
food consumption is low because consumers are imperfectly informed about the relationship between diet
and health, then my assumption maps naturally into that framework. If the measured VSL is low due to
self-control issues or due to a distrust of expert beliefs, then the relationship is potentially more complicated.
level, food diary data collected by the USDA and linked to information about individual
label use behavior, a cross-section of (national-average) prices at the product level from the
USDA, and price time-series at the product group level from the CPI.
1.4.1 Labeling Data
The standardized template mandated by the NLEA for nutrition labels is given in Figure
1-3. For a fixed serving size, the label reports the number of grams in a serving (or milliliters
for beverages), the number of grams of total fat, saturated fat, carbohydrates (with sugars
indicated when non-negligible), protein and fiber, and the number of milligrams of cholesterol
and sodium. The label also reports these values as a percentage of the FDA's recommended
daily value (RDV %). The label reports only RDV % for Vitamin A, Vitamin C, Calcium
and Iron. I focus the analysis below on the nutrients for which the label provides exact
quantities. Prior to the NLEA, any products which voluntarily reported nutritional infor-
mation were legally required to use the format shown in Figure 1-4. Several differences are
worth noting: the older label does not report the serving size in grams, it does not disag-
gregate fat into saturated fat or carbohydrates into sugar and fiber, and it does not report
cholesterol. It reports the RDV % for only a subset of nutrients, and it does not report
the total recommended intake for a 2,000 calorie diet or the number of calories per grain of
fats, carbohydrates and proteins. These differences are taken into account when I specify
consumers' information sets below.
The labeling data in this paper comes from two sources: the FDA's Food Labeling
and Package Survey (FLAPS) produces a biannual estimate of the proportion of products
labeled in 52 different product groups since 1979, and the Diet and Health Knowledge Survey
provides information about individual label use behavior. The NLEA mandated the labeling
of all prepackaged foods in the US, with a few exceptions for foods with negligible nutrient
content (seasonings and spices). The law did not cover freshly prepared foods such as fruits
and vegetables, or foods baked on site such as bakery products or restaurant products.
The FLAPS survey indicates that 61% of prepackaged foods contained nutrition labels in
1988 (measured as a proportion of total food expenditure), 66% were labeled when the law
was passed in 1991, and by 1995, 95% contained labels including all products mandated
to contain labels by the NLEA. There was also substantial variation across product groups
in the fraction of foods which were labeled prior to the NLEA. Figure 1-5 illustrates this
variation for a sample of product groups.
The labeling data from the DHKS indicates general label use behavior in 1989, 1994,
1995 and 1996 (e.g. use of nutritional information on the label, Often, Sometimes, Rarely,
Never), and elicits nutrient specific label-use information in 1990, 1991, 1994, 1995 and
1996 (e.g. use of calorie / saturated fat / fiber information on the label, Often, Sometimes,
Rarely, Never). Table 1.2 reports the proportion of female DHKS respondents in the age
range I consider who report using the nutrition facts panel "Often" or "Sometimes" in each
year the question was asked, as well as the proportion who report using the nutrition facts
panel to examine the content of a particular nutrient "Often" or "Sometimes" in each year
the question was asked. The proportion who report using the panel at all remains roughly
constant at 75%. The most commonly used information concerned calorie content and total
fats; the proportion reporting use of calorie content increased from 70% to 80% over the
period of the sample, and the proportion reporting use of total fats increased from 75% prior
to the NLEA to 80% in the years following the NLEA.
1.4.2 Food Consumption Data
The food consumption data comes from the Continuing Survey of Food Intake by Individuals
(CSFII), the most complete data source recording individual dietary intake prior to 1999.
The CSFII is linked to the Diet and Health Knowledge Survey (DHKS), which elicited
information from CSFII respondents on their stated dietary goals and their understanding
of the nutritional content and consequences of different dietary behaviors.
The CSFII is a repeated cross-section; food consumption data was collected in 1985,
1986, 1989, 1990, 1991, 1994, 1995 and 1996 for a total of 36,895 respondents. In each year,
the first day of data, was elicited through an in-person interview in which the interviewer
assisted the household member in developing accurate measurements of the quantity of food
consumed. In subsequent days, the information comes from a food diary completed by the
respondent. Data from both types of surveys are used in the analysis; I check that the main
results are unaffected if I restrict to the first day of data in Appendix A.4.
There are 6400 unique food codes across all years. The level of aggregation extends to
detailed generic descriptions of foods, but not to particular brands. A typical food name is
"Fruit Punch Flavored Drink Powder". The database was designed so that foods would be
coded separately if their nutrient content was distinctly different (e.g. there is a separate
entry for "Low Calorie Fruit Punch Flavored Drink Powder"). For each individual, several
days of consumption are reported spaced throughout the year. For each day of data, all
foods consumed were reported along with the quantity of the food consumed, the place and
time when it was consumed, how the food was prepared, where it was purchased, and which
other household members were around when the food was consumed. The data on where
it was purchased is especially important, since this allows me to distinguish between foods
purchased in a given product group at a supermarket (which might be labeled) and foods
purchased at a restaurant (which would not be labeled).
The CSFII provides several advantages over alternative data sources in analyzing the
impact of nutrition labeling: first, unlike data from individual retail establishments, it at-
tempts to give a complete record of food consumption for each individual so it is possible to
study the impact of labeling on overall nutrient consumption and to understand how different
substitution patterns would impact overall nutrient consumption. Second, it provides data
on a representative sample of the US population. Third, it is conducted during the period
when the NLEA was passed and implemented, so it is the only data source available which
can be used to study the long-term impact of a large-scale change in nutrition labeling on
food consumption.
Food diary data is known to understate total food consumption; I discuss earlier studies
documenting the extent of this bias and several steps to investigate the robustness of the
results to this bias in the Appendix A.4.
1.4.3 Price Data
The price data I employ comes from two sources: first, from the USDA, I have a cross-section
of prices for almost all foods in the CSFII database in 2003. Unfortunately, this information
was not collected during the sample period I study. To remedy this, I use CPI price series
available for 24 of the 53 product groups to deflate the 2003 prices, and I deflate the remaining
prices using a general food price index. Because it is difficult to find credible instruments
for prices, I impute price elasticities from existing studies. All prices are expressed in 1990
dollars.
1.4.4 Sample Selection
I noted above that the full CSFII sample includes 36,895 respondents. This number in-
cludes both the main survey which was designed to give a representative sample of the US
population in each year, and a separate sample which was collected prior to 1994 for only
low income individuals. To avoid the complications associated with weighting the data, I
drop all individuals from the separate low income sample. This leaves 28,965 respondents.
The included demographic groups and the number of days of food diary data elicited also
varied across years. The primary sample I use in the below analysis is the largest consistent
demographic that can be constructed from 1985-1996; this includes two days of records for
all women aged 19-50. This sample consists of 7,298 distinct individuals. The longer sample
period allows for the inclusion of product-specific linear time-trends which absorb most of
the variation if the shorter 1989-1996 window is used. The diet and health knowledge sur-
vey which is linked to the CSFII was completed only by individuals identified as the "main
meal planner" in each household. Of the 7,298 women in the final sample, 6,436 - 88% -
are identified as the main meal planner. These individuals form the primary sample used in
the analysis which makes use of individual-level label use information. Additional details of
sample creation are described in the online appendices.
1.5 Reduced Form Evidence
In this section, I present some reduced form evidence indicating that the NLEA led to a
reduction in consumption of high-calorie foods relative to low-calorie foods. As discussed
in Section 1.2, this variation - when combined with assumptions about prior information
and price elasticities - can be used to identify the willingness to pay for a change in calorie
content.
I aggregate the data, to the product-year level and ask: does consumption of products
with more calories/gram decline relative to products with fewer calories/gram when the
proportion of products labeled in a product group increases? Because the proportion of
products labeled may respond endogenously to demand, I also consider specifications in
which I instrument for this proportion to isolate the variation induced by the NLEA. I begin
by estimating the equation:
Ct = /xjL,(j)t + dj + dt + et (1.1)
where Ct gives the average per capita calories of product j consumed at time t, x gives
the calories per gram of product j, Lg(j)t gives the proportion of products labeled in product
group g (to which j belongs) at time t, and dj and dt denote product and time fixed effects
respectively. A separate instrument is constructed for each product group; these instruments
are constructed by interacting xj with a dummy variable which is 1 in product group g after
the NLEA and 0 otherwise. I estimate models using both Cjt and ln(Cjt) as the dependent
variable.
The results are reported in Table 1.4. In all cases, the OLS and IV results are quite similar
due to the fact that a large portion of the variation in labeling in the data is captured by
comparing the pre- and post-NLEA periods. The coefficient in the linear models can be
interpreted as the decline in consumption associated with an increase in caloric content of
1 calorie/gram when a product goes from unlabeled to labeled (or more precisely, when the
proportion of products labeled in the product group in question goes from 0% to 100%).
Note that 1 calorie / gram is a large increase; the mean food in the data has 2 calories /
gram. To think about identification, it will be helpful to keep in mind a simple example
with two product groups, A and B, in which all of the foods in product group A have more
calories per gram than the foods in product group B.
The first specification includes only product and time fixed effects, so the coefficient of
interest is identified based on whether consumption of high calorie foods declined relative to
low calorie foods regardless of whether they are in the same product group; if consumption in
product group A declines relative to product group B, this will lead us to estimate a negative
coefficient. This specification implies that an increase of 1 calorie/gram is associated with a
consumption decline of .09 calories (average consumption is 1 calorie; it is so small because
most foods are not consumed by the vast majority of consumers). In the second specification,
additional fixed effects are added for each group-year. This absorbs all across group variation,
so the coefficient is identified by relative changes in the consumption of high and low calorie
foods within product groups; a negative coefficient implies that individuals substituted away
from the highest calorie foods within group A towards the lower calorie foods in that group
(and the same for group B). The coefficient in this model is larger; it implies that an increase
of 1 calorie/gram is associated with a relative decline in consumption of .13 calories when
labeling changes. In the third specification, I include separate linear time trends for each
product. The results in the first and second specifications are consistent with a story in which
consumers develop a taste for low calorie foods over time in precisely those product groups
where labeling is initially less common (which might occur because ex ante labeling is less
common among less healthy product groups). The third specification shows that controlling
for such time trends makes the coefficient even larger: 1 calorie/gram is associated with a
.22 calorie decline in consumption.
The second panel in Table 1.4 reports the same three specifications using the log of
calories as the dependent variable. The coefficient in the log models expresses the change in
consumption associated with an increase in caloric content of 1 calorie/gram when labeling
changes in percentage terms. The log models imply that each increase of 1 calorie/gram
is associated with a decline from 4-39% depending on the specification. As above, the
magnitude of the coefficient grows larger when we include group-year fixed effects, and
larger still when we include product specific linear time trends. The last three specifications
in the second panel rerun the linear specifications using only foods not covered by the NLEA
as a falsification test. In all cases, the coefficient of interest is insignificantly different from
zero or positive, which is consistent with a story in which labeling induced some substitution
within product groups towards unlabeled foods.
Figure 1-6 replaces the independent variable with variables interacting the quintile of
calories / gram with the proportion of products labeled and graphs the resulting coefficient
in the linear model with group-year fixed effects. The figure suggests that labeling induced
substitution throughout the distribution of calorie intensity, with consumption declining
more for higher calorie foods.
In the next section, I develop a structural model which links these results to earlier studies
of the impact of labeling on total calorie intake by explicitly modeling substitution across
foods due to satiation. The structural model will also make explicit how labeling impacts
consumers' information sets allowing us to determine which foods are likely to be most
impacted by labeling and to separately identify the impact of information provided about
different nutrients (the results reported so far could be due to the impact of information
about calories or information about other nutrients correlated with calories). Finally, the
structural model will specify consumers' prior information about nutrient content which will
allow us to determine how much consumption changes in response to new information and,
via a comparison to price elasticities, how much consumers are willing to pay for a change
in nutrient content.
1.6 Nutrition Labeling and the Willingness to Pay for
Nutrient Content
In this section, I develop a model of food demand which allows me to evaluate via revealed
preference the welfare gains from information provision and ultimately, to assess quanti-
tatively the magnitude of the response to information relative to that implied by expert
medical knowledge combined with assumptions about the value of a statistical life.
The intuition behind the model is laid out in Section 1.2. The main idea is to capture
how information about nutrient content impacts dietary choices relative to prices when
consumers optimally choose their daily diets given their tastes for different food products, the
relative prices of products, and the fact that there are diminishing returns to individual foods
and overall satiation. I begin by laying out the formal model and deriving the estimating
equation. Next, I specify the assumptions made about consumers' information sets. I then
present estimates of the willingness to pay parameters. The meaning of these estimates in
explored in the remainder of the paper by examining their welfare consequences.
1.6.1 Food Demand Equations
Let Nt denote the number of grams of product j consumed by individual i at time t. The
utility of individual i of consuming diet di = {Ngi, ..., Nn } is given by:
Uit ZY(' +Pjt±+ C) (K + N g )O
+ 3 an((Xin) ( N + $In (1.2)
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where yj, pj, gijt parametrize individual i's taste for food at time t, ry determines the elasticity
of demand for food j, Eigt(xnj) gives the expected content of nutrient n in 100 grams of
product j at time t as a function of the actual nutrient content Xnr (so j NigEij(Xnj)
gives total expected consumption of nutrient n), and it gives individual i's income at time t.
Xin gives average consumption of nutrient n for consumer i, computed by averaging over all
reported days of consumption in the data. In the models reported in the main text, I assume
that an(Xin) = an - max(Xin - Xin, Xin - Xin, 0) where Xi, and Xin are known constants so
that the function mapping nutrient content to utility is piecewise linear as discussed below.
Note that in the model the actual nutrient content of a product j is fixed and does not
change over time; as noted above, this is part of the definition of a product. Individuals
have a well-defined maximization problem because they are aware of the number of grams
of each product that they consume (or equivalently, the number of servings of 100 grams),
but they may be uncertain about the nutrient content in each gram.
The key parameters of interest are the marginal utilities of nutrient consumption an
(and in particular, an/4, the marginal utility normalized by the marginal utility of income
so that it is expressed in dollar terms). The model in principal allows the willingness to pay
for nutrient content to vary with current total nutrient intake Xnu. The results reported
in the text allow an to vary in a piecewise linear way depending on where current nutrient
consumption falls relative to the FDA recommendation for someone of my age, gender and
activity level (so for example, I have a willingness to pay to avoid sodium if I currently
consume more than 2300 mg a day, but I am indifferent to sodium on the margin if my total
intake is below that amount). There is some qualitative evidence from the DHKS that the
marginal value of nutrients at least has the same sign for most individuals. When asked
whether they consume "too much", "too little" or "about the right amount" of a series of
nutrients "compared to what is healthy", the vast majority of respondents indicate that
they consume either the right amount or too much calories, fats, saturated fats, sodium and
cholesterol, and either the right amount or too little fiber and protein.4 Table 1.3 gives the
exact percentages.
Individuals maximize this subject to two constraints. First, the usual budget constraint:
pjtNigt + I, 5 W (1.3)
where pjt is the price of product j at time t and Wi is wealth. And second, I assume that
individuals always consume a constant weight of food in each day in expectation:
Ei3 (Nig) < Ni (1.4)
3
The second constraint addresses a worry in many earlier studies of food labeling that if
individuals consume less of some foods because they are labeled, they will just substitute
to other foods (Bollinger et al. 2010). It is motivated by a stylized fact in the literature
on consumer satiation: individuals tend to consume a constant weight of food (Rolls 2009);
when given a pre-load consisting of a certain number of grams, they reduce their consumption
later in the day by this number. The main consequence of this constraint in the model is
that the impact of any shift in consumption on overall nutrient intake will be muted, since
any decline in the grams consumed in some product groups must be offset by an increase in
other product groups. The expectation in this equation is taken over the unobserved taste
parameters eijt; this capture the fact that the satiation constraint is not binding every single
day. It is binding in expectation so that on average grams consumed do not change, but
there may be fluctuations from day to day in the number of grams consumed.
4 ro the extent that consumers care about nutrients for reasons other than health, this question may be
insufficient to determine the sign of the marginal value. For example, if consumers believe their physical
appearance would be improved by consuming more calories, they may desire consuming more calories on the
margin even if they believe that doing so would be harmful to their health. I consider such concerns in more
detail in Section 1.8.2.
An important simplifying assumption of the model is that substitution between foods
occurs only through this satiation constraint. The available data is unsuited to the estimation
of own and cross-price elasticities because I do not have exogenous pricing variation and
because the information on how prices changed over time is only available at the product
group level.5 Instead, own-price elasticities are imputed for each product group from existing
estimates through a procedure described in more detail below. In Appendix A.4, I confirm
that the main results are not impacted if we allow for somewhat richer substitution patterns
by allowing demand to vary with the number of low-fat substitutes in the same product
group.
Because calories are a linear combination of fats, carbohydrates and proteins, I consider
models with total calories included along with cholesterol and sodium, and with calories
disaggregated into saturated fats, unsaturated fats, protein, (non-fiber) carbohydrates and
fiber. Because the coefficients in the latter specification do not scale proportionately with
their contribution to total calories, the model with aggregated calories cannot be exactly
correct. There is no single willingness to pay for a change in calorie content; the willingness
to pay for a change in calories depends on the underlying change in nutrients which results
in the change in calories. Nonetheless, we can think of the estimated coefficient on calories
as the willingness to pay for a change in calories if the proportion of the change in calories
due to each of the underlying nutrients is identical to the variation caused by the NLEA. #
gives the marginal utility of income, so an/# gives the dollar willingness to play for a unit
of nutrient n.
Let O6jt = pit + #pit - En anEit (Xn) where pit is the multiplier on the food amount
constraint and yijt = yj + pjt + vij + cijt. We can rearrange the first order condition to give:
Nijt = max{0, - K} (1.5)
5Cross-price elasticities could in principle also be estimated from the changes in demand induced by
labeling, but the estimated changes are too small to obtain estimates with any precision; the exercise is
also made more difficult by the fact that labeling data is only available at the product group level, not the
individual price level.
1.6.2 Estimation
Let Yg - K. We can think of this as the latent demand for each good - if Yig < 0
consumers will not consume any of product j, and if Yip > 0, they will consume exactly Ypt
grams. To make estimation of the model tractable, I Taylor-expend about zo, the vector of
parameter values in the first year when consumption is observed. Note that Yijt depends on
the characteristics of other products k # j only through total consumption which is captured
by the pit term. Thus, because we are controlling for changes in pi, Yit depends only on
the characteristics of product j. In Appendix A.3, I show that Taylor-expanding about zo
gives:
Yip wio -p + ( an( Xin) Eg (xnj) + tij + S + dl ij + egg (1.6)
where wijo -- ooK+Yijo, jg and j are constants for each product and eig is an error term
Oijo
which is independent of the included regressors. In Appendix A.3, I show that we can
also express the weighting term as a function of observable prices and quantities: wijt =
nyt ENjt . Plugging this back into equation (1.6), gives:
Yip ~ nijo jo0 ) p + I at(Xin)Eig(xnj) + tfi + Ij + dpiu + eig (1.7)
OpionI
The scaling factor: jo E(NjoINijo>O) accounts for the fact that a change in nutrient content
per gram is expected to result in a larger change in consumption for those products where
consumption is more elastic (larger qjo) and where a larger number of grams are consumed per
serving (larger E(NgjoiNijo > 0)). I assume that elasticities are constant across individuals
within product groups so that lijo = io (in other words, I am assuming that observed price
elasticities do not vary systematically with label use behavior, or with the total quantity
of food consumed). The price elasticities for each product group are imputed based on the
mean estimates from a recent survey article of price elasticity estimates, Andreyeva, Long,
and Brownell (2010). For 33 of the 52 product group, no existing studies estimated a group-
specific price-elasticity, so the average elasticity was used (the mean elasticity for all groups
ranged from 0.34-0.79, with an interquartile range of .50-.75).6 I compute E(NjjoINjjo > 0)
in the data by dividing the population into ten cells based on deciles of total grams consumed
and computing the average serving size for each food in each of those cells.
The full model is thus given by:
Nijt = max{0,Yij} (1.8)
where Yit is given by equation (1.7). In Appendix A.3, I describe distributional assumptions
on the primitives of the model so that eijt is normally distributed.7 In this analysis, each
individual-food is a separate observation. Foods which were not covered by the regulations
in the NLEA as well as the bottom 5% of foods by total expenditure are included as an
aggregated outside good.
I construct the set of instruments as the interaction of product-specific fixed effects with
a dummy which is 1 after the NLEA and 0 prior to the NLEA. I estimate the model using the
Smith-Blundell procedure (Wooldridge 2002, p. 530-533) which involves using the residuals
from the first-stage regression as a control-function and correcting the standard errors for
the variance in the first-stage estimates.
The inclusion of fixed effects raises a computational issue due to the large number of pa-
rameters as well as a conceptual issue due to the incidental parameters problem. The models
reported in the main text treat pit as a random effect to avoid the incidental parameters
problem; this assumption is problematic because it leads the error term of observation ijt
to be correlated with the included variables of observation ikt for all k via pt. In Appendix
A.4, I attempt to remedy this problem by estimating the full set of fixed effects using the
computationally efficient procedure described in Greene (2001). While this procedure does
6There is theoretical and empirical reason to believe that to the extent that identification is problematic,
price elasticity estimates will be biased towards 0. The price elasticities reported in Chevalier, Kashyap,
and Rossi (2003) for a limited number of foods using a plausibly exogenous instrument are 4-5 times larger
than the price elasticities reported in Andreyeva et al. (2010). To the extent that the elasticities used in the
model are biased downward, the willingness to pay parameters will be biased upward. Thus, using only the
best identified elasticity parameters would only strengthen the conclusion that this willingness to pay is too
low.
7The usual semiparametric estimators for censored regression models do not apply in this ca-se because
most foods are not consumed by the vast majority of consumers (Chay and Powell 2001). For example, the
CLAD estimator would immediately trim all observations.
generate bias due to the incidental parameters problem, the agreement between these results
and the results reported in the main text suggests that the bias is not too severe. This agrees
with the simulation evidence presented in Greene (2004), which suggests that the bias in the
estimation of slope parameters in Tobit models from the inclusion of many fixed effects is
less severe than the bias in binary choice models.
1.6.3 Specification of Eijt(x,) and Identification of a,
The willingness to pay for nutrient content o,, is identified using variation in perceived
nutritional characteristics generated by nutrition labeling. In this section, I discuss the
specification of Eijt(xng), individual i's perceived content of nutrient n in 1 grams of product
j at time t as a function of the actual content zn3 .
The key issue in the identification of the willingness to pay parameters is the degree to
which beliefs about nutrient content in the absence of labels track actual nutrient content
within product groups. Recall the example discussed in Section 1.2. In that hypothetical
example, we observed in the data that consumption declined for foods with more calories
per gram after a change in labeling. The results reported in Section 1.5 show that we
observe this in the actual data as well. This observation needs to be combined with data
on the change in beliefs about nutrient content to compute the elasticity of consumption
with respect to a change in information (that elasticity normalized by price elasticities gives
the willingness to pay for a change in nutrient content). If consumers had very accurate
beliefs about nutrient content prior to the labeling law, then we would conclude that a small
change in information led to the observed change in consumption which would imply a large
willingness to pay; conversely, if consumers had inaccurate beliefs, then we would conclude
that a large change in information led to the observed change in consumption which would
imply a small willingness to pay.
Formally, I assume that the beliefs of non-label users and the beliefs of label users for
unlabeled products can be written as an additive function of the average belief about nutrient
content within product groups, the degree to which beliefs track actual nutrient content
within product groups, and an idiosyncratic noise term. That is, for non-label users or
unlabeled products:
Eig (xnj) = Eg(xnj) + ag(xnj - Eg(Xnj)) + rij (1.9)
The crucial issue in the identification of the willingness to pay parameters is the speci-
fication of the parameter ag: this determines the degree to which consumers beliefs about
nutrient content within product groups track the truth. I assume that label users (identi-
fied as individuals who "always" or "often" use nutrition labels) know the exact nutritional
content of labeled foods. Ignoring the idiosyncratic error term, the change in information
following a change in labeling is given by:
Xnj - Eig (xnj) = (1 - agn)(xnj - Eg(xnj)) (1.10)
As agn -+ 1, consumers are fully informed about nutrient content prior to labeling, the
change in information goes to 0, so the measured elasticity of consumption with respect to
a change in information goes to infinity given the observed change in consumption.
Unfortunately, group-specific estimates of agn are not currently available, and for many
nutrients, no estimates exist at all. In Appendix A.2, I estimate ag based on a survey
of consumers in Starbucks where consumers were explicitly asked their beliefs about the
calorie content of food and drinks products they just purchased. In the estimates currently
reported, I use the value agn = 0.2 calibrated from the Starbucks data for all product groups
and nutrients; this reflects the fact that consumers have a very limited ability to distinguish
the calorie content of food and drink products at Starbucks prior to labeling. In on-going
work, I attempt to obtain separate estimates of agn for different product groups and nutrients
via additional surveys. 8
8 One particular worry is that agn might vary across product groups systematically depending on the
proportion of products already labeled. For example, if the proportion of products labeled goes from 0% to
40%, then consumers may learn something about the nutrient content of currently unlabeled foods. Such
contextual inferences would be unproblematic for the identification of the a, parameters if they affected
only the overall systematic bias in beliefs about unlabeled foods (Eg(xny)), but they would be problematic
if more labeling lead to improved discernment of the differences between unlabeled foods. For example, if
a product group contains both yogurt and cream cheese, one might worry that labeling of some yogurt and
some cream cheese product informs people more generally about the nutrient content of unlabeled yogurt and
cream cheese products (making agn larger in those groups). To investigate this issue, I define sub-product
groups based on the first two characters of the food code identifier and consider a specification with separate
An important point to note is that the welfare benefits of the NLEA taking preferences
as given do not depend on the parameter a9 n- The welfare benefits depend only on the
elasticity of demand, the observed change in consumption and the degree of heterogeneity
in information across individuals; the specification of prior information determines whether
these benefits arise because consumers care a lot about nutrient content given a small change
in information or whether consumers care just a little about nutrient content given a large
change in information. The latter question is of interest here because we want to compare
the implicit value of health in food consumption decisions with the value of health estimated
in other contexts.
The specification of Eg(xj) does not impact the willingness to pay estimates directly due
to the presence of product group level fixed effects, but it does impact the model's projections
for the impact of labeling on consumption and the welfare analysis. In the specifications
reported in the main text, Eg(x,j) is estimated using dummy variables for each product
group x label status x pre/post NLEA. This value is identified based on differential changes
in the consumption of foods which experienced a change in labeling compared to those which
did not.
1.6.4 Estimates of the Willingness to Pay for Nutrient Content
In this subsection, I report estimates of the willingness to pay for nutrient content. The
main results are that I estimate a small but significant willingness to pay to avoid calories
which appears to be due mostly to a willingness to pay to avoid fat; without more data on
beliefs prior to the NLEA we cannot determine whether this is due to avoidance of saturated
fat or unsaturated fat.
Before discussing the actual results, let us consider a back of the envelope calculation
to see what the results discussed so far imply about the willingness to pay for a change
in calorie content. The reduced form results suggest that a difference in actual nutrient
content of 1 calorie/gram leads to a decline in consumption of 0.2 calories or about 20%
year specific fixed effects for each sub-product group. In this specification, reported in Appendix A.4, the
willingness to pay parameters are identified only via within sub-group estimation. and the results do not
qualitatively differ from the specification in the main text.
when a product group goes from having no labels to having all foods labeled (1 calorie is the
average consumption since most foods in the data are not consumed by the vast majority
of consumers). The average price elasticity in the data is close to 0.5, so a 20% reduction
in demand would be induced by a 40% increase in price. The average price of a gram of
food in 1988 dollars is about 0.2 cents,9 so a 40% increase in price corresponds to about
.08 cents/gram. Given ag = 0.2, when two foods differ by 1 calorie/gram in actual nutrient
content, consumers will update their beliefs about this difference by 0.8 calories/gram after
labeling. So if consumers respond to a change in information of 0.8 calories per gram the
same way they respond to a price increase of .08 cents/gram, this implies a willingness to
pay for a change in calorie content of about 0.1 cents/calorie.
Table 1.5 reports the estimates from the Tobit model described in equations (1.7) and
(1.8). All of the models include fixed effects for each product as well as dummies for each
(product group x year) and product-specific linear time trends. The reported models assume
that the healthiest foods label within product groups when the proportion labeled is less than
100%. I assume further that ag9 in equation (1.10) is equal to 0.2, and I estimate Eg(x,,)
(the average prior for each product group) by comparing the change in consumption for
foods which experience a change in labeling to foods which experience no change. Finally,
I instrument for perceived nutrient content with group-specific instruments constructed by
interacting group fixed effects with a post-NLEA dummy variable.
Model 1 from Table 1.5 reports estimates of the coefficients on calories, cholesterol and
sodium. The coefficient on calories implies willingness to pay of 12 hundredths of a cent per
calorie, very close to the value implied by the back of the envelope calculation above. In other
words, when individuals learn that a food product has 100 more calories than they previously
thought, their consumption decisions are impacted in the same way as an 12 cent increase in
price. The model also estimates a marginally significant willingness to pay to avoid sodium.
Model 2 disaggregates calories into total fats, protein, non-fiber carbohydrates, and fiber.
This coefficient on total fats is large and significant, implying a willingness to pay of 67
hundredths of a cent per gram of fat and 52 hundredths of a cent per gram of carbohydrates.
9 Annual per capita expenditures in 1988 are about $2000 according to the USDA, which translates to
about $5.50 / day for 2500 grams or about $.002 per gram, consistent with the price data used.
The point estimates also imply a negative willingness to pay for protein and a positive
willingness to pay for fiber; these estimates are not significantly different from zero, but
the standard errors are large. Note that a negative coefficient on proteins is not necessarily
anomalous: if individuals are calorie conscious and use nutrition labels to avoid high-calorie
foods, this would tend to produce a negative coefficient on proteins, carbohydrates and fiber
even if individuals ignored information specifically about those nutrients.
Models 3 and 4 further disaggregate total fats into unsaturated fats and saturated fats.
There is some uncertainty regarding the appropriate specification of this model since only
total fats were listed on nutrition labels prior to the NLEA. It is therefore unclear what
information - if any - we should assume label users possessed about the content of saturated
or unsaturated fats in labeled foods prior to the NLEA. Model 3 assumes that the content of
unsaturated and saturated fats was unknown even for labeled products prior to the NLEA
while Model 4 assumes that both types of fat content were exactly known prior to the NLEA.
The estimates in Model 3 imply that the willingness to pay to avoid fats comes mainly from
unsaturated fats; the estimates in Model 4 implies that it comes from saturated fats, although
the standard errors are larger. The results suggest that labeling lead to a reduction in fat
consumption, but lacking information on consumers' beliefs regarding the specific content
of unsaturated and saturated fats in labeled foods prior to the NLEA, we cannot determine
whether this arose through avoidance of saturated or unsaturated fats.
I report a number of additional specifications as robustness checks in Appendix A.4. The
main takeaway from these results is that structural model implies fairly small willingnesses to
pay for nutrient information despite the fact that labeling appears to have had non-neglible
impact on consumption.
1.7 Welfare Taking Preferences as Given
The results reported so far suggest that labeling did impact calorie consumption, but that
the magnitude of the response to information about nutrient content can only be consistent
with the medical evidence (given usual estimates of the VSL) if individuals have information
from other sources which allows them to evaluate the health consequences of different diets.
In this section, I use the estimated model to evaluate the welfare consequences of these claims
taking estimated preferences as given. I ask what the estimated parameters imply about the
partial equilibrium welfare gain from the NLEA and about the potential welfare gain from
additional labeling regulations which would require mandatory labeling in restaurants and
of fresh meats and vegetables. This exercise is of interest in its own right, and in the next
section, it will serve as a baseline to which we can compare the results of the behavioral
model which asks what these welfare benefits would be if consumers were fully informed.
As noted in section 1.6.3, the welfare benefits computed in this section do not depend
on the specification of prior information. The welfare benefits depend only on the elasticity
of demand and the observed change in consumption; the specification of prior information
determines whether these benefits arise because consumers care a lot about nutrient content
given a small change in information or whether consumers care just a little about nutrient
content given a large change in information.10
1.7.1 Welfare Impact of the NLEA Taking Preferences as Given
The impact of labeling on welfare is most transparent if we consider a generalized price,
P> = + pm - En Eix) This is the marginal cost of consumption in the structural
model above (normalized by the marginal utility of money). The cost of an additional gram
of product j depends on pjt, the actual price, , the cost of foregone satiation in dollar
terms, and E g Eig(Xni), the cost of consuming the nutrients in that gram (for foods with
desirable nutrients, this could be positive, reducing the generalized price). When foods are
not labeled, individuals act as if they face a generalized price Pit which is different from the
actual price Pjt obtained by substituting in the true nutrient content xzj for the perceived
nutrient content (ignore for the moment the fact that labeling also impacts the multiplier
pi). If labeling conveys good news, individuals will underconsume prior to labeling, and if
labeling conveys bad news, individuals will overconsume prior to labeling. The lost consumer
surplus is given by the area between the true generalized price if nutrient content were known
10 oo the extent that the change in consumption cannot be separately estimated for each individual, the
specification of prior information would impact the welfare calculation insofar as it is used to infer the degree
to which the observed aggregate change in consumption varies across individuals: this point is discussed
further below.
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Figure 1-1: N(P) gives the demand curve for a sample product j as a function of the
generalized price P. P gives the apparent price prior to nutrition labeling and P* gives
the price after nutrition labeling which is also the appropriate normative benchmark in this
section. The shaded region gives the welfare gain from labeling for this product: individuals
receive bad news about the nutrient content so the welfare gain comes from realizing that
the marginal cost of consumption P* is higher than they thought absent labeling.
P3 and the demand curve as shown in Figure 1-1. The total change in consumer surplus is
computed by summing across all products.
The welfare benefits computed in this section are a lower bound on the partial equilibrium
consumer surplus because the current calculation ignores heterogeneity across individuals in
prior information for a given food; that is, even if we observe no change in aggregate demand
for a given food in response to labeling, this may mask the fact that some individuals received
bad news and consumed less while others received good news and consumed more. Future
drafts will take this factor into account as well by calibrating the degree of heterogeneity
across individuals from survey evidence.
I will start by considering a. simplified model with a linear demand curve to make the
analysis in this section more transparent; that is, assume that Nij = aij - bijPi. I will
then repeat the analysis in the full structural model developed above. In the case of a.
linear demand curve, the welfare gain from labeling for a given product is given by: Wij
|ANj||AP| = JlbjI|(APg)2. Consider the simplest possible case in which only information
about calorie content changes (so in particular, ignore any changes in information about
other nutrients, changes in the multiplier, or changes in monetary price). In this case,
APij = gAcij where Acij denotes the change in calorie content per gram. So in the
simplest possible case, the welfare gain from labeling is given by:
AW = ) an |b (Ac,) 2  (1.11)
In other words, the gain from labeling is proportional to the square of the price of a
calorie (the previously estimated 7 hundredths of a cent) and the sum of squared deviations of
perceived calories / gram from actual calories per gram weighted by the price responsiveness
of each good (note that bij will tend to scale with the quantity of a food consumed, since the
responsiveness of grams consumed to price per gram will be larger for foods with a larger
serving size). In the more general case in which all nutrients are taken into account and in
which the multiplier adjusts as well in response to labeling, APi = n - Ax,. This
yields:
AW= IbjI( A i an Axz)2 (1.12)
The demand curve in the structural model is not a linear function of prices. I show in
the online appendices that the welfare gain from labeling in this model is given by:
AW = (CS(a) - N (p,* - i)) (1.13)
where CS(a) = (<D(a)a 2 + <b(a) - <(a)a), and pj5 as the price at which consumption
given full information would equal consumption when labels are not present, Nii gives con-
sumption in the world where labels are not present, Yg gives the predicted value of the latent
variable in that world, and i = Yig/oj.
Table 1.6 gives the results of this analysis. In each year, I compute the welfare gain
from all of the labeling which has occurred since 1985 in Model 1 (with calories, sodium and
cholesterol). In the years following the NLEA, labeling leads to a welfare gain of $0.07-$0.11
per day, or about $28-$40 annually in the structural model and about $50-$60 annually in
the linear model. The table also decomposes the welfare benefits into the direct benefits -
the benefits from foods which experienced a change in labeling - and the indirect benefits
from foods which experienced no change in labeling but for which consumption changed due
to substitution. About 5% of the estimated welfare benefits come from the latter type of
foods.
The FDA estimated the total cost of NLEA implementation to be between 1.4 billion
and 2.3 billion dollars (Food and Administration 1993). Industry estimates were slightly
higher; the National Food Processors Association estimated compliance costs from 3.3-4
billion dollars (Van Wagner 1992)." Taking just the sample population studied in this paper
- females aged 19-50 - implies 46.2 million label users in 1993 (62 million women times 75%
who use labels), which in turn implies an annual welfare gain of roughly 1-2 billion dollars.
This estimate is not a complete welfare analysis since it ignores general equilibrium factors,
as well as other impacts of the NLEA such as nutrition claims legislation. Nonetheless, it
suggests that the information provision element of the NLEA was successful judged from a
revealed preference standpoint; it paid for itself in the first few years of the program.
1.7.2 Potential Welfare Gains from Additional Labeling
We can also use the model to evaluate the welfare gains from additional nutrition labeling.
The NLEA exempted all fresh foods from labeling regulations, including all restaurants and
fresh meat and vegetables sold in grocery stores. Recently, the Affordable Health Care Act
mandated calorie posting in all chain restaurants (Rosenbloom 2010). In this section, I ask
question: what are the potential welfare gains from labeling all foods which are currently
unlabeled?
This exercise requires some additional assumptions. I gloss over distinctions between
different types of labeling: it may be that individuals respond differently to calories posted
on restaurant menus than to nutrition facts on the back of packaging; the rough agreement
between my results and the results in Bollinger et al. (2010) suggest that the responses may
"This estimate does not take into account the opportunity cost of "package real estate" taken up by
nutrition labeling to the exclusion of other advertising or information. This cost is difficult to quantify. An
informal survey suggests that most packages have space in the back or side where additional information
could be included if it were valuable, which suggests that this opportunity cost is not too large (it still may
not be zero because even information with positive value would not be provided if the aesthetic costs were
too large).
not be too different, but that is far from convincingly established (this agreement is discussed
in Appendix A.1). I also do not have information about the proportion of restaurants which
voluntarily provide calorie information. Many restaurants provide nutritional information
either in a booklet or on their website, but surveys suggest that this information is rarely used
and that despite its presence, individuals do not have accurate beliefs about the nutritional
content of alternative products (Bollinger et al. 2010). The majority of consumers do report
using calorie information when it is posted as prominently as prices (Elbel, Kersh, Brescoll,
and Dixon 2009).
The FLAPS survey indicates that 60% of fresh meats and vegetables currently carry
nutrition labeling. Data does not appear to exist on either the proportion of restaurants
which currently use prominent nutrition labeling of any kind; I assume that it is 0%. Given
these assumptions, the analytical framework is otherwise identical to that in the Section
1.7.1: the demand curve with labeling is computed, and the welfare gain from labeling
comes from the fact that individuals purchase the wrong quantity of each food if they are
not properly informed about nutrient content.
Table 1.7 gives the results of this analysis and compares the potential welfare gain from
more labeling to the welfare gain from the NLEA for each of the four models reported in
Section 1.6.4. The welfare gain ranges from $40-480 annually per person and is typically
larger than the welfare gain from the NLEA; this occurs despite the fact that the NLEA
applies to a larger fraction of overall consumption because of the assumption that labeling
in restaurants increases from 0% to 100%.
1.8 Welfare Gains with Consumer Errors
The welfare computations in the previous sections take the estimated willingnesses to pay
for nutrient content at face value. In this section, I attempt to determine if the estimated
parameters are consistent with the available medical evidence and VSLs estimated in other
contexts given what consumers already know about health.
The normative implications of this comparison are not completely clear-cut. At the very
least, to the extent that VSLs differ across settings, there is a positive puzzle as to why the
marginal willingness to trade-off money and expected life-years differs." I will also consider
the implications of a strong normative assumption: what gains from policy are possible if
we assume that the VSL estimated in other settings is a better guide to consumers' best
interests than the VSL estimated from food consumption? The plausibility of this normative
assumption will depend on the answer to the positive question as to why VSLs differ across
settings, as I discuss at greater length below.
With those caveats in mind, I proceed as follows. I begin by considering a thought-
experiment which suggests that nutrient information plays little role in people's consumption
decisions; if consumers are responsive to health in their food consumption decisions, it must
be from other sources of information. I then lay out a theoretical model which makes
explicit the role that assumptions about health information play in computing a normative
benchmark for the estimated willingness to pay parameters. Finally, I operationalize that
model and I use the benchmark parameters to reconsider the welfare exercises in the previous
section and to evaluate the potential additional welfare gains if consumers' response to
nutrient information were consistent with the medical knowledge of experts and the VSL
from other contexts.
1.8.1 Implications of the Estimated Parameters for Healthier Di-
ets
One way to assess the magnitude of the estimated willingness to pay parameters is to ask
what they imply about the potential gross benefits of healthier diets ("gross" in the sense
of ignoring the off-setting cost from such diets being otherwise less desirable). If we take
preferences as given, we are assuming that choices are optimal if consumers use nutrition
labels so any potential health gains would be offset by the fact that consumers would enjoy
healthier foods less all things considered; the net benefits of eating different foods must be
negative. We can however still ask the following question: what is the welfare gain implied
by the estimated parameters if consumers could continue to eat exactly the same foods, but
the nutrient profile of those foods were altered so that it matched that of a much healthier
1 2 For clarification, I am defining the VSL here as whatever marginal value of a statistical life is implicit
in consumers' food consumption decisions given the observed response to nutrient content.
diet? In other words, what would be the welfare gain implied by the estimated parameters
if consumers could continue to eat pizza and cheeseburgers, but the nutrient intake were as
if they consumed tofu and broccoli?
The main result in this section is that this gain is very small relative to the magnitude
implied if we start with pre-existing estimates of the impact of diet on health and the value
of life-years. This does not necessarily imply that consumers are undervaluing nutrient
information: it may be that nutrient information is redundant given everything else that
consumers know about the health consequences of diets.13  I investigate this question in
more detail in section 1.8.3 and by attempting to characterize consumers' beliefs about the
health consequences of foods from all sources relative to those of experts. The exercise in this
section demonstrates only that if individuals are adequately incorporating health information
into their food consumption decisions, they are not doing it via information about nutrient
content.
To conduct this exercise, I construct a profile of nutrients for the healthiest possible
diet based on FDA recommendations and the relationship between nutrient intake and the
theoretical minimum baseline dietary risk factors described in Ezzati et al. (2003) which is
used in the introduction to compute the welfare gains from longer life; on a per capita basis,
these gains range from $2,500-$4,500 year if we start with standard assumptions about the
VSL and discount factor (or $2000-$3500 in 1990 dollars, in which prices in the data are
expressed). In this section, I use the value of $3,000 in 1990 dollars as a benchmark.
The benchmark healthy diet is described in Table 1.8. The recommendation for calorie
intake is computed separately for each individual based on their height and self-reported
exercise habits, and the rule that a BMI of 18.5 kg/rm2 minimizes health risk as in Ezzati et al.
(2003).4 The remainder of the recommendations are taken from the National Academy of
Sciences Food and Nutrition Board based on their survey of the medical literature (Trumbo,
Schlicker, Yates, and Poos 2002); they characterize for each nutrient a consumption range
1 3 1n the context of the model estimated above, it may be that the product fixed effects incorporate
judgments about health which are omitted from this exercise. That is, if we want to compute the true
revealed preference gain from the counterfactual world in which cheeseburgers were as healthy as broccoli,
we would first need to decompose the product fixed effect into the portion driven by health considerations
and the portion driven by everything else. The model I consider in the next section attempts to do something
like this.
14For a sedentary female of average height. this translates to 1816 calories/day.
which minimizes health risk. The value of moving to this nutrient profile holding fixed
all other aspects of foods can be computed straightforwardly from the willingness to pay
estimates by multiplying the coefficient for each nutrient by the difference in nutrient intake
between nutrients actually consumed and nutrients consumed in the healthy diet profile.
The assumptions I make are conservative in the sense that this is a very extreme nutrient
profile (e.g. zero consumption of saturated fats is not a realistic goal). It may be that a less
extreme nutrient profile would yield most of the possible health gains, but the implied value
of a less extreme nutrient profile would be even smaller, strengthening the result that the
apparent willingness to pay for nutrients is insufficient to account for the value of the health
consequences of alternative diets according to experts.
Since this calculation depends heavily on the change in the number of calories consumed,
it is important to directly address the issue of missing data in the CSFII. In the numbers
reported in this section, I scale total grams consumed so that mean calorie consumption
matches a population average goal as estimated from the Behavioral Risk Surveillance Survey
over the time period in question. I consider two alternative ways of performing this scaling:
in the first case, I scale the consumption of all individuals in the data; in the second case,
I select a sampling of individuals whose total consumption is consistent with the estimated
BMI given the average energy requirements of a person of that BMI given their reported age
and sex according to the USDA (Trumbo, Schlicker, Yates, and Poos 2002).
The results for Models 1-4 from the previous section for each of these cases are reported
in Table 1.9. Depending on the model used, the welfare gains range from $40-$130 annually.
This is 1-2 orders of magnitude smaller than the gains of $200043500 annually computed
from the VSL and medical evidence. This suggests that if individuals are sensitive to the
health consequences of their dietary behavior, nutrient information plays little direct role.
1.8.2 A Normative Theory of Food Consumption and Health
In this section, I develop a theory describing how we can compute a benchmark responsiveness
to new health-relevant information given what consumers already know, assumptions about
discount factors and the value of a statistical life, and medical evidence about the relationship
between nutrient content and health.
Define a diet as a vector of grams consumed {N 1 , ... , Nj} for each of J foods in an
individual's choice set, and let h(d) denote the best prediction of the life-years gained from
consuming diet d relative to a benchmark diet do. Consumers choose {Naj, ..., Nji} so that:
Nij = arg max v(N, ..., Nij) + ihI(N 2 ,..., Nij) + ain (Eit(Xin)) - p Nij (1.14)
a nj
where hi(d) denotes consumer i's beliefs about the life expectancy consequences of consuming
diet d relative to a benchmark, and /3 gives consumer i's value of a statistical life, defined as
the marginal rate of substitution between expected life years and income (in this case, the
marginal utility of income is normalized to 1). As in the structural model, I assume that ain
is piecewise linear, so that an(Xin) = an - max(Xin - Xin, Xin - Xin, 0).
This is a more general version version of the structural model estimated above with one
exception. In this specification, utility from taste and utility from all health considerations
are written as additively separable; in the model above, both of these terms were encompassed
in the "taste" term which indicated utility from all sources other than nutrient information.
The benchmark responsiveness to new health information for each nutrient, the {*}, are
defined as the parameters which solve:
arg maxv(Ni*,..., N,*j) +3h(N*,.N) - ZpN* (1.15)
Cin
where N,* are solutions to equation 1.14 and #3f gives the normatively appropriate value of
a statistical life (I discuss the relationship between #fl and #i below).
In words, the benchmark parameters are defined as the additional responsiveness to nu-
trient information which would maximize utility given the true health consequences of alter-
native dietary behaviors and given the degree to which health is already taken into account.
Think of a consumer with some existing knowledge of the health consequences of different
diets (h). One way of conceptualizing the a* parameters is to imagine that consumers have
access to h at some point, but not at the time when they make their purchasing decisions.
Instead, they can carry around in their memories a few parameters telling them how to best
approximate the decisions they would make if they knew h given only the nutrient infor-
mation available at the point of purchase. The a* are the parameters they would carry
around with them. Alternatively, we can think of these parameters as defined by a social
planner: given what consumers know about health and given the true health consequences of
alternative foods, the benchmark parameters give the optimal person-specific tax on nutrient
content (assuming that the objective function in equation 1.15 is the appropriate normative
standard).1
Provided total intake for a given nutrient lies in the costly range, 16 we can compute the
solution to equation 1.15 by implicitly differentiating the objective function in equation 1.15
and then substituting in for ' and 'N42 from the first order conditions for equation 1.14.
The benchmark parameters are then characterized by the system of linear equations:
(Sx)' q = 0 (1.16)
where S is the J x J matrix of marginal price effects defined by Skj = O , x is the J x N
aPj'
matrix of nutrient contents where xj, gives the content of nutrient n in one gram of product
j and q is the J x 1 vector whose jth element is given by: qij = - O - a-nzAu.
I show in Appendix A.5 that in this case we can write the benchmark parameters as a
function of Cov(i '9 -# 9, O N r), and E(zCn,) E(3 - # Oh) for each nutrient n where
z nj k p' Xnk tells us how much a change in an will impact consumption of product j.
Intuitively, suppose nutrient n is a "bad"; if consumers understate marginal health costs a lot
for foods whose consumption is very sensitive to an, then being more sensitive to variation in
nutrient n (an further from 0) will help correct for this understatement. In a world with no
cross-price elasticities, this gives the intuitive condition that the benchmark parameters will
be large in magnitude if the bias in marginal health costs is highly correlated with nutrient
15 A more realistic formulation of the problem of optimal sin taxes might assume that the government is
restricted to a single tax rate for all consumers, and that this tax rate cannot be perfectly conditioned on
current overall nutrient intake. This is the subject of a separate investigation.
161f nutrient intake lies in the range with zero costs, I assume that individuals are unresponsive to nutrient
information and the benchmark parameters are also 0. If optimal nutrient intake falls exactly on the cut-off
point, the benchmark parameter for each nutrient is given by the value which leads total intake of that
nutrient to exactly equal the cut-off value given the remainder of the structural parameters. Given the
estimated utility functions, one can thus solve for the benchmark parameters in each of these three cases
(optimal nutrient content in the costly range, on the cut-off point and in the range with zero costs) and then
directly check which case maximizes utility.
content.
In the following subsections, I compute these sufficient statistics and use them to compute
the benchmark parameters. In the remainder of this section, I discuss the interpretation of
the benchmark parameters, and in particular, the relationship between these parameters
and the observed responsiveness to nutrient information. The model above assumes that
nutrients only enter utility for health reasons, but this may be incorrect. For example,
consumers may care about calorie consumption due to its impact on physical appearance
regardless of the related health consequences. In this case, we could rewrite equation 1.15
as:
arg max v(Ni*, ... , Nj*j) + #3 h(Ni*,..., N*j) + E oXi- Zpj N* (1.17)
ainn
n j
and the appropriate benchmark weights on X, will be given by a* + o n. I do not attempt
to directly estimate on below; instead, I argue using survey evidence that Jin will typically
have the same sign as ae*. In the case of calories, a*, will understate the degree to which
individuals want to avoid calories because the vast majority believe their physical appearance
would also be improved by consuming fewer calories. The value I compute is therefore
a conservative benchmark; to the extent that the estimated willingness to pay for calorie
content is still smaller in magnitude than a*, I am potentially understating the degree to
which individuals are less responsive than they should be to calorie information.
There are several additional reasons we might expect the estimated willingness to pay
for nutrient content to differ from a* . Consumers may be unsure how to map nutrient
information into health consequences. When I attempt to estimate a*, below, I consider some
survey evidence suggesting that consumers' beliefs about what constitutes a healthy diet
differ from expert beliefs. One explanation for this discrepancy is that consumers are ignorant
of expert beliefs about the relationship between diet and life expectancy and would change
their beliefs to match expert beliefs if the latter could be communicated in a meaningful way.
To the extent that this explanation is right, it would seem to support taking the benchmark
parameters as the appropriate normative standard.
An alternative explanation is that even if consumers were fully informed about expert
beliefs they would still respond differently from the benchmark that I calculate; that is, #,
the full information VSL measured in the context of food consumption may differ from #f , the
full information VSL measured in other settings. This may occur for several reasons. Among
others: consumers may distrust expert beliefs either for good reason (informed skepticism
about the methodologies of nutritional epidemiologists or taking into account factors not
considered below such as technological progress in treating diet related illness) or for bad
reasons ("I know an old woman who ate a jar of lard every day and lived to be 120"); self-
control issues may be especially relevant in the setting of food consumption; individuals may
respond differently to many small decisions which lead to large health consequences than
one large decision; and choices may depend on the entire distribution of mortality risk as
opposed to just the expected number of life years. The normative implications of many of
these explanations are uncertain (e.g. Bernheim and Rangel (2008) discusses several possible
normative criteria in the case of time-inconsistency).
Below, I make the strong normative assumption that the VSL estimated in other settings
is the normatively correct VSL, and that consumers err to the extent that the full-information
VSL implicit in food consumptions decisions differs from this benchmark. Future work
clarifying the positive explanation for the discrepancy between the estimated response to
nutrient information and the benchmark value computed will shed light on the plausibility
of this normative assumption.
1.8.3 Calculation of Benchmark Parameters
To calculate the benchmark willingnesses to pay for nutrient content, I begin by combining
evidence from a survey of experts about the relative health ratings of different foods with
evidence about the long-term health consequences of different diets in order to compute an
estimate of the life-expectancy consequences of consuming a unit of each food which I express
in dollar terms using the estimates of the value of a life-year. Next, I compute estimates of
the parameters characterizing current consumer beliefs by minimizing the distance to expert
beliefs subject to the constraint that consumer beliefs rationalize the judgment that the
diet reported by consumers in a survey to be a healthy diet is as healthy as the benchmark
healthy diet given by experts. I then use the estimated expert beliefs and consumer beliefs
to compute the normative benchmark for the willingness to pay estimates by solving the
system of linear equations characterized by equation A.13.
My calculation of the marginal life expectancy consequences of consuming each food im-
plied by medical evidence proceeds in four steps. First, I characterize a range of nutrient
intakes which minimize health risks based on expert recommendations. Second, for all di-
ets outside this range, I compute the distance from the benchmark healthy diet weighting
each nutrient based on weights derived from a survey of experts. Third, I scale the dif-
ference between a given diet and the benchmark healthy diet into life years based on the
assumption that the average diet leads to a loss of .04 life-years annually (this is justified
by the calculation in online Appendix based on (World Health Organization 2002)). Fourth,
I convert this into a dollar amount based on estimates of the distribution of the value of
a statistical life. I start with an average VSL of $6.4 million (Viscusi and Aldy 2003) and
compute the value of each life year by assuming that there is a constant value of a life year
and that the VSL is the present discounted value of all additional life years. That is, I solve,
E;(ZT4"i-" 3'Vyear) = V* where the expectation is taken over all individuals in the data,
ai indicates age and Ti(ai) indicates life expectancy conditional on age ai (this procedure
is similar to that used in Gruber and Koszegi (2001). The value of the marginal life-year
is given by 6Ti-aiVyear. I assume 6 = .96. This value will vary across consumers based on
their age, but it implies that the average consumer loses about $3,000 worth of life-years
by consuming their current diet rather than the healthiest possible diet (I consider below
the impact of allowing for some heterogeneity in the VSL). The result of this calculation
is a function which expresses the health cost of all diets in dollar terms which I can use
to determine the marginal health cost of all foods. The benchmark healthy diet is again
summarized in Table 1.8. More details of this calculation are given in Appendix A.5.
The next step in the calculation is to determine what individuals already know about
the life expectancy consequences of consuming different diets. To perform this calculation, I
make use of consumers' answer to the following question: "how many servings would you say
a person of your age and sex should eat each day for good health from food group [X]?" Given
a characteristic serving from each food group, we can use consumers' answer to this question
to characterize their beliefs about an optimal diet. As a robustness check, I investigate
whether consumers who list a greater proportion of servings from a given food group tend to
consume healthier foods from that group; I find that this is not the case. Details are again
given in Appendix A.5. In future work, I hope to improve the characterization of consumers
current beliefs about life expectancy consequences by drawing on additional survey and
choice evidence.1 7
The characterization of the dollar-equivalent true life expectancy consequences and the
dollar-equivalent of consumers' beliefs about these consequences along with the matrix of
price elasticities derived from the structural model allows me to compute the benchmark
parameters from equation A.13 separately for each consumer. The average of these bench-
mark weights across all individuals for each of the four specifications in Table 1.5 are given
alongside the estimated willingnesses to pay for each nutrient in Table 1.10. The benchmark
responsiveness to calorie information is about 9 times the estimated responsiveness. In the
disaggregated models, the benchmark responsiveness to total fat content is again about 8-
9 times the estimated coefficient, and the benchmark responsiveness to fiber, sodium and
cholesterol are 2-7 times what is estimated depending on the specification.
One worry with this calculation is that the least healthy consumers may eat the foods they
do precisely because they have a lower VSL. (Kniesner, Viscusi, and Ziliak 2010) estimates
the degree of heterogeneity in the VSL and estimates a 10th percentile of $3.5 million, a
median of $7.5 million, and a 90th percentile of $22 million. So if we conservatively assume
that all of the health consequences of poor dietary behavior come from people in the 10th
percentile of the VSL distribution, the scaling factor for the true health consequences and the
associated benchmark parameters will be about 40% smaller than reported in Table 1.10.18
This is still several times larger than the observed responsiveness.
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Figure 1-2: N(P) gives the demand curve for a sample product j as a function of the
generalized price P. P gives the apparent price prior to nutrition labeling, P* gives the price
after nutrition labeling, and Phat gives the true price if individuals were fully aware of all
health relevant factors. The most lightly shaded region gives the welfare gain from labeling
judged from the benchmark of P*, the value computed in Section 1.7.1. The medium-gray
region gives the correction to this welfare gain when the change in consumption is judged
using the fully informed marginal cost Ptrue. The most darkly shaded region gives the
additional welfare gain that could be realized if individuals observed Ptrte and changed their
consumption to Ntrue.
1.8.4 Welfare Gains Reconsidered
Given these normative benchmarks, I can then ask: supposing that the correct normative
utility function values nutrients at a*, (the average value of the benchmark parameter) rather
than the observed an, what is the welfare loss due to the fact that individuals behave as if
nutrients are valued at an?
Suppose as above that consumers could gain $3,000 in life-years annually by consuming
the healthiest possible diet. What fraction of this $3,000 represent gains to consumer sur-
plus that consumers can achieve by eating healthier foods? This depends on two factors:
the willingness to substitute across foods (as captured by price elasticities) and the degree
to which consumers already incorporate health information into their food consumption de-
cisions (as captured by the disparity between a* and an). Because consumption is not
infinitely elastic, consumers will not immediately switch to the healthiest possible diet even
if they understand its impact on life expectancy. The welfare gains from healthier eating are
determined in part by the elasticity of substitution: the larger the elasticity, the more readily
consumers will substitute towards healthier foods. The welfare gains are also determined
partly by the degree to which consumers already incorporate nutrient information into their
food consumption decisions; this is given by an. Finally, the welfare gains depend on the
degree to which consumers already incorporate health information from other sources. This
was taken into account in the calculation of a* through the function i. If consumers already
accurately appraise the health consequences of different foods, then a* will be small. $3,000
dollars annually represents the welfare gain that would be achievable if consumption were
infinitely elastic, if a, = 0, and if a* were computed assuming h = 0 (that is, assuming
that beliefs about health currently play no role in consumer demand). The analysis in this
section considers the welfare gain when a., h and price elasticities are estimated from data.
17While we cannot expect consumers to reliably report their current beliefs about health consequences of
different foods expressed in life expectancy units, we can elicit beliefs about health consequences from all
sources and examine how movement along this range of beliefs induced via exogenous information provision
impacts consumption decisions relative to prices. That is, the same methodology used in this paper to
compute a dollar-equivalent of nutrient information can be used to compute a dollar equivalent of health
information from all sources.
18 1More generally, the benchmark parameters do not scale exactly with the function h holding h fixed, but
due to the way h is estimated above, changing the scale of h likewise changes the scale of h, and thus the
scale of the benchmark parameters by the same amount given equation A.13.
The analysis here follows closely the welfare analysis laid out in Section 1.7. The esti-
mated model indicates the choices individuals actually make given their perceived generalized
price. For each food, the benchmark willingness to pay parameters determine a true gen-
eralized price based on the nutrient profile, and we can compute the potential welfare gain
from better choices by asking what consumption would be for each food if consumers faced
the true generalized price rather than the price they actually face. When we reevaluate the
benefits of the NLEA, three generalized prices are relevant: the price consumers face in the
counterfactual world with 1985 labeling, the price consumers face given labeling and the
weights they actually attach to nutrients, and the price consumers would face given label-
ing if they weighted nutrients correctly according to the benchmark parameters. Figure 1-2
describes how consumer surplus is computed for each product given these prices.
Table 1.11 reports the results of these additional analyses. Using the benchmark prefer-
ence parameters increases the estimated welfare gain from labeling by a factor of 4-5; the
gains from eating healthier foods are substantially larger when assessed using these bench-
mark parameters. The model implies that consumers could gain over a thousand dollars
in additional surplus per year if their assessment of the marginal cost of consumption for
each food were perfectly in accordance with what is implied by the estimated benchmark
preferences. Given the assumption that the gross health benefit of consuming the healthiest
possible diet is $3000 per year, this number suggests that 30-40% of the possible gross health
gains from consuming a healthier diet could be internalized as consumer surplus.
1.9 Conclusion
Diet has important consequences for health; this paper analyzes whether individuals incor-
porate these consequences into their food consumption decisions using information about
nutrient content from nutrition labels. I find that food consumption decisions do appear to
respond to labeling laws and that while the estimated responses are modest, such laws easily
pass a cost-benefit test and additional labeling would likely lead to welfare gains. The mag-
nitude of the response is nonetheless far too small given the health consequences of different
diets and the fact that nutrient information should be valuable in computing those health
consequences given what consumers already know about the value of those health conse-
quences from other contexts. Accounting for the facts that healthy foods are otherwise less
desirable and that consumers already have some information about health, the net benefit
to consumers possible from consuming healthier foods is 30-40% of the value of the gross
health benefit from switching to the healthiest possible diet.
The value reported here for the potential welfare gains from consuming healthier foods
is by no means definitive: instead, it is a first pass attempt to apply the model devel-
oped in Section 1.8.2 to evaluate the magnitude of the welfare gains from more informed
choices. The normative assumptions made could be better assessed given an explanation of
why the estimated willingnesses to pay for nutrient information differ from the normative
benchmark. There are many possible explanations ranging from incomplete understanding
of the relationship between nutrient content and health to distrust of expert information,
time inconsistency, and other contextual and framing effects which impact the way that
consumers respond to health information in this setting relative to other settings. Ideally,
choice evidence from experiments could be used to replace any reliance on survey evidence
in forecasting how individuals would choose under ideal circumstances. The magnitude of
the disparity identified in this paper between the observed responsiveness to nutrient infor-
mation and the normative benchmark provides a standard which can be used to assess the
results of such experiments: how much of the disparity is explained by each of these factors
alone and in concert?
Beyond provision of nutrient information, there are several additional instruments a so-
cial planner might consider to alter dietary behavior; these include nutritional education
programs, "nudges" such as listing healthier foods earlier on menus (Downs, Loewenstein,
and Wisdom 2009), or more paternalistic measures such as taxes or subsidies on certain
types of foods or even outright bans. One can view the model in this paper as an extension
of the model developed in O'Donoghue and Rabin (2006) to evaluate the welfare conse-
quences of such policies. In ongoing work, I use the model to evaluate Pigouvian taxes on
negative nutrients and subsidies for positive nutrients designed to correct for the apparent
underresponsiveness of consumers to this information.
More generally, the approach developed in this paper can be used to analyze any choices
where some desired characteristic of alternatives is observable and can be independently
priced. Food consumption decisions depend in large part on unobservable taste parameters,
but they also depend on perceptions of healthiness, and we have estimates of the value of
health from other settings. We can then ask: are consumers aware of the variation in this
desirable characteristic when they make their choices? To the extent that this is not the case,
if expert knowledge can be used to determine the amount of the desired characteristic in the
available alternatives, we can determine the scope for welfare improvements from policies
designed to lead to better choices. Whether the policy under consideration is a relatively
innocuous information provision, a "nudge" from alternative choice architecture, a tax or
subsidy or a more stringent restriction on choice, it is of interest to determine quantitatively
the magnitude of the potential benefits from better choices so that these can be properly
weighed against the costs.
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Percent Caily Values are based on a 2,000 calorie
diet. Your daity values may be higher or lower
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Figure 1-5: Proportion of Products Labeled by Year for a Sample of Product Groups
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Figure 1-6: This graph shows the coefficients from estimating equation 1.1, but substituting
quantiles of calorie intensity interacted with the proportion of products labeled for the in-
dependent variable. The dotted lines indicate 95% confidence intervals. The coefficient can
be interpreted as the change in consumption in the nth quintile relative to the first quintile
when the proportion of products labeled in a product group increases from 0% to 100%. A
coefficient of -0.5 indicates that consumption falls by 0.5 calories in the quintile of interest
relative to the first quintile when labeling increases by 0% to 100%.
Table 1.1: Sample Product Group
Label Status Calories / gram Consumption (grams)
Food Period 0 Period 1 Prior Belief Actual Content Period 0 Period 1
Dressing 1 Labeled Labeled 1 1 20 24
Dressing 2 Not Labeled Labeled 3 1 20 26
Dressing 3 Not Labeled Labeled 3 3 20 24
Dressing 4 Not Labeled Labeled 3 5 20 22
Table 1.2: Percentage of DHKS Respondents Indicating Use of Nutrient on Label
Nfacts Panel Calories Total Fats Sat. Fats Fiber Sugars Sodium Cholesterol Vitamins
1989 74 - - - - - - -
1990 - 68 72 - 53 68 66 71 62
1991 - 68 74 - 53 66 60 68 61
1994 77 79 81 70 54 67 67 69 67
1995 79 81 82 70 54 67 66 66 68
1996 73 81 82 71 50 64 63 63 66
Total 75 75 78 70 53 66 64 68 64
Each value gives the percentage of DHKS respondents in the indicated year who indicated
that they "Often" or "Sometimes" used the information on the indicated nutrient on the
nutrition facts panel out of all respondents indicating "Often", "Sometimes", "Rarely" or
"Never". In 1989, the question asking respondents about use of the Nutrition Facts panel
(the first column) replaced the "Often" choice with "Always".
Table 1.3: Beliefs about Current Nutrient Consumption Relative to What is Healthy
Calories Total Fats Sat. Fats Fiber Protein Sodium Cholesterol
Too Much 51 60 50 3 8 32 41
Too Little 6 4 5 47 19 6 4
Right Amount 43 36 46 50 72 62 55
Each value gives the percentage of DHKS respondents among those who indicated whether they
consumed "too much", "too little" or "about the right amount" of the nutrient in question compared
to what is healthy.
Table 1.4: Reduced Form Evidence: Labeling and Calorie Consumption
Linear Linear Linear Linear Linear Linear
OLS
Calories - Labeling -.0924**
(.0215)
Product F.E. YES
Year F.E. YES
Group-year F.E. NO
Product Time Trends NO
Observations 8419
Sample NLEA
Log
2SLS
OLS OLS
-. 1349**
(.0459)
YES
YES
NO
8419
NLEA
Log
2SLS
-.2214*
(.1027)
YES
YES
YES
8419
NLEA
Log
2SLS
Calories - Labeling -.0393 -. 2159** -. 3875** -.0026 .1790** -. 0228
(.0262) (.0551) (.1157) (.0166) (.0363) (.0758)
Product F.E. YES YES YES YES YES YES
Year F.E. YES - - YES -
Group-year F.E. NO YES YES NO YES YES
Product Time Trends NO NO YES NO NO YES
Observations 8419 8419 8419 7534 7534 7534
Sample NLEA NLEA NLEA No NLEA No NLEA No NLEA
* indicates significance at the 5% level and ** indicates significance at the 1% level. Each observa-
tion is a food-year. The dependent variable is average consumption of food j in calories at time t
(including 0's) in the linear specification, and the natural log of that in the log specifications. The
dependent variable is the interaction between calories per gram (a constant for each product) and
the proportion of products which are labeled. The IV specifications construct a separate instru-
mental variable in each product group which is the interaction of calories per gram and a dummy
which is 1 after the NLEA in the product group in question and 0 otherwise. Specifications with
group-year fixed effects include a separate fixed effect for each group-year, rendering the year fixed
effects redundant. Specifications with product time trends include a separate linear time trend for
each product. Specifications with the "NLEA" sample include all prepackaged foods, while specifi-
cations with the "No NLEA" sample include all fresh foods and foods consumed at restaurants as a
falsification test.
2SLS
-. 1032**
(.0204)
YES
YES
NO
NO
8419
NLEA
Linear
2SLS
2SLS
-. 1289**
(.0428)
YES
YES
NO
8419
NLEA
Linear
2SLS
2SLS
-.2271**
(.0859)
YES
YES
YES
8419
NLEA
Linear
2SLS
Table 1.5: Tobit Results: w/ and w/o Time
(1)
Fixed Effects, w/ and w/o Heteroskedasticity
(2) (3) (4)
Calories -. 1214**
(kcal) (.0310)
Total Fats - -. 6713** - -
(grams) (.2014)
Saturated Fats - - -. 0016 -2.713
(grams) (.2761) (1.555)
Unsaturated Fats - - -1.214** -. 1221
(grams) (.2788) (.3815)
Protein - -.4276 1.211 -1.590*
(grams) (1.011) (.9781) (.7031)
Carbohydrates - -.5230* -.3100 -.2911
(grams) (.2586) (.1960) (.1431)
Fiber - 2.911 1.568 2.120
(grams) (2.717) (1.088) (1.711)
Cholesterol -.0849 -.0181 -.0416 -.0120
(mg) (.0629) (.0431) (.0773) (.0723)
Sodium -.0144* .0201 .0075 .0120
(mg) (.0091) (.0211) (.0041) (.0090)
# of Consumer-Days 14596 14596 14596 14596
# of Observations 10671750 10671750 10671750 10671750
* indicates significance at the 10% level and ** indicates signif-
icance at the 5% level. Each observation is a patient day-food.
Estimation is by maximum likelihood. All specifications include
fixed effects for each food, group-year fixed effects, product-group
specific dummies for unlabeled foods, prices with a fixed coefficient
determined as outlined in the text, and dummy variables for miss-
ing prices and deflators. Model 2 disaggregates calories into fats,
proteins, carbohydrates and fibers, and models 3 and 4 further dis-
aggregate fats into saturated fats and unsaturated fats. Model 3
assumes perfect knowledge of saturated and unsaturated fat con-
tent prior to the NLEA for labeled foods, while Iodel 4 assumes
no knowledge prior to the NLEA for labeled foods (i.e. they are
treated just like unlabeled foods). All values are expressed in 1990
dollars.
Table 1.6: Average Annual Welfare Gain in Dollars
Linear Structural
Total Direct Indirect Total Direct Indirect
1985 0 0 0 0 0 0
1986 1 1 0 0 2 2
1989 4 4 2 8 8 0
1990 8 9 2 8 9 0
1991 7 9 1 8 8 2
1994 48 45 6 38 38 4
1995 52 48 4 37 37 4
1996 60 55 4 41 37 4
Estimated welfare gain from additional labeling since 1985 in the linear and
structural models. The direct column gives the welfare gain from foods
which experienced a change in labeling. The indirect column gives the gain
from substitution for foods which experienced no change in labeling. All
values are expressed in 1990 dollars.
Table 1.7: Average Welfare
NLEA Structural
Model 1 40.6
Model 2 33.4
Model 3 32.1
Model 4 28.3
More Labeling Structural
Gain from NLEA and New Labeling
Linear
60.1
49.2
51.0
56.0
Linear
Model 1 68.9 79.2
Model 2 78.5 72.1
Model 3 58.1 74.8
Model 4 40.1 55.1
Estimated welfare gain in dollars per year in Models 1-4 from the change in labeling from
1985-1996. The first panel gives the observed welfare gain from the NLEA. The second
panel gives the additional counterfactual welfare gains that would have occurred if more
products had been labeled over this period. All values are expressed in 1990 dollars.
Table 1.8: Benchmark Healthy Diet
Nutrient Recommendation Penalty
Calorie Intake BMI of 18.5kg/m 2  X
Saturated Fat As low as possible -0.4708
Unsaturated Fat 20-35% of calorie intake -0.0538
Protein >10% of calorie intake 0.123
Carbohydrates 45-65% of calorie intake -0.03
Fiber >25g 0.561
Cholesterol As low as possible -0.00398
Sodium <2300 mg -0.00254
The first column reports the nutrient intake recommended by the National Academy of Sciences
Food and Nutrition Board to minimize health risk. The second column gives the weights derived
from a survey of experts by regressing health ratings for each food on nutrient content. All values
are expressed in 1990 dollars. In models with saturated and unsaturated fats aggregated into total
fats, I assume that any fat intake greater than 0 imposes a health risk.
Table 1.9: Annual Consumer Surplus from Nutrient Profile of Healthiest Diet (dollars)
Scaled Scaled to Match BMI Representative BMI
Model 1 100.2 123.5
Model 2 49.3 62.1
Model 3 45.0 51.3
Model 4 94.8 131.0
Table 1.10: Estimated vs. Benchmark Preferences
Model 1 Model 2 Model 3 Model 4
Estimated Benchmark Estimated Benchmark Estimated Estimated Benchmark
Calories -0.12 -0.95
Tfat -0.67 -5.49
Sfat 0.00 -2.64 -11.13
Ufat 
-1.21 -.12 -1.41
Protein -0.43 2.90 1.21 -1.59 3.12
Carbo -0.52 -0.34 -0.31 -0.29 -0.41
Fiber 2.91 15.51 1.57 2.12 14.59
Choles -0.09 -0.24 -0.02 -0.08 -0.04 -0.01 -0.09
Sodium -0.01 -0.07 0.02 -0.07 0.01 0.01 -0.06
For each of the four models in Table 1.5, this Table compares the estimated willingness to pay
parameters with the benchmark parameters computed from medical evidence and VSL estimates
given the characterization of consumers* current beliefs about the health consequences of different
foods. All values are expressed in 1990 dollars.
Table 1.11: Annual Welfare Gains Re-evaluated Given Scaled Preferences
Model 1 Model 2
Original
NLEA 41 33
More Labeling 69 79
Re-evaluated
NLEA 159 172
More Labeling 281 315
Additional Welfare Gains 941 1151
Estimated welfare gain in dollars per year. The original estimates are the estimates reported in Tables
1.6 and 1.7 computed using the willingness to pay parameters estimated via revealed preferences.
The re-evaluated welfare gains recompute the gains from changes in consumption due to additional
labeling using the scaled preferences as the normative benchmark. "Additional Welfare Gains"
are the welfare gains possible if the marginal price of consumption were perfectly in line with the
estimated benchmark preferences. All values are expressed in 1990 dollars.
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Chapter 2
Choice Inconsistencies Among the
Elderly: Evidence from Plan Choice
in the Medicare Part D Program
2.1 Introduction
The Medicare Modernization Act of 2003, better known as the legislation that added the Part
D prescription drug benefit to the Medicare program, represents the single most significant
expansion of public insurance programs in the U.S. in the past 40 years. The most novel, and
controversial, feature of this legislation was the use of multiple private insurance providers
to deliver this new public insurance product. Unlike the traditional model of government
mandated uniform insurance packages for all enrollees, under the Part D program dozens
of private insurers were allowed to offer a wide range of products with varying prices and
product features. Perhaps most well-known was the extent to which plans covered the donut
hole, a broad uncovered range of expenditures in the minimum mandated plan.
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This unprecedented privatization of the delivery of a public insurance product raises a
host of important policy questions. Primary among these is the impact of allowing choice
across so many private insurance options. The typical elder in our data (described below)
faces a choice of over 40 stand-alone drugs plans, and our estimates suggest that the range
of cost from the most to least expensive option facing an elder is comparable to the mean
of those costs. Choice is clearly meaningful in this context. Yet, to date, we know almost
nothing about how elders are making these crucial choices.
This paper investigates the choices of elders for the newly formed Part D program in 2006.
We analyze data that provides information on the Part D plans chosen and prescription drug
utilization for a large sample of elders in the U.S. These data were collected by Wolters Kluwer
(WK), a switch agent that lies between pharmacies that fill prescriptions and the insurance
companies and prescription benefit managers that pay for them. WK collects information
on almost one-third of all third party prescription drug transactions, and we will use the
universe of their data for those over age 65 during 2005-2006 to examine choice of Part D
plan. We match to this data set a comprehensive set of information from the Centers for
Medicare and Medicaid Services (CMS) on the Part D plans available to each person in our
data set.
Specifically, for each elder whose claims appear in our sample, we model the financial
implications of each of the plans in their choice set, based on both 2005 and 2006 drug
utilization and several different models of expectations. We begin by presenting the basic
facts on choice, documenting that the vast majority of elders are choosing plans that are not
on the efficient portfolio of plan choice for that elder. We then turn to more rigorous multi-
nomial models of individual choice to incorporate non-financial characteristics, preference
heterogeneity and unobserved plan characteristics into our analysis.
Our findings are striking: along three dimensions, elders are making choices which are
inconsistent with optimization under full information. First, elders place much more weight
on plan premiums than they do on the expected out of pocket costs that they will incur under
the plan. Second, consumers appear to value plan financial characteristics far beyond any
impacts on their own financial expenses or risk. Third, consumers substantially under-value
variance reducing aspects of alternative plans. The first two of these conclusions are robust
to a variety of specifications and econometric approaches; the third is more sensitive.
Our paper proceeds as follows. Part I provides background on the Part D program and
reviews the growing literature on its impacts. Part II discusses our data sources, and Part
III presents initial results on choice set variation and choice behavior. Part IV describes our
choice framework, and Part V presents results and robustness checks. Part VI considers issues
of misspecification and measurement error, and Part VII assesses robustness to heterogeneity
concerns. Part VIII concludes with a discussion of the policy implications of our findings.
The appendices referenced throughout are included in the online version of this paper.
2.2 Background
2.2.1 The Medicare Part D Program
Medicare, which provides universal health insurance coverage to those over age 65 and to
those on the disability insurance program, was established in 1965. The original program
covered most medical needs for the elderly and disabled, including hospital and doctor costs,
but it excluded coverage for prescription drugs. This omission was not perceived as a major
one in the early years of the Medicare program, but in the 1990s the advancement of pre-
scription drug treatments for common illnesses among the elderly drew attention to this gap
in Medicare coverage. Medicare recipients, for example, spent an average of $2,500 each on
prescription drugs in 2003, more than twice what the average American spent on all health
care in 1965.1
In 2003, the Bush administration and Congress reached agreement on a far-reaching
prescription drug benefit package at a projected cost to the federal government $40 billion
per year for its first ten years. The most noticeable innovation of the Part D plan is that
this new Medicare benefit is not delivered by the government, but rather by private insurers
under contract with the government. Beneficiaries can choose from three types of private
insurance plans coverage of their drug expenditures. The first is stand-alone plans called
'Data for prescription drug spending comes from the Congressional Budget Office (2002). Data for
average Americans health spending comes from the National Health Expenditures section of the Centers for
Medicare and Medicaid Services National Health Accounts.
Medicare Prescription Drug Plans (PDP) (a plan that just offers prescription drug benefits).
In 2006, there were 1429 total PDPs offered throughout the nation, with most states offering
about forty PDPs. The majority of PDPs are offered by a dozen national or near national
companies. The second alternative is Medicare Advantage (MA) plans, plans that provide
all Medicare benefits, including prescription drugs, such as HMO, PPO, or Private FFS
plans. There were 1314 total plans nationally in 2006. Finally, beneficiaries could retain
their current employer/union plan, as long as coverage is creditable or at least as generous
(i.e. actuarially equivalent) as the standard Part D plan, for which they would receive a
subsidy from the government.
Under Part D, recipients are entitled to basic coverage of prescription drugs by a plan
with a structure actuarially equivalent to the following: none of the first $250 in drug costs
each year; 75% of costs for the next $2,250 of drug spending (up to $2,500 total); 0% of
costs for the next $3,600 of drug spending (up to $5,100 total, the donut hole); and 95% of
costs above $5,100 of drug spending. Over 90% of beneficiaries in 2006, however, are not
enrolled in the standard benefit design, but rather are in plans with low or no deductibles,
flat payments for covered drugs following a tiered system, or some form of coverage in the
donut hole. The main requirement for plans is that they must have equal or greater actuarial
value than the standard benefit.2 The government also placed restrictions on the structure
of the formularies that plans could use to determine which prescription medications they
would ensure. Overall, Part D sponsors have great flexibility in terms of plan design. Many
insurance companies sponsored multiple plans of differing levels of premiums and coverage
generosity. Arranging the data into cells by plan sponsor and state, we find that only a
quarter of the cells have only one plan, and 58% contain three plans. In those sponsor/state
cells with multiple plans, most sponsors offer one standard plan and one or two enhanced
plans.
Enrollment in Part D plans was voluntary for Medicare eligible citizens, although Medi-
care recipients not signing up by May 15, 2006 were subject to a financial penalty if they
eventually joined the program (to mitigate adverse selection in the choice of joining the
2Cover M\emo for Medicare Part D Benefit Parameters: Annual Adjustments for Standard Benefit in 2007
(CMS).
program). One group, however, was automatically enrolled: low income elders who had
been receiving their prescription drug coverage through state Medicaid programs (the dual
eligibles). These dual eligibles were enrolled in Part D plans by default if they did not choose
one on their own. The Part D plans for dual eligibles could charge copayments of only
$1 for generics/$3 for name brand drugs for those below the poverty line, and only $2 for
generics/$5 for name brand drugs for those above the poverty line, with free coverage above
the out of pocket threshold of $3600.3
Despite reluctance voiced before the legislation passed, there was enormous interest from
insurers in participating in the Part D program. By November 2006, 3,032 plans were
being offered to potential Part D enrollees. Every county in the nation had at least 27
plans available; the typical county had 48 plans, while some counties featured more than 70
choices, primarily due to high number of MA plans. 4
Enrollment in the new Part D program was initially fraught with problems, but in the
following months the federal government was able to iron out many of the problems that had
arisen during the initial transition. As of June 2006, there were 10.4 million people enrolled
in stand alone PDP plans, 5.5 million people enrolled in MA plans and about 6 million dual
eligibles.5
Yet 73% of people over 65 felt that the Medicare prescription drug benefit was too
complicated, while 91% of pharmacists and 92% of doctors expressed this concern. When
asked if they agree with the statement Medicare should select a handful of plans that meet
certain standards so seniors have an easier time choosing, 60% of seniors answered Yes.6
Despite these reservations, there were no signs of diminished plan choice in subsequent
3 1n addition, two other groups receive substantial subsidies those found eligible for Low Income Subsidy
(LIS) or for Partial Subsidy by the SSA. To qualify for LIS, beneficiaries must have income less than
135resources less than $7,500/individual or $12,000 couple. This group received benefits comparable to the
dual eligibles with incomes above 100% of poverty. To qualify for Partial Subsidy, beneficiaries must have
income at 135%-150% of poverty and resources less than 11, 500/individualor23,000/couple. This group
can enroll in plans with a $50 deductible, a 15% copayment up to the out of pocket threshold, and $2/$5
copayments above that point. In addition, premiums are fully paid by the government up to 135% of poverty,
and then partially subsidized up to 150% of poverty.
4 Details on number of plans in a median county obtained from Prescription Drug Plan Formulary and
Pharmacy Network Files for 2006, provided by CMS.
5Enrollment data (rounded) taken from CMS, State Enrollment Data spreadsheet at http: //www. cms.
hhs. gov/PrescriptionDrugCovGenIn/02_EnrollmentData. asp#Top0f Page. Enrollment numbers also
available at http: //www.kf f .org/medicare/upload/7453.pdf.
6Kaiser Family Foundation and Harvard School of Public Health (2006).
years. The number of PDPs increased by about 30% in 2007, from 1,429 to 1,875 and
remained at this level in 2008.7
2.2.2 Issues of Elder Choice in Part D
Duggan et al. (2008) provide a detailed overview of many of the economic issues raised by the
Medicare Part D Program. The use of this private delivery device, with such a multiplicity
of choices, is a novel feature of the Part D legislation. Standard economic theory would
suggest that this is a beneficial plan feature: allowing individuals to choose across a wide
variety of plans that meet their needs, rather than constraining them to a limited set of
choices being made by the government, can only increase welfare in the standard model in
a partial equilibrium setting.
But there are reasons to believe that the standard model is insufficient, particularly
for a population of elders. There is growing interest in behavioral economics in models
where agents are better off with a more restricted choice set, as nicely reviewed in Iyengar
and Kamenica (2006). Recent theoretical work shows that the traditional more is better
principle may be reversed in some choice set contexts, for example when the presence or
absence of options conveys information (Kamenica (2008); Kuksov and Villas-Boas (2010))
or when agents have preferences with regret (Irons and Hepburn (2007); Sarver (2008)).
And a growing body of empirical work shows that individuals are less likely to participate
in markets where they face more choice; decisions to purchase a good (Iyengar and Lepper
(2000); Boatwright and Nunes (2001), take a loan (Bertrand, Karlin, Mullainathan, Shafir,
and Zinman (2005)) or enroll in a 401(k) plan (Sethi-Iyengar, Huberman, and Jiang (2004))
are found to decrease when participation requires choosing from a larger set of alternatives.
Iyengar and Kamenica (2006) find that not only the decision to participate in a market,
but also the nature of choice itself, is affected by the size of the option set. They investigate
choice over asset allocation in both laboratory and real-world (pension plan choice) settings,
and find that individuals opt for safer investments when faced with a larger range of risky
choices. In particular, they find that the presence of more investment options in a 401(k)
7Data on 2008 plans taken from CMS 2008 PDP Landscape Source (v. 09.25.07) available at
http://www.cms.hhs.gov/prescriptiondrugcovgenin/.
plan leads to more frequent choice of money market or bond options rather than equity
investment. Iyengar and Lepper (2000) also find that satisfaction with choices made falls
with the size of the choice set in several experimental settings.
Another recent literature has shown that the nature of how choices are presented can have
important impacts on choice. For example, Hastings and Ashton (2008) examine financially
illiterate individuals choosing across retirement funds in Mexicos privatized Social Security
system. They find that presenting information on plan administrative fees in pesos, rather
than in percentage terms, causes a significant shift in choice towards lower fee plans. In
another study, Chetty, Looney, and Kroft (2007) find that consumers are much more sensitive
to tax rates when the tax burden is included in posted prices rather than added at the register.
These issues may be paramount within the context of the elderly, given that the potential
for cognitive failures rises at older ages. Salthouse (1996) shows clear evidence that the
performance on a series of memory and analytic tasks declines sharply after age 60. Part
of the reason for this may be the rise in incidence of dementia with age; starting at age 60,
dementia rates roughly double every five years (Fratiglioni, De Ronchi, and Aguero (1999)).
A recent study by Agarwal, Driscoll, Gabaix, and Laibson (2010) shows that in ten different
contexts, ranging from credit card interest payments to mortgages to small business loans,
the elderly pay higher fees and face higher interest rates than middle-aged consumers. These
types of findings raise particular concern about choice in the Part D context.
2.2.3 Previous Studies of Part D Choice
We are aware of only three previous studies of these issues in the context of Part D. The first
is a set of studies by Dan McFadden and colleagues, as summarized in Heiss, McFadden, and
Winter (2006). These researchers surveyed a set of elders about their plans for enrolling in
Part D programs, and evaluate whether enrollment intentions in the plan were rational given
the penalties for delay. They find that 71% of potential enrollees were making the appropriate
decision (under various assumptions about discount rates, etc.), while 10% of enrollees did
not intend to enroll when it would be in their interests to do so, and 19% intended enroll
when it would be in their interest to delay. Thus, for most potential enrollees, the decision
over whether to enroll seems to be made rationally.
Their findings are less sanguine, however, for choice of Part D plan. This survey offered
individuals a choice of the standard plan described above versus alternatives that provide
different levels of insurance coverage (e.g. catastrophic only, complete coverage, etc.), with
corresponding actuarially fair premiums. They find that only about 36% of enrollees choose
the cost-minimizing plan, and they do not place much value on the insurance aspects of more
comprehensive plans. They conclude that consumers are likely to have difficulty choosing
among plans to fine-tune their prescription drug coverage, and do not seem to be informed
about or attuned to the insurance feature of Part D plans.
While this is an interesting set of findings, it provides only a preliminary look at the
crucial issue of plan choice. These conclusions are based on data which do not contain pre-
cise detail about the prescription drugs used by individuals; assumptions about utilization
are made using aggregate imputations from other sources. Moreover, this is based on hypo-
thetical choices across a set of non-existing plans; individuals may become educated about
the program when they are actually faced with plan choices. Thus, the failures of choice
documented by Heiss et al. (2006) may not hold when we use data on actual individual
utilization and choices.
A recent paper by Lucarelli, Prince, and Simon (2008) uses aggregate data on plan market
shares to conduct a study of how plan features impact demand and to undertake a welfare
analysis of choice restrictions. They estimate sizeable welfare losses from limiting the option
set facing seniors. But they do so in a framework which assumes that seniors are choosing
optimally so that by definition restricting the choice set can only be harmful. Without
individualized data on plan choices, they are unable to evaluate the underlying efficacy of
plan choice.
Most closely related to our work is a recent field experiment by Kling, Mullainathan,
Shafir, Vermeulen, and Vrobel (2008). They examine how providing people with information
about the relative costs of each of the available plans in 2007 computed using their 2006
claims impacts their choices. They find that individuals who receive this intervention are
more likely to switch plans, and more likely to end up with lower predicted and realized
costs. Using our richer dataset on patient claims, we are able to model the individualized
risk characteristics of plans in addition to looking just at average costs. Our model is also
more general in terms of sample and implications. While they investigate the consequences
of one particular intervention on a sample of patients at a single hospital, our model allows
us to calculate the potential welfare gains from reforms which change the structure of the
choice set, and to do so for a large fraction of Medicare Part D enrollees.
2.3 Data
Our primary data source is a longitudinal sample of prescription drug records from the
Wolters Kluwer (WK) Company. They are the largest switch operator in the prescription
drug market: they collect the electronic claims from pharmacies and pass them on to the
Pharmacy Benefit Managers (PBMs) and insurance companies that will pay the claims.
After adjudicating the claim, it is passed back through the switch to the pharmacy. WK
performs this function for a large sample of pharmacies throughout the U.S. Once pharmacies
are in their sample, there is a 93% chance that they remain enrolled, so this is effectively
a longitudinal sample of pharmacies. On average the claims captured by the WK system
represent almost 31% of all 3rd party prescription claims filled in the U.S. 8 The geographic
distribution of these data is very closely representative of the geographic distribution of
3rd party claims as well; the correlation between the WK market share and the overall 3rd
party market share across each of the states is 0.86. WK keeps a longitudinal file that tracks
prescription drug use for more than 100 million persons in the U.S. They have made available
to us for research purposes a longitudinal sample of prescription claims for any individuals
age 65 and over in 2005. These data are crucial because they are the only available data (of
which we are aware) that contain information both on specific drug utilization by elders and
on plan choice. Information about specific drug utilization is key because plan costs vary
tremendously based on drug utilization, as we discuss below.
We begin with a sample of 1.53 million elders who (a) have a Part D claim with coverage
of any sort (e.g. past the deductible), (b) are not employer-insured, dual eligibles or eligible
for low-income subsidies/partial subsidies, (c) have claims for only one region of the country,
(d) have no claims with missing payment information, (e) are in the sample of consistently
8 Figure based on data provided by WK for Q3:2006.
reporting pharmacies, and (f) have data for both 2005 and 2006. This data file has a
rich set of information about every drug claim for individuals in the longitudinal sample,
including information on: month in which the prescription was filled; county of location
of the pharmacy; a de- personalized patient id which allows longitudinal patient linkages;
patient age; NDC code for the drug; quantity measures (days supply, dosage, package size);
patient and insurer payments; and insurer or PBM name. The total drug price is computed
as the sum of patient and insurer payments; one or both of these values are blank for a
small fraction of claims, and individuals with these claims are dropped. We constructed a
crosswalk between the drug ID variable in the claims data and the NDC numbers listed on
the formulary using a file from First Data Bank. To allow for the possibility of substitution
if individuals were enrolled in a different plan, we constructed a coarser drug ID variable
which is unique only up to drug name and assumed that individuals could substitute to the
cheapest drug with the same name were they enrolled in an alternative plan.
WK has created a sample for us that links longitudinally all claims from elders that fill
prescriptions at a pharmacy in their sample. Thus, there are three types of attrition from
the sample. First, elders may die (in which case we still observe all of their claims). Second,
pharmacies may enter or leave the sample. This can be addressed by using only pharmacies
that are continuously in their sample.' Finally, individuals may switch pharmacies. If the
switch is to a pharmacy within the WK sample, then the company does a detailed statistical
match to ensure that the patient is captured and matched to other prescriptions (based on
the de-identified form of data fields such as first name, last name, date of birth, year of birth,
gender, health insurance id and zip code). If the switch is outside of the WK sample, then
the individuals will be lost to this sample.
Unfortunately, there is no way to capture such transitions. So long as these transitions
are not correlated with premiums, it will not bias our price elasticity estimate; so long as
they are not correlated with plan cost sharing provisions, they will lead only to a general
understatement of out-of-pocket spending that will lead us to overstate that coefficient. We
can assess their importance by taking advantage of the fact that Wolters Kluwer provided us
9 A store is flagged as continuously enrolled provided that the store does not miss more than 11 days
(including weekends and holidays) of reporting in a month.
with a coverage level variable which indicates the proportion of pharmacies in each county
which are covered by Wolters Kluwer. We have rerun our models on the 10% of counties
where WK covers at least 40% of all third-party prescriptions, and our results are very similar
to what we report below. This suggests that attrition is not significantly biasing our results.
2.3.1 The CMS Plans Database
We obtain information on availability of Part D plans and specific plan features directly from
four files provided by CMS: the plan information file, the beneficiary cost file, the formulary
file and the geographic locator file. The plan information file lists plan names and identifiers,
and regions/counties in which plans are offered. The beneficiary cost file contains copays
and coinsurance rates for different tiers of each plan. The formulary file contains a list of
all the drugs that are included on the formulary for each plan. The geographic locator file
allows us to identify all the Social Security Administration (SSA) counties that correspond
to different PDP and MA regions.
The major strength of the CMS data is that it allows us to fully parameterize any elders
plan choice set based on their location. We have used these data to build a cost calculator
that mimics the calculator provided on Medicares web site. This calculator uses a given set
of prescriptions for a given elder to compute their projected out of pocket spending in each
plan available in their county.
2.3.2 Matching patients to their Part D Plan
One challenging aspect of the WK data is that we know each patients county and the name
of the company that provides the Part D plan that is covering each prescription, but not
specifically which Part D plan offered by that company is covering the prescription. For
example, we know that an elder is covered by a Humana product, but not whether it is
Humana Complete, Humana Enhanced, etc.
Fortunately, we can resolve this matching problem in most cases by using a combination
of county code, company name, and copayment structure. For each claim and each of the
plans within the same company offered in a particular county, we check if the copay that the
patient paid for this claim matches any of the prescribed copays of the plan. We assign a
person to a plan if most of their claims match to the same unique Part D plan. We carry out
this exercise for each month. To confirm that a person has been matched to a correct Part
D plan, we look at all the months together and insist that a person be consistently matched
to the same plan in each month from June 2006 on, since enrollment into Part D plans was
open until May 15th 2006.
Of the approximately 1.53 million individuals in our sample, 50.5% were matched to Part
D plans. The remainder were excluded either because they had a large number of non-Part
D claims (implying that they have some other form of coverage), because they had too few
claims to reliably match, or because their copays were inconsistent with the copays listed for
Part D plans in their region.
Of the matched individuals, 57.1% were uniquely matched to a Part D plan, and 42.9were
multiply matched (meaning that more than one Part D plan was consistent with their co-
pays). While the unique matches are clear, excluding multiple matches leads us to misstate
the proportion of enrollment in some plans. This problem is especially severe among Humana
plans because Humana offers several plans which differ only in the deductible and donut hole
coverage and thus cannot generally be distinguished on the basis of copays. While compris-
ing 20% of all matches, Humana plans are only 10% of unique matches. To deal with this
problem, we include both unique and multiple matches, with multiple matches randomly as-
signed to one of the plans to which they are matched with probability equal to the proportion
of total national enrollment in that plan in 2006.
2.3.3 Construction of Out of Pocket Cost Variables
The total enrollee costs of Part D can be decomposed into premiums, which are known for
certain at the time of plan choice, and the distribution of out of pocket costs given the
information available at the time when plans are chosen. Our focus is on estimating the
distribution of costs given all of the information potentially available to individuals at the
time when they make their choice. There are three reasons that estimating this distribution
is challenging: first, we only observe realized out of pocket costs for the plan in which an
individual is enrolled; second, we observe only a single realization of out of pocket costs for
each individual (making it impossible to compute a variance measure); and third, we do
not observe all of the information available to individuals at the time when they make their
choice.
To handle the first difficulty, we assume that the set of 2006 claims is fixed and would
remain constant had the individual in question chosen a different plan; that is, we assume
no moral hazard. This assumption allows us to use the calculator to determine what each
individuals realized costs would be for each plan in their choice set. Given typical estimates
of the elasticity of prescription drug utilization in the range of 0.2 to 0.5, and considering
that this would only impact our results to the extent that individuals have sufficient foresight
to take into account future utilization effects in their plan choices, this is a fairly innocuous
assumption, as shown in Appendix A available in the online version of this paper.
To handle the second difficulty, we sample realized costs from 200 individuals who are
identical to the individual in question at the time when the plan choice is made. In practice,
we define identical as individuals with the same decile of 2005 drug expenditures, 2005 days
supply of branded drugs and 2005 days supply of generic drugs; after extensive searching, we
found that this combination provided the best prediction of 2006 prescription drug spending
based on 2005 characteristics. We therefore assign each individual to one of 1000 cells de-
marcated by the interacted deciles of these measures. We restrict our sample to individuals
for whom there are at least 200 other individuals in their cell, and we use these 200 individ-
uals in each cell to compute both our rational expectations measure of utilization in 2006
(described below) and our variance measure.
The third difficulty is that individuals may actually know more than can be predicted
given 2005 costs at the time when they make their plan choices. Intuitively, we can attempt
to determine whether individuals know more than can be predicted given 2005 costs by
analyzing whether their choices are sensitive to the component of the variation in realized
costs across plans which cannot be predicted given 2005 characteristics. We discuss a model
of this type in
2.4 Final Sample Creation
Under Part D individuals could enroll not only in a stand alone PDP plan, but also in a
more comprehensive MA plan; we distinguish between individuals matched to MA and those
matched to PDP plans based on copay and exclude the former. We focus just on PDP plans
(and therefore, just on individuals who chose PDP plans) because MA plans involve broader
health care decisions which are beyond the scope of our data (e.g. regarding HMOs and fee-
for-service plans). This exclusion is justified by the independence of irrelevant alternatives
assumption that underlies our logit modeling, as discussed (and tested) further below. We
also exclude individuals who have fewer than 500 observations in their state or fewer than
100 observations in their brand/state cell to increase the speed of estimation of the model
by reducing the required number of brand/state fixed effects; this restriction has no effect
on our final results.
Our final sample consists of 477,393 individuals. The typical patient in this sample is
almost 75 years old, three-fifths are female, and they have an average of 34 claims per year.
Their total prescription drug spending averages $1,711 per year. While some individuals
were enrolled in Part D for the full year, others enrolled as late as May. The average total
premiums paid after enrollment was $287 and the average OOP costs paid out over the
same period was $666. This is the sample used in the efficient frontier analysis below. In our
conditional logit models, we randomly subsample 20% of these individuals for computational
reasons. We estimate the more computationally demanding random coefficients models on
a randomly chosen subsample of 15,000 patients.
The distribution of enrollees across Part D plans is highly correlated in this final sample
with the national facts on PDP enrollment provided by CMS. The correlation between the
share by brand in our sample and the CMS sample is 0.98, and the correlation between the
share of our sample in the top 10 plans is correlated with the CMS reported share in those
plans at 0.89 (the correlation for the top 100 plans is 0.91).
2.5 Facts on Plan Choice
To motivate our regression framework, Figure 2-1 shows the basic facts on the relationship
of plan choice to total plan costs. For each individual in the data, we estimate the total
cost of enrolling in each PDP plan in their county, adding both premiums and expected out
of pocket costs. We then estimate the difference in total costs between the plan chosen by
that individual and the lowest cost plan in their county. For this exercise, we use a perfect
foresight model of expectations, using actual 2006 expenditures to estimate the costs that
individuals face in each plan.
As Figure 2-1 shows, only 12.2% of individuals choose the lowest cost plan in their state.
Indeed, on average, individuals could save 30.9% of their total Part D spending by choosing
the lowest cost plan rather than the plan they chose. If we redo these calculations using
actual 2005 expenditures, or predicted 2006 expenditures based on 2005 expenditures rather
than actual 2006 expenditures, we find even stronger deviations from the lowest cost plan. 10
Of course, individuals are not simply choosing a fixed payment stream when choosing a
Part D plan; individuals who are highly risk averse may explicitly be choosing plans with
higher mean expenditure to protect themselves against variance in expenditure. Yet this
does not seem to be the case. Even if we only include plan choices where the variance is
non-increasing, over 70% of enrollees could have chosen a lower cost plan, and the typical
enrollee could have saved 23.3% of their Part D expenditures without raising their variance."
The explanation for these facts is shown in Figure 2-2, which shows the choice set for
individuals in California. The X axis in this graph is the mean of total costs for each plan,
and the Y axis is the average standard deviation in costs (where the standard deviation is
computed using the 1000 cell method, and the average is taken across individuals). In this
graph, there is a clear efficient frontier of plans which dominate others in terms of both
'OIt appears that some plans may have offered low premiums in 2006 in order to entice consumers to choose
their plan in the first year of the Part D program before raising their premiums in subsequent years. This
behavior should not impact our analysis except insofar as there are large switching costs because consumers
have the option to switch plans after each year, but one might still wonder to what extent the above results
are driven by such plans. To assess this issue, we repeated the above analysis using the 2007 premiums for
all plans and found that the average potential cost savings fell slightly from 30.9% to 25%.
"The fact that this number is smaller than the 30.9% number is because we are searching for cost savings
over a small set of plans, not because individuals are especially sensitive to risk, a point we document further
below.
cost and variance. This graph masks considerable heterogeneity across individuals: different
plans lie on the efficient frontier for different individuals, so the fact that a plan lies off
the efficient frontier in this graph does not imply that it is suboptimal for each individual.
Nonetheless, most of the plans are well off the efficient frontier, meaning individuals could
have either lowered their mean costs or their variance by picking a different plan.
As we will document below, one reason for the large amount of choice off the efficient
frontier is that individuals consider plan characteristics in making their choices but not how
those plan characteristics matter for themselves. This is perhaps best illustrated by a simple
examination of the decision to choose a plan with donut hole coverage. Figure 2-3 shows
the probability of choosing donut hole coverage, and the financial implications of doing so,
sorted by 2006 spending percentiles; the results are once again similar for other measures
such as 2005 actual spending or 2006 predicted spending. The bottom line shows the percent
of the population at each percentile choosing donut hole coverage; the top line shows the
average savings for individuals in that quantile from switching from the lowest cost plan in
their region which offers donut hole coverage to the lowest cost plan that does not.
The plans which offer donut hole coverage actually have slightly inferior coinsurances
relative to the lowest cost non-donut hole plans in the initial coverage range, and so the cost
of donut hole coverage is rising with expenditures until the point when individuals become
likely to enter the donut hole.
The results here are striking: the percentage choosing donut hole coverage is virtually
flat throughout the spending distribution at around 10%. Even if individuals are willing to
pay extra in mean costs for the protection provided by donut hole coverage, it is hard to
rationalize the fact that the same proportion of individuals in the 10th and 85th percentile
of the spending distribution choose donut hole coverage.
2.6 Base Model of Part D Plan Choice
In this section, we extend the efficient frontier analysis presented above by considering several
discrete choice models. These models serve three general purposes in our setting. First, they
allow us to control for additional plan characteristics such as plan quality. Second, they allow
us to understand more precisely how preferences combine with choice set characteristics so
we can forecast how individuals might choose in counterfactual choice environments. Third,
they allow us to quantify the welfare consequences of choices. We begin by specifying a
CARA utility model with a normally distributed cost distribution:
U(C) = - exp(-y(W - C)) where C~ N(p, a2 ) (2.1)
In this case, indirect utility is given by:
1
u(,, a2 ) = EU(C) = -a exp(Y7p + 72 0 2 ) (2.2)
2
where a = - exp(-yW) is a constant. A first-order Taylor expansion about the point (p', o2')
yields:
u(p, a) u(p' o') - ayu(', )( - p) - -a y2u(p' 2')(a2 _ p2') (2.3)
We can write total costs as C =± 00P and since 7 is known for any given plan, Var(C)
Var(OOP) = o2 and y = E(C) = + E(OOP) = I + p2. Adding an error term (and
dropping constant terms) we can rewrite the approximate indirect utility as:
U = -a'yu(p', o2')(7r + *) - CaY2u(r*, 02')ar2 + 6 (2.4)
2
This maps into a conditional logit model of plan choice where the utility of individual i from
choosing plan j is given by:
Ui = r7j O + pij + U3 2 + xjA + qb(j) 6 + Cij (2.5)
with #0 = ayu(p*', o2') and #2 = -'ajy 2 n(,-* a2'). In this equation x represents any
financial plan characteristics which impacts choice, qb(j) represents plan quality ratings and
other non-financial aspects of plans (which vary only across brands), and eij are i.i.d. type
I extreme value random variables.
This gives us -y = 20 which allows us to map the ratio of the coefficients on the vari-
ance of costs and the coefficient on the mean of costs into the coefficient of absolute risk
aversion. This assumes that wealth is constant across all states of the world: the only risk
facing individuals is uncertainty about the distribution of out of pocket costs. The same
expression would hold if we added idiosyncratic risk that was uncorrelated with prescription
drug expenditures, but it is not implausible that there would be correlated risks: in states of
the world where prescription drug expenditures are higher, other medical expenditures are
higher as well. Such correlated risks would tend to bias upwards our already low estimates
of risk aversion.
We include in our model several financial plan characteristics beyond premiums, out of
pocket costs, and the variance of out pocket costs. These are: the deductible of the plan; a
dummy for whether the plan covers all donut hole expenditures; a dummy for whether the
plan covers generic expenditures in the donut hole only; and a cost-sharing index. The cost
sharing index is calculated for each plan as the average percentage of expenditures covered
by the plan between the deductible and the donut hole. This variable differs from expected
out of pocket costs in that it has the same value for everyone in the sample for each plan,
and because it is not directly impacted by whether plans have deductibles or donut hole
coverage. We also include two measures of plan quality: the share of the top 100 drugs used
by elders that is included in the plans formulary and a quality index. The quality index is
computed by CMS on a 1-5 scale by aggregating consumer ratings at the brand level collected
along 17 dimensions which are categorized as Customer Service, Drug Pricing Information
(availability / rate of price changes), and Using Your Plan to Get Your Prescription Filled.
Identification is a natural concern in this context. All of the plan characteristics included
in our model may be endogenous due to unobserved demand factors, and they may be
biased by correlation with unobserved plan characteristics. To address this concern, we
observe and include in our model all of the publicly available information that might be
used by individuals to make their choices. We also consider models where we control for a
full set of brand dummies, as well as a full set of interactions of state dummies with brand
dummies. When we include brand dummies, the coefficient on the quality index (which is
measured at the brand level) is no longer separately identified although it can be recovered
by a GLS regression of these dummies on the quality variable. When brand-state dummies
are included, coefficients on plan characteristics such as the premium, deductible and donut
hole coverage are identified by the variation across plans offered by the same brands in a
given state.1 2
Even with these fixed effects, it is possible that premiums are endogenous because they
are set based on brand-state specific assessments of demand conditions. If premiums are
higher in regions where insurers anticipate more demand for their particular plan (relative
to other plans offered by the same insurer), our estimate of the coefficient on premiums will
be biased towards zero since individuals will appear to be less averse to higher premiums. To
the extent that these factors make high premiums appear less undesirable than they actually
are, our conclusion that premiums are overweighted relative to out of pocket costs would be
strengthened, as would our estimates of the welfare loss due to consumer mistakes.13
2.6.1 Restrictions on Preferences
The model laid out above suggests three natural restrictions on preferences which extend
the efficient frontier concept to the discrete choice setting.
Restriction 1 : 30 = #1 (2.6)
This restriction states that the coefficient on premiums should equal the coefficient on ex-
pected out of pocket costs. Controlling for the risk characteristics of plans, individuals should
be willing to pay exactly one dollar in additional premiums for coverage which reduces ex-
pected out of pocket costs by one dollar. If this restriction fails to hold, individuals are not
choosing on the efficient frontier: they could switch to alternative plans with comparable
risk characteristics but lower total costs.
Restriction 2 : A = 0 (2.7)
1 2 For instance, in many states Humana offers a Standard plan with lower premiums but limited coverage,
an Enhanced plan with higher premiums but no deductible, and a Complete Plan which offers superior cost
sharing and full donut hole coverage at much higher premiums.
1 3 We did attempt estimating the models reported below using two instruments using the control function
approach: these were the average premium for a given plan in all states where the plan is offered (designed
to avert local demand shocks) and a marginal cost instrument constructed using the average covered expen-
ditures for individuals enrolled in the plan. In both cases, the magnitude of the coefficient on premiums
increased in the IV models. We are not confident that the exclusion restriction is satisfied for either of these
instruments, so we continue to estimate the model without an instrument below.
This restriction states that financial plan characteristics other than premiums, expected out
of pocket costs and the variance of out of pocket costs do not impact choices. Individuals
should not care about deductibles, donut hole coverage or copays per se; they should only
care about these factors to the extent that they impact the distribution of out of pocket
costs. Once we control for this distribution, these factors should be redundant.
Restriction 3 : #2 < 0 (2.8)
This restriction states that individuals should be risk averse.
While these restrictions follow naturally from utility maximization with full information
and standard preferences, the model from which they are derived makes several important
functional form assumptions: we assume that the distribution of out of pocket costs can be
summarized by its mean and variance, that indirect utility is a linear function of this mean
and variance, and that the errors are i.i.d. type I extreme value. In Appendix A, we show
that the restrictions assumed in the previous section still hold even when these functional
forms assumptions are weakened."
Of course, it is always possible to write down preferences that would violate the above
restrictions, but these restrictions are generally compatible with commonly used expected
utility functions given the observed cost distributions.
2.7 Results
In this section we present the results from the conditional logit model described above. At
the outset, it is important to mention that the results we present here are not very sensitive
to misspecification or measurement error. Appendix A-C (available in the online version)
investigate these issues extensively via simulation. We take the distribution of realized costs
observed in the data for each of the 1000 cells, assume it is the true distribution, and simulate
individuals choices using known utility functions by assuming individuals maximize expected
14 In particular, we simulate choices using the actual distribution of costs and several commonly used utility
functions (CRRA, CARA) with varying levels of risk aversion. In some cases, the restrictions do not hold
exactly, but the violations are much smaller in magnitude than we observe when we estimate the model
using actual choices.
utility. We then investigate to what degree the above restrictions on choice are violated if
we add various types of known misspecification or measurement error. For example, if the
true utility function is CARA with risk aversion 1, does estimating the model in the logit
framework with linearized indirect utility generates choice inconsistencies? What if we only
observe a noisy measure of OOP costs which contains attrition and measurement error?
The upshot of this analysis is that with very large risk aversion or substantial amounts of
measurement error, we do sometimes observe statistically significant choice inconsistencies,
but these are always smaller in magnitude than we report below and have inconsistent signs.
In our discussion below, we make this comparison more explicit.
2.7.1 Base Results
Table 2.1 reports the results from several conditional logit models. Model (1) includes only
the premium, realized out of pocket costs,the variance of out of pocket costs, and the quality
variables. As noted in the discussion of the cost variables, expected out of pocket costs
meaning the individuals expectation of out of pocket costs at the time of plan choice is
not directly observed, so we use realized costs as a proxy for expected out of pocket costs.
This proxy has noise (where noise includes the component of realized costs unknown to the
individual at the time when the choice is made) and so its coefficient is biased downwards.
We address this problem at length in the next section and show that it does not much impact
our conclusions.
The cost variables premiums and out of pocket costs are measured in hundreds of dollars.
Model (1) therefore shows that a $100 increase in premiums leads to a 32% reduction in the
probability that a given plan is chosen, implying an average elasticity of -0.75.15
There are two ways to interpret the remaining coefficients. First, we can divide by
the premium coefficient in order to compute the willingness to pay in dollars for a one
unit increase in the characteristic. Second, the coefficient itself can be interpreted as the
percentage increase in the probability that a plan is chosen from a one unit increase in
15 The implied elasticity varies across plans based on premium level and market share. The 32% number
given in the text is derived from the equation . Thus, for which holds for a large number of plans, we can
interpret as the percentage change in associated with a one unit change in .
the characteristic provided that probability is small (as it is for most plans). When we
compare models estimated using actual choices with simulations, we compare the implied
dollar value of plan characteristics computed by dividing by the coefficient on premiums. This
is because the scale of the coefficients is determined by the proportion of choices explained
by the included variables, and in the simulations, this scaling factor is arbitrarily set by
whatever standard deviation we assume for the structural error term. We can and do use the
simulations to compare ratios of coefficients with the actual results, but nothing substantive
can be inferred from the absolute magnitude of the coefficients in the simulation. Two points
about the model (1) results are noteworthy. First, the coefficient on out of pocket costs is
only about as large as the coefficient on premiums, violating Restriction 1. Second, the
coefficient on the variance term is negative and significant, but extremely small, implying
risk aversion substantially less than we obtained in the simulations with CRRA = 1.
Model (2) adds additional covariates to control for deductibles, donut hole coverage,
average cost sharing, formulary coverage and plan quality. Many of these covariates enter
the model with significant coefficients. When we add plan characteristics, the coefficient on
premiums increases suggesting that it was initially biased downward due to omitted variable
bias. The coefficient on the variance term drops even further once we add a control for the #
of the most popular 100 drugs which are included in the plans formulary. One explanation
for this is that that while individuals prefer plans which cover more drugs, they do not have
sufficient foresight to choose plans which cover drugs which they (or at least people in their
cell) might need in the future but are not already taking. Alternatively, it may be that there
is substantial measurement error in the variance term, and that # of top 100 drugs is a
proxy for the variance. Models (3) and (4) add brand dummies and brand-state dummies
respectively. The coefficient on premiums actually shrinks once we include brand-dummies,
but the effects of the premium remain large; a $100 increase in annual premiums leads to a
50% reduction in the probability that a plan is chosen, corresponding to an average elasticity
of - 1.17. The coefficient on out of pocket costs has similar magnitude across all of the models,
which reflects the fact that it is identified based on individual variation. In columns (3) and
(4) the coefficient on the premium is more than five times as large as the coefficient on out
of pocket costs.
The coefficients on plan characteristics are also very large in all specifications. Controlling
for the out of pocket cost consequences, model (4) which has the smallest plan characteristics
- suggests that individuals are willing to pay over $300 for full donut hole coverage, $50 for
generic donut hole coverage, about $80 to go from a deductible of 250 to a deductible of 0,
about $80 to go from the plan with the least cost sharing (25%) to the plan with the most
cost sharing (65%), and $12 for each of the top 100 drugs which appear on the formulary.
These numbers are not enormous, but they are an order of magnitude larger than the results
in the simulations,16 and have non-trivial consequences for the welfare evaluation of plan
choice as we investigate in the welfare analysis section.
It is important to underscore the fact that these numbers are not the full hedonic value of
those plan characteristics these are the willingness to pay above and beyond the implications
of those plan characteristics for out of pocket costs.17  Because individuals appear to be
underweighting the individualized component of out of pocket costs, we can interpret these
numbers as saying: individuals are willing to pay a price in premiums for desirable plan
characteristics, but this price is insufficiently sensitive to their individual circumstance.
We noted above that in some of the Appendix simulations, plan characteristics had
statistically significant coefficients even controlling for out of pocket costs, due to (imposed)
measurement error or misspecification of the utility function. We might worry that the
results using actual choices likewise reflect these factors rather than choice inconsistencies.
The coefficients on plan characteristics estimated using actual choices imply larger dollar
values for plan characteristics than do the simulations, however. For example, our estimate
16 For comparison, in the simulations where true utility is CRRA with risk aversion of 10 (misspecification
is increasing in risk aversion), we estimate - controlling for OOP costs - a $9 value for full donut hole coverage,
a -$8 value for generic donut hole coverage, a $33 value of moving from a $250 deductible to a 0 deductible,
a $32 value of going from the plan with the least cost sharing to the most cost sharing, and -$1 for each of
the top 100 drugs which appear on the formulary (since these values are driven entirely by misspecification
in the simulations there is no reason the signs should be sensible).
17 To recover the hedonic value of plan characteristics, it would be necessary to add the values reported
below to the values of plan characteristics implicit in our out of pocket cost measure. We can attempt to
recover these values by regressing our OOP cost measure on plan characteristics controlling for individual
fixed effects. This procedure will give biased results to the extent that plan characteristics not included in
the regression impact out of pocket costs so we try not to lean heavily on this exercise when interpreting
the above results. Nonetheless, we report the results of this regression here for reference: $88 increase in
OOP cost for a $250 deductible, $99 decrease in OOP costs for full donut hole coverage, $12 decrease for
generic donut hole coverage, $810 decrease moving from cost sharing of 0% to cost sharing of 100% (or $324
moving from the 25th percentile plan to the 75th percentile), and a $1.3 decrease for each of the top 100
drugs covered.
of the implied value of donut hole coverage controlling for OOP costs is larger than the
average OOP cost savings from donut hole coverage observed in our data, so even with
infinite measurement error in OOP costs, the simulations could not match what we observe.
Thus, formal modeling of choice reveals a violation of all three of the preference restric-
tions we laid out above. The coefficient on premium is an order of magnitude larger than the
coefficient on out of pocket expenditures; generalized plan characteristics enter the model
highly significantly, even conditional on individual out of pocket risk; and individuals are
not willing to pay more for plans with lower variance in expected spending.
One potential shortcoming of our last conclusion, however, is the reliability of our variance
measure. We compute the variance by assessing the variability in out-of-pocket spending
across a sample of similar individuals; we have tried several alternative specifications of risk
preferences (such as including quantiles in the right-tail of the distribution of costs) and this
does not appear to alter our results. We have also constructed alternative cells for a subset of
the sample which also take into account information on the particular drugs each individual
uses, and have found that our current method captures more than 90variance term across
plans. It is not a foregone conclusion that the coefficient on our variance variable would
be zero even if elders do not explicitly consider the cost of alternative plans under a range
of hypothetical outcomes: if patients with a greater risk of getting sicker in the following
year also chose plans with more coverage, we might expect this to show up in the variance
variable even after we control for the average value of plan characteristics. The result appears
to buttress our finding that individuals are insensitive to the individualized consequences of
plan choice. Nevertheless, we place less weight on this last choice inconsistency because of
concerns about the appropriate specification and measurement of risk in our setting some of
which are discussed further in the robustness section.
2.7.2 Robustness
While our unique data set makes this analysis possible, the data do have a number of
shortcomings. In this section we show the robustness of our basic conclusions to efforts to
address these shortcomings.
First, we are able to match only 50.5% of our sample of 1.53 million individuals to Part D
plans, partly because we use very stringent criteria designed to minimize false matches. The
cost of such an approach is that our matched sample may not be representative of the full
sample of 1.53 million; in particular, the individuals in our sample have more claims because
that makes it easier to match them to a plan. We therefore consider a less stringent matching
strategy; in this less stringent match, we consider a copay as matched for a given claim if
the appropriate copay appears anywhere on the claims formulary, even if the copay listed
for drugs in that particular tier and days supply is not correct. We also accept matches if
just 50% of overall claims are matched rather than requiring that this threshold be exceed in
every month after the first Part D claim is observed. Using this strategy, we are able to match
1.28 million of our 1.53 million individuals, or 84%. The first column of Table 2.2 shows
the robustness of our findings to this alternative measure. None of our main conclusions are
altered. Our coefficients of interest are somewhat smaller than in the original sample, which
may be because we of noise introduced by being less stringent in our willingness to accept
matches, but the fundamental choice inconsistencies persist.
Second, a limitation of our approach is that we exclude individuals with low numbers of
claims, since our matching algorithm requires enough claims to identify the plan copayment
structure. This clearly leads to bias to our variance measure which is constructed by selecting
matched individuals in the same cell; this is yet another reason why we have less confidence
in the variance results than in our results for other forms of choice inconsistency. But there
is no reason why this should lend a particular bias to our other results; if anything, we might
think that failing to correctly specify the variance would make low OOP cost plans seem
more desirable (since they also have lower variance), thus biasing upwards the coefficient on
OOP costs. If this were the case, our results would be too conservative in reporting mistakes.
The exclusion of individuals with a small number of claims also raises selection issues,
since these individuals may make better choices or have systematically different price elastici-
ties. To address this problem, we have reestimated our model including additional individuals
who we have excluded thus far. First, assuming some serial correlation in claims behavior, we
can mimic the inclusion of low claims individuals in 2006 by including those with no claims
in 2005 (we have excluded them thus far to allow for the creation of our variance measure
and the rational expectations measure used below). We reran our base-case discrete choice
model using a random sample drawn from the larger sample including individuals with 0
claims in 2005. In our original sample, the variance variable was constructed by assigning
each individual to one of one thousand cells based on 2005 claims. Because all of these
individuals are identical in 2005, we assigned all of them to a single cell, and computed the
variance by running 200 randomly chosen individuals in that cell through every plan. The
results of this analysis are shown in column 2, and they do not differ much from our original
results.
In column (3), we extend this analysis further by restricting the analysis to those who
have zero claims in 2005 and fewer than 12 claims in 2006; this is the closest we can get to
the zero claim sample in 2006 while still matching plans. The results are once again quite
similar.
Third, we include in our analysis both unique matches and multiple matches, imputing
the latter based on market shares. This adds a degree of noise to our estimation that could
plausibly bias the results. We address this issue in two ways in Table 2.2. First, we reestimate
the model including only those multiple matches where we can identify the plan with 95based
on the relative enrollment given by CMS for the matched plans in the patients state (e.g.
one of the plans has at least 19 times the enrollment of the other matched plans combined).
Including unique matches, this was 75% of the original sample. Going further, in column
5, we reestimate the model only with those observations for which we can make a unique
match. Neither of these changes alters any of our main conclusions.
Fourth, we do not know with certainty which individuals in our sample are dual eligibles.
If we mistakenly include dual eligibles in our sample, we will measure them has having a
lot of variation in OOP costs when they really have none, so we wrongly interpret them
as insensitive to OOP costs. We are fairly confident, however, that we are excluding dual
eligibles from our sample because they have such a limited range of possible copayments.
For example, for 90% of the observations we use, more than one-quarter of their claims
have copayments which are inconsistent with being a dual eligible (e.g. more than $5). To
further ensure that problems identifying dual eligibles were not biasing our results, we have
reestimated our model only on individuals where at least 50% of their claims are inconsistent
with the copaymnent rates for duals. As we show in column 6 of Table 2.2, this has little
impact on our results.
Finally, in column 7, we show the impacts of decomposing further the aggregate quality
index that we have used in our work thus far. We decompose the index into its three primary
components. Doing so, we find that choice is positively associated with each of these quality
components. The most important characteristic of quality to consumers appears to be the
ease in filling prescriptions. Most importantly, decomposing the quality measure has no
impact on our results.
2.8 Misspecification and Measurement Error
In the previous section, we presented results from a conditional logit model of plan choice
and identified three apparent irregularities in choices. Our interpretation is that these results
reflect consumer errors plan characteristics are more salient than are their implications for
the distribution of out of pocket costs, and individuals are unable to compute the individ-
ualized risk characteristics of the alternative plans. In this section we consider two related
alternative explanation: we have misspecified out of pocket costs because we have failed to
appropriately model the information available to individuals at the time when they make
their plan choice; and that our findings are driven by measurement error in out-of-pocket
costs. Modeling Private Information
Thus far we have measured out of pocket costs using the realized cost measure constructed
from 2006 claims. An alternative measure that we consider in this section we label our
rational expectations measure. Recall that to create our variance measure we classified all
individuals into 1000 cells defined by deciles of 2005 total spending, generic prescriptions and
branded prescriptions, and ran the 2006 claims of 200 persons in each cell through the cost
calculator for that plan. This procedure generates a distribution of costs for each patient and
plan. Our rational expectations measure is defined as the mean of this distribution. Under
the strong assumptions discussed above (CARA utility and a normal distribution of costs),
the mean and the variance would completely summarize the impact of the cost distribution
on utility; our simulations in the Appendix A show that they summarize this distribution
well anyway even if these assumptions are relaxed.
It is useful to compare this rational expectations measure to the perfect foresight/realized
costs measure we have been using. The latter measure is too broad in the sense that it
includes information not available to individuals at the time when they choose (provided
that is, that they do not know exactly what their drug needs and drug prices will be for
the coming year). The former measure is too narrow in the sense that individuals may
have private information at the time they choose beyond what can be inferred from their
2005 costs. If a patient learns they have cancer just prior to choosing their 2006 plan, they
would correctly forecast that their drug needs would likely exceed the average of those with
similar 2005 spending. We address these concerns by developing a model with which we can
identify the information available to consumers at the time when they choose. The intuition
behind this model is that we can determine if individuals know more than we can predict
given just their 2005 spending by evaluating whether their plan choices are responsive to the
component of 2006 spending which is not known in 2005.
The formal derivation of this model is presented in Appendix B. In summary, we augment
our model in two ways. The first is to include a normally distributed term which captures
the degree of private information: the difference between actual out of pocket spending in
2006 and what we would have predicted for 2006 based on our rational expectations model.
If we were estimating a linear model, this would be comparable to, estimating our model
by instrumental variables, where we instrument the perfect foresight level of costs with our
rational expectations cost measure., which is independent of private information. In our
non-linear setting, the comparable correction is to include this noise term, which essentially
amounts to estimating a random coefficients model with one extra parameter to identify the
degree of private information.
Second, the measured variance from the 1000 cell exercise overstates the true variance
in costs because some of this variation represents variation in realized costs which is unpre-
dictable based on 2005 costs but is known to the individual at the time when they choose. We
develop a correction for the variance based on the estimated degree of private information.
Table 2.3 reports the results from estimating this model. For computational reasons, we
estimate this model on a much smaller sample by randomly selecting 15,000 patients from
our earlier sample. Column (1) reports our earlier results, column (2) reports the earlier
specification on the new sample, and column (3) the results from adding the term for private
information and correcting the variance. The model is estimated using the Laplace approxi-
mation developed in Jerry A. Hausman and Matthew C. Harding (2007) with bootstrapped
standard errors, including controls for the various plan characteristics.
The results in Table 2.3 suggest that there is substantial private information: individual
choices take into account about 60% of the variation in out of pocket costs which cannot be
predicted given their cell. We also continue to find that the coefficient on realized costs is
well below that on premiums, and that financial plan characteristics such as the donut hole
and deductible continue to enter highly significantly in this model. Therefore, two of the
major choice inconsistencies persist even when we model private information.
This model implies, however, that individuals know much of what their costs will be to
each plan in their choice set in the coming year so there is little insurance motive. Under
this interpretation, the variance in out of pocket costs is small for all plans because there is
little uncertainty. This means that any measured response to the variance term would imply
high levels of risk aversion, and that the standard errors in our estimates of risk aversion are
much larger than we concluded in the model ignoring private information. The risk index in
these models (obtained by dividing the variance coefficient by the premium coefficient and
multiplying by 200) is comparable to what we obtained in our Appendix B simulations for
CRRA = 3 with wealth = 17000.18
The bottom line from our models of private information is that our conclusions about
the gap between the premium and out of pocket expenditure coefficients, and the powerful
role for general plan financial characteristics in driving choice, are robust to a, wide variety
of specifications of out of pocket spending risk. Our conclusion about the low degree of
estimated risk aversion, however, is more sensitive to the precise specification of the model.19
18 As we highlight in Abaluck and Gruber (2008), the results reported in Table 2.2 are also consistent with
an alternative model of information where individuals are not using all available information, but rather are
paying attention only to a part of their prescription drug expenditures. For that portion to which they are
attentive. individuals are rationally weighting premiums and out of pocket costs in the same way in making
their decision. Yet individuals do not respond to variation in out of pocket costs beyond that portion. Under
this interpretation, we find that the degree of private information is smaller and the coefficient on the risk
measure once again becomes very small.
19
'To further explore robustness here, we also consider an alternative measure of predicted out of pocket
costs: predicting those costs based only on use of regular drugs. A regular drug is defined as any drug for
which the individual consumed at least 90 days supply in 2005. In our new measure, we construct the OOP
2.8.1 More General Measurement Error
The private information model can also be interpreted as correcting for a specific form of
measurement error in our model: that arising from idiosyncratic variation across individuals
in their knowledge about expected out of pocket costs at the time that they choose their
Part D plan. Our private information model is the non-linear equivalent to a linear model
that addresses measurement error in 2006 realized costs by instrumenting them by predicted
costs based on 2005 characteristics. The fact that our conclusions are robust to controlling
for private information is therefore equivalent to saying that instrumenting for idiosyncratic
measurement error across individuals does not change our conclusions. However, idiosyn-
cratic measurement error is only one of several types of measurement error in our out of
pocket cost coefficient. In this section we consider robustness to alternative forms of mea-
surement error. To model the impact of measurement error, we draw on the simulation
model developed in Appendix A, which captures the no inconsistency baseline. Without
measurement error, this model illustrates that choices under a variety of specifications of
risk would not demonstrate the inconsistencies we see in our data. We can augment that
analysis by adding measurement error in out of pocket costs to this simulation model, and
using predicted costs as our measure of OOP costs in the simulation. We consider three al-
ternative specifications of measurement error, and present the detailed results of our analysis
in Appendix C.
The first is purely idiosyncratic individual-specific measurement error in forming expec-
tations of out-of-pocket costs. Consistent with the discussion above, even with very large
error of this form we find that our simulated out of pocket and premium coefficients are
similar, and the coefficients on plan-specific plan charcteristics are very small; that is, our
predicted out- of-pocket cost is effectively acting as an instrument for measurement error in
this case.
We then consider a form of multiplicative error designed to mimic what might be observed
if there were attrition due to patients having claims at pharmacies not included in our data.
Our simulations then show that even sizeable attrition bias causes only a small upwards
cost variable assuming that drug use in 2006 will consist only of regular drugs in 2005. Our results are very
similar using this alternative measure.
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bias to the out-of-pocket coefficient, and causes only very modest coefficients on the plan
characteristics, an order of magnitude smaller than what we observe in our logit models.
The final simulation we consider is one in which there is a systematic plan-specific error,
perhaps because of errors in assigning individuals to the correct plans.
We consider a multiplicative specification to capture the fact that the impact of such
errors on OOP costs would likely be proportional to the number of claims an individual
possessed. In most cases, this once again leads to an upwards-biased out-of-pocket cost
coefficient, although if the error becomes large enough the bias becomes slightly downward
(but much less than in our regressions). In this case we do estimate some sizeable coefficients
on plan characteristics, with the coefficient on full donut hole coverage rising to 2/3 of what
we observe in our regressions, but the plan characteristic coefficients are not consistently
signed; we estimate a large positive coefficient on the deductible, for example, and a large
negative coefficient on generic donut hole coverage.
Thus, our simulations do not provide any evidence to suggest that our consistent pattern
of a small out-of-pocket cost coefficient and large plan characteristics coefficients are due to
measurement error. Rather, they appear to correspond to true choice inconsistencies.
2.9 Heterogeneity
The independence of irrelevant alternatives assumption that underlies the conditional logit
model places strong restrictions on how elasticities vary across plans and will lead to in-
consistent estimates if preferences are heterogeneous across the population. To address this
concern, we assess the robustness of our model to heterogeneity driven by both observed and
unobserved factors. We first note that our model already allows for a substantial amount of
individual variation: we estimated the coefficients on individualized out of pocket cost pa-
rameters. Nonetheless, it may still be the case that preferences vary in ways not included in
our model. In terms of observed heterogeneity, we have reestimated our model for a number
of separate samples: by gender; by age; and by tercile of the 2005 prescription drug expendi-
ture distribution. In every case, we find that our results are very similar across all samples.
In particular, each of these samples illustrates the three choice inconsistencies documented
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thus far: the premium coefficient is many multiples of the out of pocket cost coefficient;
financial plan characteristics enter significantly; and the estimated degree of risk aversion is
very low.
We therefore turn to considering unobserved heterogeneity. We use the Laplace approxi-
mation developed by Hausman-Harding (2007) to estimate a model with normally distributed
random coefficients on all included characteristics. Our goal here is primarily a robustness
check: does accounting for heterogeneity change any of our qualitative conclusions? Table
2.4 shows the results of this analysis. As before, column 1 is the original model on a small
sample. Column 2 adds random coefficients on premium, perfect foresight OOP, variance
and quality, while column 3 adds random coefficients on all variables. Again, we see that the
choice inconsistencies are present even after accounting for unobserved heterogeneity. Fur-
ther, the magnitude of the coefficients estimated in the model without heterogeneity (which
correspond to the mean of the random coefficients in this model) is not much affected. We
do estimate significant heterogeneity in the coefficients on premium, quality, the deductible
and the generic donut hole term; allowing for this heterogeneity turns out not to have a
significant impact on the welfare results we report below.
We can also interpret the results in Table 2.4 as a test of the IIA assumption. To the
extent that any of the coefficients are significant, this suggests that the HA assumption
does not hold exactly. Nonetheless, the fact that the magnitude of the coefficients does not
change substantially once we allow for random coefficients suggests that this assumption is
not altering our conclusions.
2.10 Conclusions and Implications
The new delivery mechanism for a public insurance benefit introduced by the Medicare
Part D program is a radical departure from the traditional public insurance model and an
exciting opportunity to understand the role of choice in the delivery of public insurance.
Using a unique data set we have provided the first evidence on the efficacy of the choices
made by individuals under Part D. While individual choices are consistent with maximizing
behavior such as preferring plans with lower premiums, lower out of pocket exposure and
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higher quality, they are inconsistent with the standard model in three important respects:
individuals underweight out of pocket spending relative to premiums; they overweight plan
characteristics beyond their own circumstances; and they do not fully appreciate the risk-
reducing aspects of plans for themselves.
Our conclusions do imply that the distribution of health insurance plan coverage would
be quite different if there were no choice inconsistencies. We estimate that the share of our
sample with some coverage in the donut hole gap would fall by 40% if these inconsistencies
were corrected. This would have led to a major shift away from Humana, the insurer that
offered the most generous donut hole coverage, towards other insurers.
Yet we also note that our are results are not inconsistent with those of Heiss, McFadden
and Winter (2009), who use survey data of individuals to document significant adverse
selection in plan choice. The fact that we estimate a non-zero coefficient on out of pocket
costs in our logit models is consistent with some adverse selection: controlling for premiums
and plan characteristics, individuals prefer plans which offer better coverage for the drugs
they plan to take. Our estimated degree of adverse selection is lower than that estimated
by Heiss et al., however. They estimate that among those with more than 3 drug claims
in a year, the odds of choosing some gap coverage is 10.5% higher than for those with 3 or
fewer claims; that difference is only 2.7% in our data. They also estimate that among those
with more than $2250 in prescription drug spending in a year, the odds of choosing some gap
coverage is 8.8% higher than for those with less spending; that difference is 7.4% in our data.
This difference in results between our analyses is partially driven by the fact that they have
individuals with zero claims in their data, while we do not in ours; although, as discussed in
the robustness section, our conclusions do not appear sensitive to that exclusion.
One means of assessing the implications of these findings is to consider the partial equi-
librium welfare gains that would occur were individuals making fully informed and rational
decisions about plan choice (ignoring, for now, any supply side considerations or compu-
tation costs; these are discussed later). If individuals were fully informed, their choices
would be given by the model estimated above but satisfying three additional restrictions:
the coefficient on premiums is equal to that on expected out of pocket costs; financial plan
characteristics other than premiums are excluded from the utility function once we control
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for the individuals expected out of pocket costs; and individuals exhibit risk aversion in their
plan choice. We assume that the coefficient on premiums represents the marginal utility of
a dollar if individuals were fully informed (this in turn determines the dollar value of quality
variables and risk characteristics).We define a normative utility function to include premiums
and out of pocket costs (equally weighted), variance and quality, and value the latter char-
acteristics in terms of dollars of premiums. We then ask: if individuals had chosen the plan
which maximizes this normative utility function rather than the plan which they did in fact
choose, by how much would utility be improved when assessed according to the normative
utility function?2 o The answer in this model is about 27% of total costs this is comparable
to the 30.9% we found when we looked only at cost savings. The small difference is due to
the fact that the lowest cost plans also have slightly lower quality ratings on average.21 We
can interpret the 27the potential partial equilibrium utility gains. If there were some inter-
vention that would make individuals fully informed and fully rational, this is the amount by
which their utility could be improved (in partial equilibrium). This large effect suggests that
policy makers consider reforms that realize some of these gains. Some possibilities include
directly providing individualized information about costs (as in Kling 2008) or appointing
surrogates such as doctors or pharmacists to play some role in plan choice.
A more difficult question is whether these findings justify actual restrictions in the choice
set facing seniors. As discussed in Abaluck and Gruber (2008), if policy makers are able
to restrict choice to the plans on the efficient frontier, there are sizeable welfare gains for
seniors (in partial equilibrium). It is unclear, however, whether policy makers would be able
to effectively
A full modeling of policy implications must also consider the general equilibrium impli-
cations. For example, restricting the size of the choice set may lower competitive pressure on
the supply side. Of course, there are possible reforms which would preserve the competitive
nature of the bidding process while reducing the number of plans ultimately offered to con-
20 Appendix D of Abaluck and Gruber (2008) contains the formula used to make this calculation as well
as a derivation.
21The 27alternatively impose a coefficient which corresponds to a coefficient of absolute risk aversion of
.0003 (roughly CARA = 3 with wealth of 17,000). In that case, the number rises to 27.6lowest cost plans offer
comparable risk protection to the plans which are actually chosen. distinguish such plans; simply restricting
choice to a random subset of plans does not raise welfare.
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sumers, such as first stage bidding across plans to offer one of a limited set of plan structures.
On the demand side, this analysis assumes that the estimated choice process is fixed. We
assume that individuals choose according to the same positive utility function regardless of
the size of the choice set any utility increases from smaller choice sets arise because there is
less scope for error. If individuals are in fact better able to evaluate alternatives in a smaller
choice set, then our analysis would understate the potential gains. Moreover, surveys indi-
cate that elders spend an average of 3 hours selecting their Part D plan (Kling et. al. 2008),
so the dollar value of the hours saved by dramatically simplifying the choice process may be
non-trivial as well. Our models do not distinguish between the case of boundedly rational
consumers choosing plans they trust as a heuristic given the time-costs of fully evaluating
choices, and the case where consumers simply err in underweighting out of pocket costs due
to a lack of cognitive ability. While this distinction is important for evaluating the potential
efficacy of providing consumers with additional information, it is less relevant to consider-
ing the welfare impact of altering the choice set: in either case, our estimates imply that
consumers would be better off if there were less scope for choosing the wrong plan.
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Table 2.1: Conditional Logit Results
OOP Cost
Premium -
(hundreds)
s (realized) -
(hundreds)
Variance -
(times 106)
Deductible
(hundreds)
Donut Hole
Generic Coverage
Cost Sharing
# of top 100 on Form
A
Bra
Brand-Sta
vg. Quality
nd Dummies
te Dummies
Risk Index
# of patients
# of plans
# of states
# of brands
(1) (2)
.4330** -.7663**
-0.0029 -0.0038
.2127** -.1172**
-0.152 -0.0015
.0189** -0.0004
-0.0027 -0.0007
x -.2899**
-0.0049
x 3.023**
-0.0181
x .4203**
-0.014
x 3.282**
-0.0538
x .0937**
-0.0007
.4091** .7398**
-0.0032 -0.0039
NO NO
NO NO
10 0
95742 95742
702 702
47 47
36 36
106
(3)
-.4990**
-0.0061
-.0961**
-0.0015
-0.0006
-0.0007
-. 1628**
-0.0067
1.762**
-0.0277
.3004**
-0.0175
1.189**
-0.0741
.0587**
-0.0017
(4)
-.5218**
-0.0069
-.0967**
-0.0016
-0.0005
-0.0007
-. 1674**
-0.0072
1.865**
-0.0303
.2700**
-0.0177
1.057**
-0.0778
.0644**
-0.0018
YES
NO
0
95742
702
47
36
NO
YES
0
95742
702
47
36
Table shows conditional logit results from estimating the model given in equation
(6) by maximum likelihood. Each column shows coefficients from a single regression.
The coefficients reported are the parameters of the utility function, not marginal
effects. Standard errors are in parentheses. * indicates significance at the 5%
level and ** indicates significance at the 1% level. The first column includes only
premium, realized out of pocket cost and the variance measure. The second column
adds controls for the indicated plan characteristics, the third column adds brand
fixed effects and the fourth column adds brand-state fixed effects. Premiums, out
of pocket cost and deductibles are in hundreds of dollars and the variance term is
in millions. The cost sharing variable is computed as the average value of covered
expenditures divided by total drug expenditures for individuals in the choice set.
The average quality variable is a normalized version of the "average rating" index
provided by CMS. The risk index is twice the coefficient on the variance divided
by the coefficient on premiums scaled by 100. In the model in the text, this value
equals one million times the coefficient of absolute risk aversion.
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Table 2.2: R.obustness Checks
Premium
(hundreds)
OOP Costs (realized)
(hundreds)
Variance
(times 106)
Deductible
(hundreds)
Donut Hole
Generic Coverage
Full Cost Sharing
# of top 100 on Form
Customer Service
Prescription Filling
Pricing Avail./Changes
Missing Quality Dummies
Brand Dummies
Brand-State Dummies
Risk Index
# of patients
# of plans
# of states
# of brands
(1)
-.4099**
-0.007
-.0508**
-0.0016
-0.0009
-0.001
-.0456**
-0.0072
1.224**
-0.0302
-0.0241
-0.0158
.9973**
-0.1313
.0737**
-0.0013
x
x
x
NO
NO
YES
0
99999
888
49
48
(2)
-.5717**
-0.0076
-.0808**
-0.0018
-.0067**
-0.0029
-.2680**
-0.007
2.023**
-0.0299
.1168**
-0.0173
2.129**
-0.1316
.0664**
-0.0015
x
x
x
NO
NO
YES
0
99981
861
49
42
(3)
-.5099**
-0.0074
-.0846**
-0.0018
-0.0011
-0.0014
-.2179**
-0.0068
1.907**
-0.0296
.1345**
-0.0296
1.319**
-0.1295
.0599**
-0.0014
x
x
x
NO
NO
YES
0
99981
861
49
42
(4)
-. 4935**
-0.0072
-. 0977**
-0.0016
-0.0003
-0.0007
.4378**
-0.0095
2.872**
-0.0346
.7570**
-0.0233
1.357**
-0.0838
.1173**
-0.0023
x
x
x
NO
NO
YES
0
99988
702
47
36
(5)
-. 5517**
-0.0078
-.0986**
-0.0016
0.0002
-0.0012
.4876**
-0.01
3.956**
-0.038
.8362**
-0.0265
-0.0986
-0.0897
.1126**
-0.0022
x
x
x
NO
NO
YES
0
99999
702
47
36
(6) (7)
-.5220** -.7422**
-0.007 -0.0043
-.0944** -. 1100**
-0.0015 -0.0015
-0.0007 -0.0004
-0.0008 -0.0008
-. 1723** -.2730**
-0.0072 -0.0051
1.837** 2.935**
-0.0304 -0.0204
.2597** .4206**
-0.0178 -0.0141
1.076** 3.633**
-0.0781 -0.0555
.0654** .0952**
-0.0018 -0.0007
x .1644**
-0.0066
x .5666**
-0.0037
x .4142**
-0.0054
NO YES
NO NO
YES NO
0 0
99994 95742
702 702
47 47
36 36
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Table shows conditional logit results from estimating the model given in equation (6) by maximum
likelihood on different subsamples to check robustness. Each column shows coefficients from a
single regression. The coefficients reported are the parameters of the utility function, not marginal
effects. Standard errors are in parentheses. * indicates significance at the 5% level and ** indicates
significance at the 1% level. Premiums, out of pocket cost and deductibles are in hundreds of dollars
and the variance term is in millions. The cost sharing variable is computed as the average value of
covered expenditures divided by total drug expenditures for individuals in the choice set. The first
column estimates the model on a random sample of 100,000 patients selected from the sample of
individuals who were matched to a PDP plan in the "Lax match" discussed in the text. The second
column estimates the model on the original sample used in Table 1 plus individuals with zero claims
in 2005. The third column uses the same sample as the second column, but dropping individuals
with zero claims in 2005 and more than 12 claims in 2006. The fourth column includes only unique
matches and multiple matches which could be assigned with 95% certainty. The fifth column includes
only unique matches. The sixth column uses the original sample but restricting to individuals for
which more than 50% of their claims were non-dual. The seventh column disaggregates the quality
variable. Note that the seventh column also does not include brand or brand-state dummies since
these are collinear with the quality variables. The risk index is twice the coefficient on the variance
divided by the coefficient on premiums scaled by 100. In the model in the text, this value equals
one million times the coefficient of absolute risk aversion.
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Table 2.3: Results with Private Information
Final Sample Restricted Sample Private Info
% Private Information .5818**
-0.0618
Premium -.7383** -. 7156** -.7489**
(hundreds) -0.0038 -0.0094 -0.0132
OOP Costs (realized) -.1169** -. 1040** -. 1687**
(hundreds) -0.0016 -0.0039 -0.0094
Variance -0.0026 -. 1103* -.8574**
(times 106) -0.0014 -0.0517 -0.2947
Deductible -.2677** -. 3079** -.2767**
(hundreds) -0.0014 -0.1257 -0.0137
Donut Hole 2.823** 2.805** 2.870**
-0.0181 -0.049 -0.0478
Generic Coverage .3066** .4743** .4784**
-0.0143 -0.0341 -0.0347
Full Cost Sharing 2.990** 3.391** 2.829**
-0.0546 -0.1417 -0.1743
# of top 100 on Form .0939** .0995** .1005**
-0.0007 -0.0019 -0.0021
Avg. Quality .7167** .7418** .7512**
-0.0039 -0.0098 -0.0095
Brand Dummies NO NO NO
Brand-State Dummies NO NO NO
Risk Index 1 31 229
# of patients 95742 15001 15001
# of plans 702 702 702
# of states 47 47 47
# of brands 36 36 36
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Table compares conditional logit results with results from estimat-
ing the random coefficients model given in equations (11) and (14)
using the Laplace approximation to the likelihood function devel-
oped by Hausman and Harding (2007) with bootstrapped standard
errors. Each column shows coefficients from a single regression.
The coefficients reported are the parameters of the utility func-
tion, not marginal effects. Standard errors are in parentheses. *
indicates significance at the 5% level and ** indicates significance
at the 1% level. The first column is identical to the second column
of Table 1. The second column estimates the same model on a
random subsample of 15,000 and the third column estimates the
random coefficients model on this same subsample. Variable defi-
nitions are identical to Table 1. The "Percent Private Information"
field corresponds to the variable rfrac in the model in the text.
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Table 2.4: Random Coefficients Results
Premium -
(hundreds)
Std. Deviation of Premium
OOP Costs (realized) -
Std. Deviation of
Std. Deviation
(hundreds)
OOP Costs
Variance
(times 106)
of Variance
Deductible -
(hundreds)
Std. Deviation of Deductible
Donut Hole
Std. Deviation of Donut Hole
Generic Coverage
Std. Deviation of Generic Coverage
Full Cost Sharing
Std. Deviation of Cost Share
# of top 100 on Form
Standard Deviation of top 100
Avg. Quality
(1) (2) (3)
.7156** -.7677** -.7354**
-0.0094 -0.0111 -0.0841
x .2940** .2659**
-0.056 -0.033
.1040** -.1091** -. 1193**
-0.0039 -0.0052 -0.0171
x 0.0001 0.0226
-0.0003 -0.0506
-. 1103* -0.1486 -0.0866
-0.0517 -0.0926 -0.1237
x .2035** 0.2603
-0.0685 -0.1769
.3079** -.2524** -0.2354
-0.1257 -0.0107 -0.1903
x x .2922*
-0.1452
2.805** 2.775** 2.523**
-0.049 -0.063 -0.3538
x x 0.8078
-0.5997
.4743** .4845** -0.0037
-0.0341 -0.0427 -0.232
x 1.106*
-0.5108
3.391** 2.083** 1.829
-0.1417 -0.1852 -1.304
x 0.129
-0.4828
.0995** .0992** .1405**
-0.0019 -0.0023 -0.0078
x 0.1071
-0.079
.7418** .7729** .7622**
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-0.0098 -0.009 -0.0358
Standard Deviation of Quality
Brand Dummies
Brand-State Dummies
Risk Index
# of patients
# of plans
# of states
# of brands
N
N
12
150C
70
4
3
Table shows results from estimating the rand
x .3753** 0.3503
-0.0146 -0.2182
O NO NO
O NO NO
4 124 124
1 15001 15001
2 702 702
7 47 47
6 36 36
om coefficients model
discussed in the heterogeneity section. estimated using the Laplace
approximation developed in Hausman-Harding (2007) with boot-
strapped standard errors. This model is identical to the model in
equation (6), adding the normally distributed noise term (which is
a function of ) and the variance adjustment. Each column shows
coefficients from a single regression. The coefficients reported are
the parameters of the utility function, not marginal effects. Stan-
dard errors are in parentheses. * indicates significance at the 5%
level and ** indicates significance at the 10% level. In columns (2)
and (3), each set of four rows reports the mean and standard de-
viation of random coefficient (and their standard errors). The first
column estimates the conditional logit model on the subsample of
15000 (and is identical to the second column of Table 2). The sec-
ond column adds random coefficients on financial characteristics
and quality and the third column adds random coefficients on all
variables. Variable definitions are otherwise identical to Table 1.
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Figure 2-1: Histogram of cost savings from switching to lowest cost plan
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Figure 2-2: Average mean and standard deviation for each PDP plan in CA
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Chapter 3
The General Equilibrium Impact of
Information on Prices, Quality and
Welfare
3.1 Introduction
When does information provision lead to welfare gains? More generally, is it social welfare
maximizing in a general equilibrium setting for consumers to choose as they would if they
were fully informed? Lipsey and Lancaster (1956) suggests otherwise; if producers price
above marginal cost or firms do not internalize the full benefits of investment in quality, then
the theory of the second best says that it will in general not be social welfare maximizing for
consumers to choose optimally either. These paper delves more deeply into the relationship
between the partial and general equilibrium welfare gains from information.
The motivation is as follows. Suppose we observe that consumers receive information
about a given product characteristic and that ex post, consumers' choices are more sensitive
to that product characteristic. It is common practice to take ex post preferences as the
appropriate normative benchmark (e.g. Chernewa, Gowrisankaran, and Scanlon (2008)).
0Thanks especially to my advisors Jon Gruber, Michael Greenstone, and Glenn Ellison, and to Jim
Poterba and Bill Wheaton for helpful comments. Funding for this work was provided by NIA grant T32
AG000186-21.
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We can use those preferences to compute the partial equilibrium consumers surplus gain
from information, and if we observe costs as well, we can compute partial equilibrium total
surplus. In many cases however, the general equilibrium response of prices and quality to
a change in information is difficult to estimate. Among other reasons, this might occur if
the time frame is too short, the scale of the information intervention too small, the data too
coarse, or if the intervention itself is only simulated (as with the second chapter of this thesis,
Abaluck and Gruber (2009)). Because of this, it is helpful to understand theoretically the
relationship between the partial and general equilibrium social welfare impact of information.
The main contribution of this paper is to derive a set of sufficient conditions on demand
under which the general equilibrium response of quality to information provision must be
welfare improving relative to the world in which quality is held fixed. As long as one has
estimated partial equilibrium demand as a function of product characteristics, one can check
whether these conditions are satisfied. If these conditions are met then the welfare calculation
taking into account changes in prices but not changes in quality will be a lower bound
on the general equilibrium welfare gain from the provision of information. The primary
case I consider are models in which quality is undersupplied if consumers value quality
appropriately (this occurs because competitive firms internalize only a fraction of the surplus
from each unit of quality). In such models, the sufficient conditions I identify imply that it is
optimal in general equilibrium for consumers to overweight quality relative to its true impact
on their utility and that if consumers currently either underweight or correctly appraise
product quality, any intervention which causes them to weight quality more in their product
choices will be welfare improving.
The results apply in more general settings than just information provision; comparing the
weight attached to a given product characteristic before and after an information intervention
and taking ex post preferences as correct is one way of determining the value of a given
characteristic to consumers, but it is not the only way. The other chapters in this thesis
consider alternatives in which the value of particular characteristics (nutrient content in the
case of foods and out of pocket costs in the case of insurance plans) can be computed ex ante
given the relationship between the characteristic in question and alternative characteristics
whose value we know from other settings. The welfare results in this paper apply equally well
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in those cases. In any setting where we can distinguish between the positive weight attached
to product characteristics and the normative weight appropriate for computing consumer
surplus, we can use these results to evaluate any policy that would alter the positive weight
attached to those characteristics. The results here relate the partial equilibrium welfare
calculation - in which it is always optimal for the positive and normative weights to coincide
- with the general equilibrium welfare calculation, where generically this will no longer be
true.
In Section 3.2, I briefly consider some related literature. Section 3.3 discusses how I will
model perceptions of product quality as a function of information and how this relates to
earlier approaches. Section 3.4 presents the main theorems along with some discussion of
the assumptions and why they are necessary, Section 3.5 presents an explicit model which
allows a closed form solution which is used to study the relationship between allocative and
productive inefficiency, and Section 3.6 concludes.
3.2 Literature Review
This paper is most closely related to a small number of earlier studies which consider the
general equilibrium impacts of information. Dranove, Kessler, McClellan, and Satterthwaite
(2002) considers the general equilibrium impact of health plan report cards; while patients
respond to these report cards, hospitals are incentivized to improve their score by selectively
treating healthier patients. They find that overall, more resources are utilized for reduced
health benefits. The main disanalogy between their environment and the models considered
here is the disconnect between reported quality (that observed by consumers) and actual
quality (which matters for social welfare). In the Dranove et al. (2002) world, firms can
manipulate reported quality without improving actual quality. In the models considered in
this paper, this disconnect is not present. For this reason, the paper most closely related
to this study is Jin and Leslie (2003), which analyzes the impact of mandating restaurant
hygiene reporting on consumers' choice of restaurants and the level of product quality. They
observe that quality increases following the provision of information. This paper sets out
general conditions under which we would expect this to occur and attempts to draw some
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conclusions about the relative importance for welfare of the allocational impact of infor-
mation provision (i.e. helping people choose better) and the productive impact (i.e. firms
altering their quality choices).
This paper also relates to a broader literature in behavioral industrial organization, re-
viewed by Ellison (2006). Whether the analysis here is fully behavioral is partly a semantic
distinction. The welfare impact of information in general equilibrium is a topic of neoclassical
concern, but the model applies equally well to settings where consumers underweight prod-
uct characteristics for more behavioral reasons (such as hyperbolic discounting or framing
effects). An important question underlying the analysis presented here is why - if consumers
are biased - firms would not seek to correct this bias. Ellison (2005) and Gabaix and Laibson
(2006) develop models in which firms do not necessarily want to de-bias consumers in equi-
librium, but these features are not explicitly incorporated into the models considered here.
I take as given the empirical fact that mandated information provision impacts demand and
ask - whatever the reason why firms chose not to provide this information ex ante - what
can be said about welfare given the direct impact of information on demand, and given the
firms response along price and quality margins.
3.3 When Does Imperfect Information Impact Demand?
In this section, I consider the question of when consumer errors impact demand, and when
they tend to offset when another, leading the aggregate demand of firms to be unchanged.
This will motivate the specification used in subsequent sections. By errors, I mean any
deviation between positive and normative utility. As discussed in the introduction, these
deviations could be identified by comparing demand before and after an information inter-
vention, or via some other method.
Suppose that given perceived quality f', consumer i's utility from purchasing a product
from firm j is given by:
Ugy = 6Osi - py (3.1)
The primary case I consider will be a setting in which information improves consumers ability
to differentiate between products. Prior to receiving information consumers may distinguish
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imperfectly between products. In the first Chapter of this thesis, I present evidence that
consumer's imperfectly distinguish between the nutrient content of products within product
groups. We can write their perceived nutrient content as jj = (1 - a)E(vj) + av where v3
is the actual nutrient of product j and E(vj) is an expectation within product groups. Note
that these beliefs might be unbiased within product groups, but they will be systematically
biased for particular products. In this case, within product groups, consumers will respond
to a difference in quality of Av as if the quality difference were only aoAv. In the above
utility framework, substituting this expression in for Pj gives:
U Ov = a~  + (1 - a)E(vj) - pj (3.2)
An alternative model of information commonly studied in the literature allows for only
idiosyncratic errors across products. Prior to an information intervention, fij = vj + ei
where the eij are independently and identically distributed across consumers and firms. In
that case, utility becomes:
Uzj = 07oy - pg + Oeij (3.3)
which is the random utility framework of Luce (1959) and McFadden (1980). Gabaix,
Laibson, and Li (2005) characterize the behavior of mark-ups in this model as the number of
firms go to infinity. It is clear in this model that the variance of the error term will impact
overall demand for a product for even a small amount of noise: as this variance rises, a
smaller fraction of observed choices will be explained by quality or prices, so elasticities of
demand with respect to quality and prices will fall.
The impact of noisy quality perceptions on demand in this model is dependent on the
assumption that the errors are independently distributed. Consider for example a model of
horizontal differentiation, where a unit mass of consumers are uniformly distributed on a
line of length 1 with firms at both ends. Utility is given by:
Uj = Ovj - pj - dtij + Oeij (3.4)
Where tj is the distance of consumer i from firm j. In this model, demand is given by:
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D1(A i) = A zr+d. Because demand is linear in vi , a small amount of mean 0 noise
will no longer have any impact on demand. Formally, provided range of the noise is small
enough that some consumers always go to the nearest firm regardless of their realizations of
eij, noise will have no impact on the demand for each product (and thus, no impact on pricing
or quality decisions). Noise will still matter for welfare because it will create allocational
inefficiencies, but that is all it will do.
The upshot of this discussion is that there are two reasons to study systematic rather
than purely idiosyncratic misperceptions. Firstly, there is empirical evidence that such mis-
perceptions are relevant. Secondly, the impact of such misperceptions will be less dependent
on difficult to verify assumptions about the functional form and correlational structure of
the error term. As the next section makes clear, it will be possible to draw fairly general
conclusions about the welfare impact of systematic misperceptions.
3.4 The General Case: Endogeneous Prices and Qual-
ity
Suppose there are two firms j 1, 2, and a continuum of consumers of mass 1. Consumer
i's utility from firm j is given by:
Uij = af(Vy) - Pi + f y (3.5)
where f is strictly increasing in vj. I make no assumption about cij except that it is inde-
pendent of v and pj. Thus, among other cases, this model includes logit models or models
with horizontal differentiation. As discussed in the previous section, I assume that welfare
is appropriately evaluated at a = 1, either because this is how consumers choose ex post
with full information, or because this is the standard implied by some alternative criterion. I
assume that firms maximize profits given by (pi - ci)Di where pi, ci and Di are all potentially
functions of quality. Assume without loss of generality that vi > 1v2 . The first result I will
prove is as follows:
Proposition 1. Suppose that quality is fixed but prices can adjust endogenously in response
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to changes in demand. Provided mark-ups are larger for the high quality firm and _ aD2 a
6p2
ain(-BD2(_ (P2 < 0, social welfare is maximized at a* > 1 and increasing in a for all a < a*.
The intuition for this result is straightforward: because mark-ups are higher for the higher
quality firm, prices are too high for the high quality firm from the standpoint of allocative
efficiency (that is, relative to the prices the social planner would choose). If a = 1, too few
consumers will choose the high quality firm because of the high price. a > 1 can offset this
distortion so that the competitive allocation matches the social planner's allocation. The
condition: e a32 a < 0 guarantees that a does not increase price elasticities so much that
aP2*
the endogenous response of prices to changes in quality offsets the direct impact of a causing
demand for the high quality firm as a increases. This condition holds under a wide-variety
of commonly used demand functions - for example, it holds if demand is a linear function
of prices and qualities as in the models of uniformly distributed horizontal and vertical
differentiation considered below. The proof of this claim is in Appendix B.1.
The next proposition gives the conditions under which endogenizing quality only strength-
ens this result. That is, consider the decomposition: dsw = asv + EL [ asw a 
Proposition 1 sets the third term of this decomposition equal to 0, and shows that under
this condition dSW > 0 for all a < a* where a* > 1. The next proposition explicitly con-
siders asv y9. I consider in particular settings where dsw > 0 for a = 1 so that quality is
undersupplied if consumers value quality appropriately. I will show that:
Proposition 2. Suppose that mark-ups are higher for the high quality firm and weakly in-
creasing in quality a'g' ) > 0 and c_ D2,= a(nP2) < 0 and that demand satisfies theavj OP 'a ino
following additional conditions:
L -ED,a nD <a
2.CD 3 , = di -- C >aln 'D
Then wej have:d > 0an
Then we have: > 0 and 4 > 0, which implies that social welfare with endogeneous
prices and quality is increasing in a for all a < a* with a* > 1.
The high quality firm (firm 1) always wants to produce higher quality when a increases.
For the low quality firm, there are offsetting effects. There are competitive effects wherein
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mark-ups and demand increase more with quality when a is larger (since raising quality lures
more consumers at the margin), but these are off-set by the fact that demand and mark-ups
are lower overall so the return each unit increase in demand or mark-ups is lower. With
ir(vi, v 2 , a) = (P2 - c2 )D 2 , we can write:
9 2  D2 - (P2 - C2) (3.6)
Ov2 (V 2  OV2
The first new condition implies that the increase in the marginal impact of quality on
mark-ups when a increases outweighs the decrease in demand (so the impact of a on the
first term is positive). The condition says that demand does not decrease "too much." The
second new condition implies that the increase in the marginal impact of quality on demand
outweighs the decrease in mark-ups (so the impact of a on the second term is positive). In
particular, it says that the increase in demand when quality increases is "large enough." The
proof of this claim is in Appendix B.2.
3.5 An Explicit Example
In this section, I develop a model of differentiated product competition in which we can
decompose the welfare impact of consumer misweighting into the partial equilibrium welfare
loss from misallocation, and the general equilibrium impact of misweighting on prices and
product quality. This will serve to illustrate the general theorem in the previous section.
Because the model can be solved in closed form, it will also be possible to say more about
the relative magnitude of the allocative and productive inefficiencies and how these relate to
exogenous determinants of competition such as the degree of product differentiation.
The model explored in this section has two related unusual properties. First, each firm's
choice of quality does not depend on the quality choices of competitive firms (that is, a 2 7V,
aviavl1
0, so quality choices are neither strategic complements nor strategic substitutes). Because
of this property, quality choices will not depend on either the number of firms or the degree
of differentiation between firms; they will depend only on own-costs and demand. Second,
the qualities chosen by optimizing firms match those chosen by the social planner. These
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properties dramatically simplify the analysis.
3.5.1 Set-up
A mass 1 of consumers are located on a circle with two firms located at opposite ends. If
consumers purchase the good from firm j, they obtain utility:
Ui = aOvij - dtij - pij (3.7)
where v is quality, pj is price, and tj is the distance of consumer i to firm j. For ease of
exposition, I will focus on the case with two firms located at opposite ends of the circle and
with constant 0. The main results also hold in the n-firm case, and the case where 0 is
uniformly distributed in [a, b] so there are both horizontal and vertical differentiation. These
extensions do not change the main results. Profits for firm j are given by (pj - cjv)Dj.
Suppose that firm j chooses (vj, pj). I will focus on the case where both firms have positive
demand in equilibrium.
We can think of the cj functional form as capturing any product for which it costs
more to make each unit well: it could apply directly to foods (where the ingredients are
more costly for better foods), cars, electronics or housing among many other products. We
can also think of this functional form as a kind of reduced form model of an insurance
market with selection where quality is the proportion of expenditures which are insured. In
such a model, insurer costs for each consumer would be ujDj where Dj gives the average
expenditure of insured consumers. If Dj(v ) = cvj due to adverse selection, we will obtain
the functional form considered here. Depending on the product involved, we can think of the
horizontal differentiation as arising due to literal location decisions (e.g. geographic networks
of pharmacies with insurance plans), or due to consumer preference for some brands over
others.
3.5.2 Competitive Demand, Prices and Qualities
Let. I denote the distance of a consumer from firm 1. Consumers of type t will purchase
from firm 1 rather than firm 2 if: a06 1 - dt - p, ;> atv 2 - d(- I) - P2 which yields
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aOAv-Ap± d
t* = 2d 2 where Av = V1 - v 2 and Ap = PI- P2. Demand for firm 1 is then given
by: D1 = 2t* and demand for firm 2 is given by D2  1 - 2t*. Firms choose p to maximize
lr(pj, p~) = (pg - civy)Di which yields mark-ups:
2 d aAv - Aic (3.8)
2 3
where Aiv = vi - vj and Aic = civ2 - c-iv2  Markups are increasing in the degree of
horizontal differentiation between firms, increasing in the quality differential between firms
and decreasing in the cost differential (i.e. increasing in rival's costs and decreasing in own-
costs).
This implies Aip = Ac+2""Av and substituting into the demand functions gives: Di =
( + ""^i"-A") and profits are given by:
1 (d a6Aiv7 - Aic) 2
7ri = - - + - ) (3.9)
Differentiating gives vi = '. We can use these to reexpress mark-ups and demand as a
function of costs. Mark-ups as a function of costs are equal to:
2 d (a6)2 c-i - ci
pA - civi - + -(3.10)2 12 cic2
And demand is given by: Di = + ( "o)2 C2-C.2 12d \ C1C2/
In Appendix B.3.1, I show that the social planner chooses vi = ±. Thus, when consumers2c< s hn osmr
value quality appropriately (a = 1), the competitive qualities match the social planner's
qualities. This is because of two off-setting effects. Consider for simplicity the world where
CI = c2 , so firms are symmetric and we can ignore transportation costs. Relative to the social
planner, competitive firms do not internalize the full surplus from each unit of quality for
each existing consumer. The social planner has net benefit 0-2cv from raising quality for each
firm, while competitive firms gain only "(4c)D = 0-2cv . However, unlike the social planner,
plans benefit from stealing demand from rival firms (on the margin, the consumers who
switch are indifferent so social welfare is unchanged). This gives benefit: (p - c)j = 3 2cv
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So on net, firms have exactly the same net benefit to quality as the social planner. This is a
"knife-edge" result coming from the fact that the increased quality incentive from business
stealing exactly offsets the decreased quality incentive from not internalizing the full surplus
for existing consumers.
3.5.3 Welfare Cost of Mistakes
I first show that the general theorem developed in Section 3.4 applies to this model. First note
that mark-ups are larger for the high quality firm: Ap-Ac - 2(a3se-sc) _ 3 i c2 ci c
a2o2 - - > 0. Further, ED 2  = 0 so Proposition 1 holds and a* > 1 is optimal ignor-4 ( &C P2a
ing quality changes. Further, one can check that -eD,, < a and E ODj > a so Proposition
2 holds as well.
The other papers in this thesis consider the cost to consumer surplus of mistakes with
prices and quality held fixed. In this section, I will discuss how considering producer surplus,
endogenizing prices, and endogenizing quality impact this calculation.
The consumer surplus for fixed p and v is given by: 2(t(1) - t(a))(OAv - Ap - E[dt -
d(1/2 - t)]). E[dt - d(1/2 - t)] = 2dE[t] - d. E[t] - t(1)+t(a) - (1+o)OAv-2Ap+d So2 2 4d
E[dt - d(1/2 - t)] = (+a)Osv-2p+d _d - (1+a)OAv-2sp2 2 2
CS(a = 1) - CS(a) a)OAV] (3.11)2d
For a different from 1, consumers purchase too little quality and the welfare loss is
proportional to the value of quality. The welfare loss is also larger if firms are less horizontally
differentiated, since consumers will more readily choose based on quality. The social welfare
difference for fixed prices and qualities is given by:
[(1 - a)OAv]2  (1 - a)OAvSW(a = 1) - SW(a) = + d (Ap - Ac) (3.12)
Provided mark-ups are increasing in quality so that Ap > Ac, the sign of producer surplus
from informing consumers depends on whether consumers overweight or underweight quality
characteristics. If consumers underweight quality - as was the case in the empirical work
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in this thesis - then informing consumers will generate gains for producers as well. The
intuition is that holding quality and prices fixed, giving more weight to quality will lead more
consumers to choose the higher quality product. Because mark-ups are higher for the higher
quality product, producers gain more as well. If however consumers currently overweight
quality, the sign of this expression need not be positive. Informing consumers (meaning
setting a = 1) may reduce welfare if consumers currently overweight quality, because this
overweighting offsets the distortion from higher mark-ups for the high quality firm.
3.5.4 Productive vs. Allocative Efficiency
To endogenize prices and quality, I consider social welfare in the competitive equilibrium
relative to a social planner's benchmark. This makes explicit how the competitive equilibrium
deviates from the optimal quality.
Let SW(allocation,qualities) denote social welfare as a function of the allocation and the
quality choices. The allocation determines which firm consumers purchase from, while the
qualities enter utility conditional on purchasing from a given firm. The allocation itself is a
function of the allocation rule and the qualities at which the allocation rule is applied (e.g.
the social planner's allocation changes as the qualities change). The qualities to which the
allocation rule is applied need not be the same as the qualities at which the social welfare
function is evaluated. We could compute social welfare at the allocation determined by
the social planner's allocation rule applied to the social planner's qualities - this determines
who purchases from which firms - while still evaluating the social welfare function given this
allocation rule at the competitive qualities. Thus, I write SW(a(b), c) where each of a, b, c C
{social planner, competitive} to denote social welfare with allocation a(b) and qualities c. I
denote the social planner's allocation by "sp" and the competitive equilibrium allocation by
"ce". I will decompose the welfare difference between the competitive equilibrium and the
social planner's choices of allocation and quality into the productive inefficiencies and the
allocative inefficiencies. That is, I write:
SW(sp(sp), sp) - SW(ce(ce), ce) = [SW(sp(sp), sp) - SW(sp(ce), ce)] +
[SW(sp(ce), ce) - SVV(ce(ce), ce)] (3.13)
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The first line gives the productive inefficiency. Given the social planner's allocation rule
- what is the welfare loss if the competitive qualities are not equal to the social planner's
qualities? The second line gives the allocative inefficiencies - given the competitive qualities
- what is the welfare loss from the fact that the good is misallocated relative to what the
social planner would choose?
When a = 1, there are no productive inefficiencies, but there are still allocative in-
efficiencies because mark-ups are increasing in quality. The social planner would allocate
consumers to firm 1 if Ov - dt - civy ;> Ov - d(1/2 - t) - c2v2. Consumers choose firm 1 if
6v - dt - pi > Ov - d(1/2 - t) - P2. Thus, unless Ac = civ2 - c2v2 = Ap = Pi - P2, there will
be allocative inefficiencies. In this model, Ap > Ac and so too few consumers will choose
firm 1 given fixed levels of qualities. The allocative inefficiencies are given by:
1
SW(sp(ce), ce) - SW(ce(ce), ce) = ((3 - a)6Av - 2Ac) 2
18d
04 (C2 - c1)2 )2
-dcl
2 2(a(3 - 2a)) (3.14)72d(cic2 )2
When firms have symmetric costs, they produce the same quality and charge the same
prices, so consumers always travel to the closest firm and there is no allocative inefficiency.
As the degree of horizontal differentiation increases, the allocative inefficiency decreases.
The price difference between the two firms is unaffected by the degree of differentiation, but
as firms become more differentiated horizontally, demand for each firm moves closer to 1/2
regardless of the cost differences. Thus, allocative inefficiency is actually more problematic
for more competitive firms in this sense, because consumers more readily purchase the wrong
product. Note that allocative inefficiencies are minimized at a = 3/2 > 1 as Proposition 1
requires.
Next, let us consider productive inefficiencies. The welfare impact of these inefficiencies
is given by:
SW (sp(sp), sp) - SW (sp(ce),ce) =
02 (1 - a)2 29 2(-5
21 2 ((c1 - c2)202 (1 - a) 2 + 4dc1c2 (c] + c2 )) (3.15)32dcyc2
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Note that at a = 1, there are no productive inefficiencies because the competitive quali-
ties match the social planner's qualities. Also, note that unlike the allocative inefficiencies,
the productive inefficiencies from a! =1 do not go to zero as firms become sufficiently differ-
entiated. Thus, while for more competitive firms allocative inefficiencies may predominate,
as firms become more differentiated (and thus less competitive), the productive inefficiencies
will be first order.
3.6 Conclusion
This paper examines the relationship between the partial equilibrium welfare gains from
information and the general equilibrium welfare impact once one endogenizes prices and
quality. There are two main theoretical results: first, holding fixed quality, it is generally
optimal from a social welfare standpoint for consumers to overweight quality in order to
offset the adverse allocational impact of high prices. A corollary of this result is that infor-
ination provision tends to improve social welfare if consumers currently underweight quality.
Second, I derive conditions under which firms provide higher quality when consumers are
more informed, meaning that the partial equilibrium welfare impact of information holding
quality fixed will be a lower bound on the general equilibrium welfare gain.
There are a number of immediate next steps: first, the "general" theorem is proven only
in the case of 2 firms, so it should be extended to a model with n firms. Second, the cost
structure is also somewhat restrictive: I allow marginal costs to vary flexibly with quality
but I do not currently allow for fixed costs. The theorem should be extended to these
cases. Third, the general equilibrium analysis incorporates prices and quality choices but
does not yet incorporate entry. A more complete analysis would study how entry modifies
the conclusions presented here. The model could also be specialized to particular industries
which raise new general equilibrium considerations - for example, in health care markets,
the model should be extended to explicitly incorporate adverse selection and moral hazard.
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Appendix A
What Would We Eat: Appendices
A.1 The Impact of the NLEA on Daily Caloric Intake
In this section, I use the structural model to generate the predicted change in consumption
of label users relative to non-label users and I relate this change to the existing literature
and to additional reduced form analyses. Depending on the specification used, the structural
model implies a 50-90 calorie decline in consumption among label users relative to non-label
users; this range is consistent with earlier studies of the impact of labeling on consumption.
From equations (1.7) and (1.8), we can compute the predicted consumption of each food
as follows:
E(Nijt) = <b( /oj)( ig + s O(Yit/) (A.1)
where #(-) is the standard normal density function and <b(-) is the standard normal dis-
tribution function, oj is the standard deviation of eijt and Yig is the predicted value of
Yig.
I assume that label users and non-label users differ only in the specification of expected
nutrient content for labeled foods. Label users are assumed to know the exact content of these
foods, while non-label users know only their prior belief; given the estimated willingnesses to
pay, non-label users are less able to substitute towards foods with desirable nutrient profiles.
Given simulated consumption, it is straightforward to compute the expected value of
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total caloric intake. This is given by:
E(Cit) = zyE(Nij) (A.2)
where xot gives the actual calories per gram of product j at time t. Given these projections, I
compute a difference in difference estimate of the impact of the NLEA on label users relative
to non-label users.1
Appendix Table A.1 presents the results for the four models reported in Table 1.5 which
estimate willingness to pay parameters at varying levels of aggregation. Depending on the
level of aggregation, the projected change in calorie consumption ranges from 45 to 96
calories.
Given reported label use behavior, we can also compute the difference in difference es-
timator directly. This estimator is unfortunately confounded by selection due to the fact
that the pool of label-users is changing over time. To correct for this, I have considered
both triple difference estimates using changes in consumption of foods not impacted by the
NLEA as a control group and estimates using a pseudo-panel constructed based on predicted
label use behavior by demographic cell which allows me to control directly for the change in
the proportion of label users within cells. The best identified of these specifications suggest
that the NLEA led to a decline in calorie consumption of 50-100 calories among label users
relative to non-label users, consistent with the projections of the structural model. Details
of these estimates are available upon request.
The online version of this appendix contains a more detailed comparison of my results
with the results of two earlier studies of nutrition labeling: Bollinger et al. (2010) and
Variyam and Cawley (2006). The magnitude of the observed response to labeling is consistent
with the findings of these earlier studies.
I In particular. I compute the change in the consumption of label users as the average simulated calorie
consumption in 1994-1996 minus the average simulated calorie consumption in 1989-1991. 1 compute the
change in consumption of non-label users via the same method. The difference in difference estimate is the
difference between the change in consumption for label users and the change in consumption for non-label
users.
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A.2 Specification of Egj(xnj)
The willingness to pay for nutrient content a, is identified using variation in perceived
nutritional characteristics generated by nutrition labeling. In this section, I discuss the
specification of Ej(Xnj), the expected content of nutrient n in 100 grains of product j at
time t as a function of the actual content xnj. The following questions need to addressed to
specify this variable:
" Who uses labels?
" Which products are labeled within product groups?
" What beliefs do consumers have about the nutrient content of labeled and unlabeled
foods?
The data available indicate for all "main meal planners" whether they use labels and
how frequently on an "Often", "Sometimes", "Rarely" or "Never" scale in 1990, 1991, 1994,
1995, 1996. Because labeling data is only available from 1990 onward and to avoid selection
issues generated by the fact that the data is a repeated cross-section, I specify the model
as if the only information available on label-use were the proportion of individuals using
labels for each nutrient in each year.2 This information is sufficient to identify the impact on
consumption of having more products labeled (the inframarginal impact of labeling) while
controlling for the impact of an increase in label-use (the marginal effect).
The data give the proportion of products labeled in each year in each of 52 product
groups; I do not know at the product level whether a food product is labeled if fewer
than 100% of products are labeled. I consider two alternative assumptions: either that the
healthiest products within each group voluntarily label, or that all products label randomly
with probability equal to the proportion of products in each product group which are labeled.
The index used to compute the health of each product is taken from Fulgoni III et al. (2009).
2 Prior to 1990, I assume that the proportion of label users for each nutrient remains constant at the 1990
level.
3 The health index is computed by first finding the nutrient content in a fixed serving (I use 100 grams)
and then computing: protein/50 + fiber/50 + VitaninA/5000 + VitaminC/60 + Calciun/ 1000 + Iron/18 -
SaturatedFat/20 - Sodium/2400.
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There is evidence that healthier products are more likely to voluntarily label, although
the effect seems to vary by product group (Mathios (2000) finds that only the healthiest
salad dressing label while Mojduszka and Caswell (2000) finds mixed results across product
groups). The main text assumes that the healthiest products label, while random labeling
is considered as a robustness check in Appendix A.4.
The specification of prior information is discussed in the main text. The parameter ag is
estimated based on a survey of consumers in Starbucks conducted by the authors of Bollinger,
Leslie, and Sorensen (2010). Consumers are asked to estimate the calorie content of food and
drink products that they purchased, and this value can be compared to the actual nutrient
content. I restrict to those consumers who purchased a single food item. The estimate of
ag for food items is .19 with a standard error of (.20). The estimate for beverages varies
depending on whether we include caffeinated beverages with close to 0 calories. If these
drinks are excluded by restricting to beverages with at least 20 calories, the estimate is .11
(.23). If these drinks are included., the estimate is .66 (.05). In other words, consumers
appear to recognize that some drinks have almost know calories, but they are unable to
distinguish between the calorie content of foods or drinks with a non-negligible number of
calories. In the models in the main text, I use the estimate a = 0.2 for all product groups.
A.3 Estimating Equation for Structural Model
Let Ygt = __ - K where, as in the text, Oij = c + pit + #pgt - E ,Eig(zny) and
7yj= -y + pjt + vij + eg. I Taylor-expend about zo, the vector of parameter values in the
first year when consumption is observed. Note that Yjjl depends on the characteristics of
other products k # j only through total consumption which is captured by the pit term.
Thus, because we are controlling for changes in pit, Y, depends only on the characteristics
of product j. Taylor-expanding about zo gives:
Yip YiJO + (zo)dpjt + (zo)dpit
Opp OPa+
+ Oyj (zo)dEat(xny ) + (zo)(pj t + deijt) (A.3)
nBiEigt (x~y ) *y 0 ,
134
Note that I have implicitly assumed that an(Xnit) does not change over time. This
assumption ignores the complications that arise at the boundary for the small fraction of
individuals predicted to cross the threshold points where an changes from 0 to a non-zero
magnitude for each nutrient. Instead, all individuals are treated as if an(Xnjt) = a,(Xaj),
a constant over time determined by the value of Xnj observed for each individual (recall
that we observe only a single time period for each individual since the data are a repeated
cross-section).
To evaluate equation (A.3), note that for any parameter zit in Oijt we have:
Y(z*) = 9j(z*) 
-- t (Y*t + K) (A.4)i~t( ) (z0*
zijt zjjt ijt
Note also that for parameters qjjt in ijt, we have:
____ *(z*) = (z*) 
- - + (A.5)
Oq g Oqiyt Yig
This allows us to rewrite equation (A.3) as:
K+Yio i tpj + duijt 1
Yp + o 6jO±jo '-#d dpa+(K + Yijo)/J (A.6)
I write Eijt(xj) = LiE (x) (1 - )E(x) where Li is a dummy variable for
label use, EL represents the beliefs of label users and EU represents the beliefs of non-label
users. We can rewrite this as: E jt(xj) = E±(Lj)Ef(xj) + (1 - Et(L))Ef(xnj) + (Li-
Et(L ))(Ef(xnj) - EU(Xnj)).
Define wijo = 0 K±Yo , and ei 0+ wOZ an(Xin ) [(Li - Et(Li))( Ef(xng ) - E '(xnj))] +Dfn ij _7ioOijo ' an ejt =Jio io na
(K E - Fs+ (K 7 . This implies that we can rewrite equation (A.6) as:
Yip ~ 2 [0c(pjt - Pio) + E an (X n)(Eig(xn ) - Eijo(xus)) + E jK 1 + eitLn~ njn E(K + Yjj 0)u/~j
= mjo -4p + + (n(Xn)Eig(xnj tpj + + dpa +e ig (A.7)
nI
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where Eijt(x,,) = [E(Li)Ej(xnj)n+(1I E'(Li))Ej(xnj)], j = E(K+Y jo)l Jiand j
-#Po - En an(Xin) [Eo(Li)Ejf(xnj) - (1 - ))E (xn)].
I now attempt to rewrite wig as a function of the prices elasticity, prices and quantities.
In particular, define the marginal price elasticity as:
- aE(Nigt) pg (A.8)7ij Dpjg E(Nig)
where the expectation is taken over all individuals for each j and t. Note that we can write:
( 1  P(Yij > 0) =-#wigtP(Yip > 0). The first equality follows even if we allow09Pg aPj t 3 /eult
for heteroskedastic errors provided we use a marginal effect defined in (Honor6 2008). In
particular, consider lim6, 0 E max{OY(x+6)+c-n ax{OY(x)+] = 'P(N > 0). This marginal
effect corresponds to the thought experiment: what happens to N if we change x by a small
amount holding c constant. In the more standard case, if eij is dependent on x due to
heteroskedasticity, we would allow c to change as well when we perturbed x; this leads to a
much more complicated expression. Note further that E(Nigt) = E(Yit|Yigt > 0)P(Yt > 0).
Thus, equation (A.8) simplifies to:
ijt = Owijt Pjt(A9
EW itE(NiNt > 0) (A.9)
where I have also used the fact that E(Yit|Yit > 0) = E(Nig|Nig > 0). We can rearrange
this to solve for wig (and thus wijo). Substituting the resulting expression back into equation
(A.7), gives:
E(Nijo|Nijo > 0) - + an(Xin)Eig (xnj) t + +
__________ _ +ij +pi -Oj+ alXnEj(n)tj+ d 1tJ + eij(A.10)
The full model is thus given by:
Nig = max{0, Yit} (A.11)
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where Yig is given by equation (A. 10) where
eig = Yijo+ wijoqijt and
qijt = an(Xin) [(Li - Et(Li))(Ef (xnj) - Ej (xn))] +
n
tp 
_ tpj + duijt (A.12)
(K + Yijo)1/i Ej (K + Yio) 1/bb (K + Yio)1/A1
The usual semiparametric estimators for censored regression models do not apply in this
case because most foods are not consumed by the vast majority of consumers (Chay and
Powell 2001). For example, the CLAD estimator would immediately trim all observations.
For this reason, I parametrically specify the distribution of the error term. I assume that
Yio ~i.i.d. N(0, a2 ) and qijt ~i.. N(0, T2 ) and that they have constant correlation p. This
implies that eg ~ N(0, o2 + W 2 T 2 + 2w 2 0pu2 i 2 ) N(0, 2 + E(Nij >0)2 2pU
2 )).
This is a heteroskedastic Tobit model where the variance a2  2 E(Ny i>O) T (1+2p 2
varies across foods based on the elasticity of demand and the average serving size. To im-
plement this, I compute the index ^2E(Nijt i t>0)2 for each individual and food and estimate
a separate variance for each of 20 quantiles of this index. Further details of estimation are
discussed in the main text.
A.4 Robustness of Specification of Structural Model
In this section, I discuss several estimates designed to check the robustness of the willingness
to pay estimates to the assumptions made in the main text. These estimates are reported in
Appendix Table A.2. All specifications include the same control variables as specification (1)
in Table 1.5. All specifications in this section use the linear model rather than the piecewise
linear model used in the main text (in future drafts these checks will be repeated with the
piecewise linear results). Column 1 repeats specification (1) from Table 1.5, except with the
linear rather than piecewise linear model.
The first issue I consider is alternative assignment of labels to products within product
groups when the proportion labeled is less than 100%. The estimates in the main text assume
that only the healthiest foods labeled. The estimates in column 2 of Table A.2 assume that
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the probability that a food is labeled in a given year is equal to the proportion of products
in its product group which label (so that labeling is random within product group). These
estimates are an informal bootstrap, in that they average point estimates and standard
errors from 5 alternative estimates (the standard errors are not bootstrapped, since they are
the average of the standard errors computed for each individual estimate rather than the
standard error of the 5 specifications I have run). These estimates suggest that assignment
of labels does not change the main results.
The second issue I consider is whether the introduction of new products in response to the
labeling law may be biasing the willingness to pay estimates. In the model, the introduction
of new products impacts demand for existing products only through the constraint on the
total amount individuals can eat. Nonetheless, in a more realistic model the introduction
of similar products would be more likely to induce substitution than the introduction of
a random food product. To deal with this, for each product, I create a variable which
indicates the number of low fat (or otherwise nutrient enriched) versions available in each
year. Column 3 of Table A.2 reports the model with this variable included; it has little
impact on the willingness to pay estimates.
A third issue I consider is attrition. Studies which attempt to validate food intake
from food diaries or 24-hour recall in person interviews find that these methods understate
food consumption by roughly 200 calories or 10% of total intake, with the degree of under-
statement greater in food diary data (Sawaya, Tucker, Tsay, Willett, Saltzman, Dallal, and
Roberts 1996). In the CSFII, on days when in person interviews are conducted, the reported
average nutrient calorie for females aged 19-50 is 1640 calories, and on days when food di-
aries are used the average is 1520 calories. Combined with some assumptions about average
energy expenditure, these numbers imply steady state weights below those measured in the
same population (Livingstone and Black 2003 and Cutler et al. 2003). The degree of bias
also appears to vary across individuals, with larger understatement of total calorie intake
for more obese individuals and to vary across food groups, with understatement especially
common for side dishes such as cooked vegetables and eggs (Willett 1998). Because this is
a potentially serious problem, I consider three alternative specifications to deal with attri-
tion. Column 4 restricts only to the first day of data for each individual in which attrition
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is less severe. Column 5 restricts to those product groups which Willett (1998) finds that
attrition is least problematic. Finally, Column 6 scales all estimates of nutrients and grams
consumed so that the estimated caloric intake is consistent with the mean bmi reported over
this period. These estimates are similar in magnitude to the estimates reported in main
text.
Column 7 reports estimates of the model with the individual-fixed effects included. The
estimates with individual-fixed effects are comparable to those obtained in the model in
which these are treated as a random effect.
Column 8 reports estimates of the model with the additional sub-product group / year
fixed effects discussed in footnote 8. Once again, the estimates are comparable to the baseline
case.
One important issue I have not yet addressed are impacts of the NLEA through avenues
other than nutrition labeling. In addition to mandating nutrition labeling of prepackaged
foods and altering the format of nutrition labels, the NLEA standardized the language
allowed for nutrient content claims elsewhere on the packaging. The standardization rules
apply to absolute nutrient claims (e.g. "low fat" requires 3 g of fat or less per serving),
relative nutrient claims (e.g. "Reduced Fat" requires 25% less fat than the reference food),
and health claims (only an existing list of health claims are allowed, and foods touting the
health benefits of a particular nutrient must meet the requirements for absolute health claims
for that nutrient) (Ippolito and Mathios 1993). After 1991, the FLAPS survey collected
information on the proportion of products in each product group making nutrition claims
in several different categories. This data is currently being processed, and once it is made
available it will be possible to control for nutrition claims as well.
A.5 Details of Behavioral Welfare Calculation
Provided Xi, {X , _XiJ, we can compute the solution to equation 1.15 by implicitly
differentiating the objective function in equation 1.15 and then substituting in for OV andfaN
O~Jfrom the first order conditions for equation 1.14. The benchmark parameters are then
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characterized by the system of linear equations:
(Sx)'q = 0 (A.13)
where S is the J x J matrix of marginal price effects defined by Ski = , xis the J x N
matrix of nutrient contents where Xyn gives the content of nutrient n in one gram of product j
and q is the J x 1 vector whose jth element is given by: qij = A - a - En ainzn. Definej ON-i3  ON13
W = (Sx)'. Equation A.13 defines a system of N equations, one for each nutrient, given by:
Ej way( 0  - - E a*Xn) = 0. If we divide these equations by J and take the limit
as J -+ oo, then we can write the benchmark parameters as a function E (wnna3 ( )
for each nutrient, which in turn depends on Cov(#3f Oh - Oh i, z%4), and E(zni)E(Oh -
# h ) for each nutrient n where zVni = E ' Nxn tells us how much a change in an will
impact consumption of product j.
I begin by describing the metric used to calculate the dollar cost of alternative diets
compared to diets which minimize health risk. Martin, Beshears, Milkman, Bazerman, and
Sutherland (2009) survey nutritional experts and elicit a health rating for each of 205 different
foods in light of their nutritional characteristics on a scale of -5 to 5. This rating is then
regressed on the underlying characteristics to recover the relative weight attached to different
nutrients by experts in evaluating food healthiness. The authors perform several additional
checks which suggest agreement among experts regarding the relative weights attached to
different nutrients. I use the weights recovered from this regression to evaluate the relative
importance of different nutrients in computing the distance of a given diet from the range of
benchmark healthy diets. Let Xn denote the minimum recommended consumption of nutrient
n in the benchmark diet and X, the maximal recommended consumption (for protein and
fiber, X. = 00). I compute the distance from a given diet d to the benchmark healthy diet
as:
w(d) = an max(Xd - X , X d 0) (A.14)
where 6n is the negative of the absolute value of the coefficient from the Martin et al. (2009)
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regression (this appropriately accounts for the fact that Fiber and Protein consumption
below the recommended level negatively impacts health). Thus, w(d) = 0 for any diet in
the benchmark range, and w(d) < 0 for diets outside the benchmark range. I scale w(d)
into life years by choosing a such that 1(d) =aw(d) and E(l(d)) across all consumers is .04
life-years. Finally, I convert this into a dollar amount based on estimates of the distribution
of the value of a statistical life. I start with an average VSL of $6.4 million (Viscusi and
Aldy 2003) and compute the value of each life year by assuming that there is a constant
value of a life year and that the VSL is the present discounted value of all additional life
years. That is, I solve, Ei(af -" 6tVyea ) = V* where the expectation is taken over all
individuals in the data, ai indicates age and T(ai) indicates life expectancy conditional on
age ai (this procedure is similar to that used in Gruber and Koszegi (2001). The value of
the marginal life-year is given by 6Ti-aiVyear. I assume 6 = .96. This value will vary across
consumers based on their age, but it implies that the average consumer loses about $3,000
worth of life-years by consuming their current diet rather than the healthiest possible diet (I
consider below the impact of allowing for some heterogeneity in the VSL). The result of this
calculation is a function which expresses the health cost of all diets in dollar terms which I
can use to determine the marginal health cost of all foods.
I next describe how I characterize consumers current beliefs about the life expectancy
consequences of alternative diets. I make use of consumers' answer to the following question:
"how many servings would you say a person of your age and sex should eat each day for
good health from food group [X}?" for each of grains, fruits, vegetables, dairy and meat and
poultry products. Because consumers may understand the word "serving" differently from
the official definition, I rescale all of their responses so that the total number of servings
indicated would match their food consumption in grams (which I assumed in the structural
model was fixed). This is a conservative assumption, in the sense that the only deviations
detectable between consumers' beliefs and the benchmark diet recommended by experts are
deviations in the relative consumption of different food groups. I consider two strategies
for characterizing a typical serving. In the first case, I assume that the nutrient profile of
a serving from each food group is the average profile constructed by weighting all foods in
that group by their proportion of group-consumption in grams. In the second case, I use the
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nutrient profile constructed using only those individuals who rank in the top 5% in terms of
the health of their consumption in the group in question. I report results from the first case;
the results in the second case are not appreciably different.
Define a set of indicator variables An which indicate the range into which X, falls (An
0 if X, <= Xn, An = 1 if Xn < X, < Xn , An= 2 if Xl <= Xn). We can write
h(d) =En [Sn(An)Xn + Qn(An)] where 6n (0) = -6n, 6n(1) = 0 and 6n(2) = 6n, and
Qn(0) S6nXn, Qn(1) = 0 and Qn(2) = -SonXn. For each food we can define hij(d) =
En [Son(An)xn + Q "(A with the property that hi(d) = Ej Nijhij(d). I normalize the
hi(d) by subtracting a constant so that the life expectancy consequences of the benchmark
diet are normalized to 0.
Define hi(A) as consumers beliefs about the marginal life expectancy consequence of
consuming a unit of food j given their current nutrient consumption (which is summarized
by A, as defined in Section 1.8.2). Let d* = (N*,..., N*) denote the benchmark diet rec-
ommended by experts and d' = (NI', ..., Nj) denote the diet consumers believe is healthiest.
Let A' = {An} evaluated at diet d' and A* = {An} evaluated at diet d*. To characterize
consumer beliefs over the entire range of possible nutrient intakes (that is, all possible A
rather than just A'), I assume that the hj(A 1 ) - hj(A 2) = hj(A 1 ) - hj(A 2 ). This is again
conservative in the sense that it assumes that consumers correctly evaluate changes in the
marginal value of food with respect to their overall nutrient intake.
I compute hj(A') for each food by minimizing the distance from hj(A') to hj(A') while
nonetheless rationalizing the judgment that the diet given by consumers is healthier than
the benchmark healthy diet recommended by experts. That is, I solve:
(h1, ... ,h) argmin E [Cov(hj(A') - hbj(A')),zn2 ) +( E(h1 (A') - b( A'))
(i--hJ) n
s.t. N'NI h(A') ;> N*Nh(A*) (A.15)
Because the benchmark is actually a range of risk-minimizing nutrient intakes rather than
a particular profile of food consumption, many different diets are consistent with this range.
For this reason, I also maximize equation A.15 over the set of diets (N*, ... , Nj) which are
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at least as healthy as the benchmark diet (i.e. E, Njhj 0, the normalized health of the
benchmark diet). That is, I solve:
(hi, h) - argmin.,j [Cov(hj(A') - N2(A')),zn3 ) + E(hj (A') - h (A')) s.t.
(Nh(A') > ZN; I(A* ), ( Nh (A*) > 0,( Nj =(f.16)
The second constraint, Ej Njhj > 0 states that candidate benchmark diet is consistent
with the range of values given in Table 1.8 (whose health value is normalized to 0). The
third constraint, Ej Nj = N, states that candidate benchmark diets must also have total
consumption in grams equal to a fixed constant.
This calculation results in estimate of hj (A), consumers' beliefs about the life expectancy
consequences of consuming a unit of each product j, expressed in dollar equivalents as a
function of current nutrient consumption from which I can directly compute the covariance
and expectation parameters of interest.
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Appendix Table A. 1: Impact of NLEA on Label Users
Specification Calories/Day
Model 1 -96.3
Model 2 -61.1
Model 3 -62.3
Model 4 -45.1
The reported value is the models projection of the
changed in calories consumed per day induced by
the NLEA for each model from Table 1.5.
Appendix Table A.2: Robustness of Willingness to Pay Estimates
(1) (2) (3) (4) (5) (6) (7) (8)
Calories -. 1078** -.0812** -. 1085** -.1251* -. 1415** -.1283** -. 1211** -.0895**
(.0260) (.0211) (.0241) (.0526) (.0401) (.0309) (.0114) (.0210)
Cholesterol -.0864 .0123 -.0710 -.0322 -. 1011* -. 1028 -.0913** -.0312
(.0648) (.0070) (.0510) (.0782) (.0415) (.0771) (.0315) (.0514)
Sodium -.0145* -.0110 -. 0209* .0252 .0215* -.0173* -.0155** -.0212*
(.0090) (.0140) (.0102) (.0442) (.0100) (.0107) (.0050) (.0108)
Column 1 replicates specification (1) in Table 1.5. Column 2 assigns labels randomly within
product group rather than by health. Column 3 includes an additional control for the
number of low fat substitutes. Column 4 restricts just to food consumption data from the
1st day, reported based on an in-person interview (the 24-hour recall data). Column 5
restricts to those product groups where attrition is least problematic in this type of data.
Column 6 scales all consumption to match a BMI benchmark. Column 7 includes individual
fixed effects. Column 8 includes sub-product group-year fixed effects.
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Appendix B
General Equilibrium Impact of
Information: Appendices
B.1 Proof of Proposition 1
The proof is as follows: consumers of type c will choose firm 1 if af(vi) - pi + Eii >
af (v 2 ) -p 2 +C 2 , or equivalently, aAv- Ap+Ac, > 0 where Av = f(vI) - f(v 2 ), Ap = Pi -P2
and Ac = eil - ei2. Let AE* = Ap - aAv. For Ac < Ac*, consumers will choose firm 1,
and for Aci > Ae*, consumers will choose firm 2. Social welfare is thus given by:
Loo [f 2 [f+v* f0_ 00 _0 V ~[(Vi) - ci + e(ilf (eii, - 2)desii i+ [f(v 2 ) - C2 + Ei2l fGil, Ci2)dci1 deAB.1)
a enters this equation implicitly via Ac*. Next, I show that we must have OA<* = Av -
aAP > 0. Suppose instead that ag* < 0. Then 9 > 0 and 'D1 < 0. Differentiating profit
functions with respect to own prices gives the first order condition: (pj - cj) O + Dj = 0.
Implicitly differentiating this with respect to a gives a& aD + (pj - cj). + - = 0 which0 w Pj r tgi
we can rearrange to give:
aD
a, - + (pg - cjLOn aDfn (noj.
Let F denote the dlistribuition function for A(.
8)ln (D.)) (B.2)
Then Di = F(aAv - Ap) and D 2 =
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1 - F(aAv - Ap), which implies 21 = D = -f(aAv - Ap). This implies that ap)
aPi UP2 a
is equal for both firms. By assumption, this term is negative, so mark-ups larger for firm
1 imply that the second term of equation B.2 is more negative for firm 1 than firm 2. But
since the first term is negative for firm 1 and positive for firm 2, this implies ' j- < ! and
O' 'P < 0. Since Av > 0, this implies: Av - a > 0 which is a contradiction. So we must
have: ay* > 0 as desired. Differentiating equation B.3 with respect to a thus gives:
S([f(v 1 ) - c1 + Ei2 + Ae*]f(Ei 2 + AE*, Ei2) - [f(v2 ) - c2 + Ei2]f(Ei2 + AE*, Ei2)) dci 2 =
([(1 - a)Av + (Ap - Ac)]f(Ci 2 + Ae*, Ci2)) dC2  (B.3)
Because mark-ups are higher for the higher quality firm, Ap - Ac > 0, so this expression
can only be zero if (1 - a)Av < 0 or a = a* > 1 as desired. Finally, note that for a < a*,
aSW > 0 as desired.
B.2 Proof of Proposition 2
The proof is as follows: profits for each firm are given by 7rj = (pj -cj )Dj. Differentiating with
respect to v gives the first-order condition: 2-= PJc,)Dj + (pj - cj) . Differentiating
once more gives:
-+ D + 0(p, - + (p --c ) (B.4)Ovj aj Ov Da 0aOv- Oa Dvj Ov~a
By the monotone comparative statics theorem in Milgrom and Roberts (1990), if this
expression is positive than we will have a > 0.
The following argument suffices to show that this expression is positive for both firms
(although in fact, fewer conditions are required for Firm 1). 1 start by considering the latter
two terms. Condition 2 of the theorem is equivalent to the claim that: 'aD > DD > 0.
Provided we have that: (pj - cj) > a(pc c , the sum of the last two terms will be positive.
This condition is equivalent to -cM, < a. Taking logs of the first-order condition of the
profit function with respect to pj gives ln(pj - cj) = ln(Dj) - ln(- ). Differentiating with
146
respect to a and multiplying both sides by negative a gives: -eM 3,a = D-,a +CaDj a where
Mj = pj - cj. The first term on the right-hand side is less than a and the second term is
less than 0 by assumption, so we have the desired result and the third and fourth terms of
equation B.4 sum to a positive number.
Next, consider the first two terms. Condition 1 of the theorem implies that - D, <aDo Dj
or -2 ' < Dj. The second term of equation B.4 will thus be larger than the first provided we
have: Dac) > "D(p.-c) We can equivalently write this condition as a a > 1. StartDOavi D9vi a
with the first-order condition of the profit function with respect to prices: (p, -cj) +D =
0. Differentiating this with respect to vj gives: (pj-c) (p -c ) , + which implies:av aP3 P7aja-
8(pj - c3 ) _
1Dvi
(jC)a2Dj aDj(pa - c ±) +
Dvj
ap3
Taking logs of both sides gives:
= ln (pj 
-
c 8) a2D .
cDpfv) - In -
BD)
api
The next step is to differentiate both sides of equation B.6. By assumption
(B.6)
-aa<0
so the second term is positive. The derivative with respect to a of the first term on the
03 Dj _
2 D
right-hand side is givey by: + 4" >
(jC)a 2Dj aDj(p,-c3 j )-'- --
a D3
o"j > 1 where the second inequality
follows by assumption and the first follows provided we have: (pj - cy) aD 3  > 0 and
(pj - cj )aa9 D < 0.
Start with: (pj - cj) a < 0. Differentiating the first order condition with respect to
pj for firm j with respect to v and rearranging implies that this expression has the same
sign as:
(p - c3 ) Dj +D
Oy3 Opy +oy
(B.7)
aD
From the first order condition of profits with respect to oi, we have: D(p" - "POV3 Dj
which plugged back into equation B.7 gives: DI D
OD,
= g[ >- 2D] < 0.-
1
147
In a(p- - cj)ln j
(B-5)
Next, consider: (pj - cj) aa > 0. Rearranging the definition of e_ and using the
fact derived above that-CM,,, = -Dj,a + COD, yields the equation:
OD-
_ _(_Dj,a 
- (M,,a) (B.8)
Denote the term in parentheses by q (and note that this is equal to com which is
less than 0 by assumption). Differentiating both sides with respect to v2 and denoting the
derivative of the elasticities in parentheses by q gives:
ani&3 Dj 1 &2Dj a__8
=pV& -a9q (B.9)Opj Ov, 09a az Opj Oy a 09vj
I showed above that aD I -< 0 so the first term in this expression is positive. Since
[ D 1
<0, we just need to show: < 0. We can get this as follows: [D ,a
aPi aDy_5 3  Dj avj Dj
F a(p3  c3 ) 1
a P~ - -L1 + . Comparing these two quantities, we get the inequality:
Bln D F~ BlnD1 Bln(pj - cj) 1 _ D(p - c3)la j a I >a a (B.10)
This equation holds if: aInDj > aln(p"-c3 ) and - alnD > -a(p c). Taking logs of the
first-order condition with respect to own-price and differentiating with respect to v2 and a
respectively yields the desired results given the assumptions that: c_ D' < 0 and the above
ap 3
result that 2 D2 < 0.
B.3 Specific Example Calculations
B.3.1 The Social Planner's Problem
Let t denote the distance of a consumer from firm 1. It is efficient for a consumer of type t
to purchase from firm 1 rather than firm 2 if: Ovi - dt - c1v 2 > 0v 2 - d(j - t) - c2 v2 which
yields t* = where Ac = civ,- C2 vY. Ignoring transportation costs, if everyone
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purchased the good from the nearest firm, social welfare would be given by: O(V+V 2 )-Ac2
This expression misstates social welfare since consumers located at distances between 1/2
and t*, purchase from firm 1 rather than firm 2. Thus, we need to add: 2(t* - 1/2) -
(GAv - Ac) =(OAv - Ac - 4)(OAv - Ac). Finally, we need to add in transportation costs,
dt* + d(1/2t) _ d-2dt* _ +Ac-OAv. Combining these gives the expression:
O(v1 + v2 ) - Ac 1 [(OA d (OA A OAv -,Ac = dSW = + - (6 -Ac)2 -(Av-Ac) -2_ (B. 11)
2 d 2 4
Differentiating this expression gives the optimal quantities: vi = - and v2 = 0-
B.3.2 Calculation of Allocative and Productive Inefficiencies
More generally, demand for firm 1 in the competitive case is given by: Du" - I + a3AV1 /C
while the social planner would choose DSP - 1 + OAv-A. The welfare loss is given by (D5 P -
Dce)(OAv - Ac - E[dt - d(1/2 - t)]). The average t for a switcher between the competitive
and social planner's allocation is: ts''tc= DsP+Dce So E[dt - d(1/2 - t)] = 2dE[t] -d =2 4 2
dD8P+Dcc-1. DsP - De _ (3-a)O0v-2Ac D"P + Dce - 1 = (3+a)OAv-4Ac. dDsP+Dce-1 _2 3d 3d 2
(3+a)OAv-4Ac so (GAv - Ac - E[dt - d(1/2 - t)]) = 6-Q"0AC
1
SW(sp(ce), ce) - SW(ce(ce), ce) = ((3 - a)6Av - 2Ac) 2
18d
04 (C2 
- c1)2 )2
=)(a(3 - 2a)) (B.12)72d(cic 2)2
When firms have symmetric costs, they produce the same quality and charge the same
prices, so consumers always travel to the closest firm and there is no allocative inefficiency.
As the degree of horizontal differentiation increases, the allocative inefficiency decreases.
The price difference between the two firms is unaffected by the degree of differentiation, but
as firms become more differentiated horizontally, demand for each firm moves closer to 1/2
regardless of the cost differences. Thus, allocative inefficiency is actually more problematic
for more competitive firms in this sense, because consumers more readily purchase the wrong
product.
More generally, demand for firm 1 in the competitive case is given by: De - +
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aOAo-Ac while the social planner would choose DSP - 1 + OAv-AV. The welfare loss is given
by (DsP - Dce)(OAv - Ac - E[dt - d(1/2 - t)}). The average t for a switcher between
the competitive and social planner's allocation is: t5s+tce - DsP+Dce . So E[dt - d(1/2 -
t)] = 2dE[t] - .= dDsP+Dce-. DsP - Dce - (3-a)OAv-2Ac. D"P + Dce _ 1 (3+c)OAv-4Ac2 2 3d 3d
d_?_ce-1_ (3+a)6Av-4Ac so (OAv - Ac - E[dt - d(1/2 - t)]) = (-a)afv-2Ac
Next, let us consider productive inefficiencies. For consumers between 0 and tP"( ) and
between tsP('P) and 1, there is no change in allocation between the (sp(sp), sp) world and the
(sp(ce), ce) world. The only change in utility comes from the change in quality. The impact of
this change on utility is given by: 2tsP(ce)(O(v"P - ie)) + (1- 2tsP(sP))(6(v"p - voe). Consumers
between tSP(ce) and tsP('P) move from firm 2 to firm 1 and experience a change in quality.
Their change in utility is thus given by: 2(tsP(sP) - tsp(ce))(9(v"P - vce) - E[dt - d(1/2 - t)]).
The average t for a switcher is: tSP(SP)+tsp(ce) . So E[dt - d(1/2 - t)] = 2dE[t] - d(tP("P) +
tsp(ce) - OAV Ac P OAvceAcc+ 2 0 (C2 Cl). So in total, we have:
ASW = 2tsP(ce)(O(v1" - vie)) + (1 - 2t"P("P) )((v"P - vce) +
2(tsP(sP) -tP(ce) 6( P - 17ce) - OAVp - AcsP + OAvce - Acce (B.13)1 2k~ 2 )(.3
sP(ce) - 2AV Acc+ C_1a c2-Ci (vp - ce) - 2(1- 1 - sp(sp) -
d 2 2d 2 (C1 C2 z 2ci
Acspg-OAvP+ 2 c o 2-C1
d 2 4d CI2 *
SW(sp(sp), sp) - SW(sp(ce),ce) =
02(1 - a) 2 (c
2 2 ((CI - c2 )202(1 - a) 2 + 4dcic2 (c1 + c2 )) (B.14)32dc c 2
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